You are on page 1of 723

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dev Madhok Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: Blood
IRON 14

Age/Sex: 69y/Male MRN:SH/LKO/002657/08/09 Lab No.:B-09/04/485 Date: 16/4/2009


g/dl Male 59-158
Female 35-150

T.I.B.C

415

g/dl

35-150

% Saturation

3.4

20-55

*Levels of serum Iron is lower in iron deficiency , also in infections and in anemia of chronic disease,while serum Iron Binding Capacity is increased in iron deficiency anemia and is normal or decreased in anemia of chronic disease.If chronic infection coexists with chronic blood loss,the TIBC may be decreased ,even though the patient is iron deficient %Saturation of TIBC is the ratio of serum iron toTIBC.It is the percent saturation of TIBC.Normally this is 20-55%;values below 15% indicate iron deficient erythropoiesis
The test was performed at RELIGARE SRL Diagnostics

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Prashant Tripathi Pt. Location: EMERGENCY Referred By: Dr. Specimen: Blood

Age/Sex: 32 yrs/M MRN: SH/LK000398/08-09 Lab No.:B-09/02/0145 Date: 15-02-2009

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Pushplata Tiwari Pt. Location: OPD Referred By: M.H.C Specimen: Blood Tr.No.7350 PARAMETER RESULT Age/Sex: 43y/F MRN:SH/LKO/007794/09 Lab No.:B-/08/1223 Date: 18.8.2009 REFERENCE RANGE

UNIT

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Abhinandan Swaroop Pt. Location: IPD/Neuro.ICU Referred By: Dr.Abhishek Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 67y/M MRN:SH/LKO/007651/09 Lab No.:B-/08/1387 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

118 2.49

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Sodium Serum Potassium

137.0 3.3

nmol/l nmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Girja Shanker Tripathi Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Age/Sex: 62y/M MRN:SH/LKO/007765/09 Lab No.:B-/08/1389 Date: 20.8.2009 REFERENCE RANGE

UNIT

Blood Sugar Fasting

151.6

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Girja Shanker Tripathi Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
206 mg/dl

UNIT

Age/Sex: 62y/M MRN:SH/LKO/007765/09 Lab No.:B-/08/1389 Date: 20.8.2009 REFERENCE RANGE

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 190 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 40 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

128

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

38

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.15

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.2

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Anarpati Pt. Location: IPD/E.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Age/Sex: 60y/F MRN:SH/LKO/007920/09 Lab No.:B-/08/1392 Date: 20.8.2009 REFERENCE RANGE

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

128 3.6

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Sodium Serum Potassium

156.0 3.7

nmol/l nmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

128

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Upasana Pt. Location: OPD Referred By: Dr.Anjali Somani Specimen: Blood PARAMETER RESULT Age/Sex: 31y/F MRN:SH/LKO/007445/09 Lab No.:B-/08/1311 Date: 19.8.2009 REFERENCE RANGE

UNIT

ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 79.8 97.2 90.6 mg/dl mg/dl mg/dl 95 180 155

*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Upasana Pt. Location: OPD Referred By: Dr.Anjali Somani Specimen: Blood PARAMETER RESULT Age/Sex: 31y/F MRN:SH/LKO/007445/09 Lab No.:B-/08/1311 Date: 19.8.2009 REFERENCE RANGE

UNIT

ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 79.8 97.2 90.6 mg/dl mg/dl mg/dl 95 180 155

*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Ratna Mukharjee Pt. Location: IPD/E.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Age/Sex: 54y/F MRN:SH/LKO/007612/09 Lab No.:B-/08/1393 Date: 20.8.2009 REFERENCE RANGE

UNIT

Blood Sugar Post Prandial

201.8

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Dinesh Bajpai Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 65y/M MRN:SH/LKO/007336/09 Lab No.:B-/08/1403 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

59 0.85

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shanti Devi Pt. Location: IPD/N.ICU Referred By: Dr.M.Husain Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 32 0.61

UNIT mg/dl mg/dl

Age/Sex: 60y/F MRN:SH/LKO/007741/09 Lab No.:B-/08/1404 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Sodium Serum Potassium

142.0 3.40

nmol/l nmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shanti Devi Age/Sex: 60y/F Pt. Location: IPD/N.ICU MRN:SH/LKO/007741/09 Referred By: Dr.M.Husain Lab No.:B-/08/1404 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.39 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.09 0.3

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

54

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

62

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

104

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.28

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.22 3.06 1.06

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Santosh Kumar Sahu Age/Sex: 29y/M Pt. Location: IPD/G.W MRN:SH/LKO/007925/09 Referred By: Dr.M.Ahamad Lab No.:B-/08/1406 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.29 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.1 0.19

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

36

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

34

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

106

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.14

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.73 3.41 1.09

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Santosh Kumar Sahu Pt. Location: IPD/G.W Referred By: Dr.M.Ahamad Specimen: Blood PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 29y/M MRN:SH/LKO/007925/09 Lab No.:B-/08/1406 Date: 20.8.2009 REFERENCE RANGE

97.92 11.83

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Sodium Serum Potassium

139.0

nmol/l nmol/l

135 - 145 3.5 - 5.5

2.90

Serum Calcium Ionized :

0.81

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Shubhadra Pandey Pt. Location: IPD/P.ICU Referred By: Dr.M.U.Hasan. Specimen: Blood PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)

UNIT
mg/dl mg/dl mg/dl

Age/Sex: NB/F MRN:SH/LKO/001408/09 Lab No.:B-/08/1408 Date: 20.8.2009 REFERENCE RANGE


0.30 - 1.20 0 - 0.20 0.08 - 0.75

12 0.6 11.4

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

C reactive protein(C.R.P)

< 3.08

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.

Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Gudiya Pt. Location: IPD/P.ICU Referred By: Dr.M.U.Hasan. Specimen: Blood PARAMETER Spot urine Chloride Age/Sex: NB/F MRN:SH/LKO/007666/09 Lab No.:B-/08/1409 Date: 20.8.2009 REFERENCE RANGE

RESULT 109

UNIT

mmol/l

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast Ankit Pt. Location: IPD/MICU Referred By: Dr.M..Husain. Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 31 0.56

UNIT mg/dl mg/dl

Age/Sex: 15y/M MRN:SH/LKO/007559/09 Lab No.:B-/08/1410 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Sodium Serum Potassium

135.0 5.20

nmol/l nmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mrs.Asha Rawat Pt. Location: IPD/E.W Referred By: Dr.Sandeep Specimen: Blood PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic

RESULT 16.9

UNIT mg/dl

Age/Sex: 28y/F MRN:SH/LKO/007649/09 Lab No.:B-/08/1419 Date: 20.8.2009 REFERENCE RANGE

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.56

mg/dl

0.70 - 1.30

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surendra Kumar Pt. Location: OPD Referred By: MHC Age/Sex: 45y/M MRN:SH/LKO/007583/09 Lab No.:B-/08/1405

Specimen: Blood PARAMETER Blood Urea Nitrogen


Method Urease GLDH Kinetic

Tr.No-7281 RESULT 13.13 0.76 8.58 2.62

UNIT mg/dl mg/dl mg/dl mg/dl

Date: 20.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

4.16

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.16

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surendra Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood Tr.No-7281 Age/Sex: 45y/M MRN:SH/LKO/007583/09 Lab No.:B-/08/1405 Date: 20.8.2009

PARAMETER

RESULT

UNIT

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 5.6% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surendra Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood Tr.No-7281 Age/Sex: 45y/M MRN:SH/LKO/007583/09 Lab No.:B-/08/1405 Date: 20.8.2009

PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay)

RESULT

UNIT

REFERENCE RANGE

110

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

54.7

apo-A1/apo-B Ratio

2.01

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surendra Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood Tr.No-7281 Age/Sex: 45y/M MRN:SH/LKO/007583/09 Lab No.:B-/08/1405 Date: 20.8.2009

PARAMETER

RESULT

UNIT

REFERENCE RANGE

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

0.46 0.12 0.35

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

13.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

22.5

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

51.7

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.29

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.1 3.18 1.29

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs .Promita Chakraborty Pt. Location: OPD Referred By: Dr.Manjusha Specimen: Blood Tr.No-19609 Age/Sex: 27y/F MRN:SH/LKO/004163/09 Lab No.:B-/08/1401 Date: 20.8.2009

PARAMETER

RESULT

UNIT

REFERENCE RANGE

ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 97 144 122 mg/dl mg/dl mg/dl 95 180 155

*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Vishal Verma Pt. Location: OPD Referred By: Dr.P.K.Shamshery Specimen: Blood Tr.No-19609 Age/Sex: 37y/M MRN:SH/LKO/007939/09 Lab No.:B-/08/1395 Date: 20.8.2009

PARAMETER
C reactive protein(C.R.P)

RESULT 15.8

UNIT

REFERENCE RANGE

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.

Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009

PARAMETER Blood Sugar Fasting

RESULT 100.0

UNIT mg/dl

REFERENCE RANGE 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

118.0

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10 0.95 9.45 3.07

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

7.4

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.22

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009

PARAMETER

RESULT

UNIT

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.2 5.6% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009

PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay)

RESULT

UNIT

REFERENCE RANGE

159

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

80

apo-A1/apo-B Ratio

1.98

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009

PARAMETER

RESULT

UNIT

REFERENCE RANGE

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

0.72 0.25 0.48

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

12.1

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

19.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

80

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.5

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.51 2.99 1.51

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Sumit Ranjan Pt. Location: OPD Referred By: MHC Specimen: Blood Age/Sex: 40y/M MRN:SH/LKO/007933/09 Lab No.:B-/08/1397 Date: 20.8.2009

PARAMETER

RESULT
LIPID PROFILE

UNIT

REFERENCE RANGE

Total Serum Cholesterol

180.9

mg/dl

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 153.9 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 61.4 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

88.8

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

30.79

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.95

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.45

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE

UNIT

Blood Sugar Fasting

84.5

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

116.1

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

7.1 0.79 9.52 2.46

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

3.47

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.24

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.2 6.1% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE

UNIT

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 128

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

83.7

apo-A1/apo-B Ratio

1.52

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE

UNIT

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

0.54 0.15 0.39

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

53

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

22

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

68.4

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.2

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.58 2.62 1.75

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Anil Kumar Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 48y/M MRN:SH/LKO/007923/09 Lab No.:B-/08/1398 Date: 20.8.2009 REFERENCE RANGE

UNIT

LIPID PROFILE
Total Serum Cholesterol
169.8 mg/dl

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 101.5 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 43.9 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

105.6

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

20.31

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.87

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.41

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 91.1 Age/Sex: 46y/F MRN:SH/LKO/007924/09 Lab No.:B-/08/1402 Date: 20.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

112

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

8.04 0.58 9.1 3.24

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

6.85

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.15

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Age/Sex: 46y/F Pt. Location: OPD MRN:SH/LKO/007924/09 Referred By: MHC Lab No.:B-/08/1402 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl 0.30 - 1.20

(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.20

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

10

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

12

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

112

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.48

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.33 3.15 1.37

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
LIPID PROFILE

UNIT

Age/Sex: 46y/F MRN:SH/LKO/007924/09 Lab No.:B-/08/1402 Date: 20.8.2009 REFERENCE RANGE

Total Serum Cholesterol

172 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 143 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 48.3 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

95.4

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

28.6

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.57

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.98

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
ApolipoProtein Estimation

UNIT

Age/Sex: 46y/F MRN:SH/LKO/007924/09 Lab No.:B-/08/1402 Date: 20.8.2009 REFERENCE RANGE

Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay)

149

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

77.8

apo-A1/apo-B Ratio

1.91

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saroj Chaudhary Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 46y/F MRN:SH/LKO/007924/09 Lab No.:B-/08/1402 Date: 20.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 5.7% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ram Shankar Mishra Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 120 Age/Sex: 41y/M MRN:SH/LKO/007935/09 Lab No.:B-/08/1400 Date: 20.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

9.38

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.62

mg/dl

0.70 - 1.30

Serum Calcium
(Method: arsenazo III)

9.25

mg/dl

8.4- 10.4

Serum Uric Acid


(Method : Uricase-POD)

6.63

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.18

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ram Shankar Mishra Age/Sex: 41y/M Pt. Location: OPD MRN:SH/LKO/007935/09 Referred By: MHC Lab No.:B-/08/1400 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.40 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.30

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

103

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

60

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

116

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.91

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.83 3.07 1.57

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ram Shankar Mishra Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
235.1 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 41y/M MRN:SH/LKO/007935/09 Lab No.:B-/08/1400 Date: 20.8.2009 REFERENCE RANGE

Serum Triglycerides 229.7 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 41.7 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

147.7

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

45.94

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.63

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.53

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 99 Age/Sex: 27y/M MRN:SH/LKO/007883/09 Lab No.:B-/08/1399 Date: 20.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

8.13

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.62

mg/dl

0.70 - 1.30

Serum Calcium
(Method: arsenazo III)

9.71

mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

2.79

mg/dl

2.5 - 4.5
2.5 6.8

Serum Uric Acid


(Method : Uricase-POD)

7.2

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.2

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Age/Sex: 27y/M Pt. Location: OPD MRN:SH/LKO/007883/09 Referred By: MHC Lab No.:B-/08/1399 Specimen: Blood Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.53 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.15

mg/dl

0 - 0.20

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

0.38

mg/dl

0.08 - 0.75

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

35

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

25

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

110

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.30

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.71 3.64 1.29

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
187.2 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) 97 mg/dl

UNIT

Age/Sex: 27y/M MRN:SH/LKO/007883/09 Lab No.:B-/08/1399 Date: 20.8.2009 REFERENCE RANGE

Serum Triglycerides (Method-GPO-PAP)

(Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 39 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

128.8

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

19.41

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.8

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.3

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 121

UNIT

Age/Sex: 27y/M MRN:SH/LKO/007883/09 Lab No.:B-/08/1399 Date: 20.8.2009 REFERENCE RANGE

142 105

mg/d mg/dl mg/d mg/dl

115 115210 210 55 135

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

95.3

apo-A1/apo-B Ratio

1.26

1.35

Ratio Ratio

0.91 0.91 2.63 2.63

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amit Kumar Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 27y/M MRN:SH/LKO/007883/09 Lab No.:B-/08/1399 Date: 20.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8

8.6 5.8% %

A 1C

(%)

Degree of Glucose Control Action Suggested

<7 4 -- 6

Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Raja Singh Pt. Location: OPD Referred By: Dr. I.Tyagi Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 30 0.85

UNIT mg/dl mg/dl

Age/Sex: 37y/M MRN:SH/LKO/00/09 Lab No.:B-/08/1426 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. G.S Triphati Pt. Location: IPD/G/W Referred By: Dr Specimen: BLOOD PARAMETER Age/Sex: 56/M MRN:SH/LKO/007785/08/09 Lab No.:B-/08/1424 Date: 20.8.2009 REFERENCE RANGE

RESULT

UNIT

Blood Sugar Post Prandial

214.0

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Surender Bahadev Pt. Location: IPD/G/W Referred By: Dr. I.Tygi Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 90 Age/Sex: 32/M MRN:SH/LKO/007748/08/09 Lab No.:B-/08/1425 Date: 20.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.89

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 222 6.37

UNIT mg/dl mg/dl

Age/Sex: 51/M MRN:SH/LKO/006354/08/09 Lab No.:B-/08/1427 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

121.0 4.70

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Avi Age/Sex: 8y/M Pt. Location: IPD/ PICU MRN:SH/LKO/006693/08/09 Referred By: Dr. M.U Hasan Lab No.:B-/08/1428 Specimen: BLOOD Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.40 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.30

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin

(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

27

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

21

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

231

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.83

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.98 2.85 1.05

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Avi Pt. Location: IPD/ PICU Referred By: Dr. M.U Hasan Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic

RESULT 14.56

UNIT mg/dl

Age/Sex: 8y/M MRN:SH/LKO/006693/08/09 Lab No.:B-/08/1428 Date: 20.8.2009 REFERENCE RANGE

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.35

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

132.0 4.40

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1429 Date: 20.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

156.0 3.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kamlesh Kumari Pt. Location: IPD/ MICU Referred By: Dr. R. Kohli Specimen: BLOOD PARAMETER RESULT Age/Sex: 35y/F MRN:SH/LKO/007860/08/09 Lab No.:B-/08/1430 Date: 20.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

136.0 3.70

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fzhar Ahmed Pt. Location: IPD/ G/W Referred By: Dr. P.Gupta Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 47y/F MRN:SH/LKO/007958/08/09 Lab No.:B-/08/1423 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

28 0.87

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fzhar Ahmed Age/Sex: 47y/F Pt. Location: IPD/ G/W MRN:SH/LKO/007958/08/09 Referred By: Dr. P.Gupta Lab No.:B-/08/1423 Specimen: BLOOD Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.20

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

31

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

28

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

163

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.0

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.94 4.06 0.97

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vishi Devi Pt. Location: IPD/ M.I.C.U Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

RESULT 0.52

UNIT mg/dl

Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1434 Date: 20.8.2009 REFERENCE RANGE 0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium

146.0

mmol/l

135 - 145

Serum Potassium

3.3

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Rukaiya Baua Pt. Location: IPD/ G/W Referred By: Dr. Rajesh Arora Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 92.1 Age/Sex: 30y/F MRN:SH/LKO/007837/08/09 Lab No.:B-/08/1435 Date: 20.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ramesh Kumar Pt. Location: IPD/ E/W Referred By: Dr. Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 55y/M MRN:SH/LKO/005994/08/09 Lab No.:B-/08/1436 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

122.4 1.31

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

126.0 3.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ramesh Kumar Age/Sex: 55y/M Pt. Location: IPD/ E/W MRN:SH/LKO/005994/08/09 Referred By: Dr. Somani Lab No.:B-/08/1436 Specimen: BLOOD Date: 20.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 18.18 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

15.25 2.93

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)

103.8

IU/I

0 - 42

(Method: IFCC Without Pyridoxal Phosphate))

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

165.3

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

147.2

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.32

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

1.99 3.33 0.60

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Izahar Ahmed Pt. Location: IPD/ G/W Referred By: Dr. Puneet Gupta Specimen: BLOOD PARAMETER RESULT Age/Sex: 47y/M MRN:SH/LKO/007958/08/09 Lab No.:B-/08/1437 Date: 20.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

138.0 3.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Avtar Dwivedi Pt. Location: OPD Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Sugar Fasting 108.5 Age/Sex: 45y/M MRN:SH/LKO/002004/08/09 Lab No.:B-/08/1461 Date: 21.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

183.7

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.47

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

140.0 3.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sunita Malhotra Pt. Location: IPD/MICU Referred By: Dr. S.K.Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl U/L U/L

Age/Sex: 54y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1442 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30 28 - 100 13 - 60

277.5 2.71 111.2 148

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Amylase Serum Lipase

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

153.0 3.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sunita Malhotra Age/Sex: 54y/F Pt. Location: IPD/MICU MRN:SH/LKO/007253/08/09 Referred By: Dr. S.K.Somani Lab No.:B-/08/1442 Specimen: BLOOD Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 3.09 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

2.44 0.65

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

48.6

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

46.5

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

84.3

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.98

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.64 3.34 0.79

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Hari Shanker Shukla Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 70y/M MRN:SH/LKO/007921/08/09 Lab No.:B-/08/1443 Date: 21.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

133.0 4.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 38y/M MRN:SH/LKO/007836/08/09 Lab No.:B-/08/1444 Date: 21.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

143.0 3.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kamlesh Kumari Pt. Location: IPD/MICU Referred By: Dr.Vaibhav Khanna Specimen: BLOOD PARAMETER RESULT Age/Sex: 35y/F MRN:SH/LKO/007860/08/09 Lab No.:B-/08/1445 Date: 21.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

137.0 3.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Rasna Devi Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic

RESULT 8.86 0.53

UNIT mg/dl mg/dl

Age/Sex: 85y/F MRN:SH/LKO/006643/08/09 Lab No.:B-/08/1446 Date: 21.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

134.0 3.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Ankit Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 15y/M MRN:SH/LKO/007559/08/09 Lab No.:B-/08/1448 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

25.3 0.45

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

133.0 4.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Brij Nath Yadav Pt. Location: IPD/MICU Referred By: Dr.Sandeep Agarwal Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 45y/M MRN:SH/LKO/007653/08/09 Lab No.:B-/08/1449 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

240 8.15

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 4.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Tara Singh Pt. Location: OPD Referred By: Dr.Self Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

Tr.No,2108 RESULT 49.2 1.35

UNIT mg/dl mg/dl

Age/Sex: 51y/F MRN:SH/LKO/006664/08/09 Lab No.:B-/08/1394 Date: 20.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Vishi Devi Pt. Location: IPD/MICU Referred By: Dr. Specimen: BLOOD PARAMETER Serum Sodium Serum Potassium Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1450 Date: 21.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5

RESULT 143.0 3.2

UNIT mmol/l mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Rawat Pt. Location: IPD/E.W Referred By: Dr.Sandeep Agarwal Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 28y/F MRN:SH/LKO/007649/08/09 Lab No.:B-/08/1451 Date: 21.8.2009 REFERENCE RANGE

50.38 1.06

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

143.0 4.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Ratna Mukharjee Pt. Location: IPD/E.W Referred By: Dr.Swadesh Singh Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 52y/F MRN:SH/LKO/007612/08/09 Lab No.:B-/08/1451 Date: 21.8.2009 REFERENCE RANGE

18.71 1.37

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

134.0 4.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Abhinandan Pt. Location: IPD/N.ICU Referred By: Dr.Abhishek Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic

RESULT 57.2 2.33

UNIT mg/dl mg/dl

Age/Sex: 19y/M MRN:SH/LKO/007651/08/09 Lab No.:B-/08/1453 Date: 21.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

138.0 3.2

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.G.C.Metha Pt. Location: IPD/M.ICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 30.9 0.78

UNIT mg/dl mg/dl

Age/Sex: 80y/M MRN:SH/LKO/007405/08/09 Lab No.:B-/08/1454 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kamla Kapoor Pt. Location: IPD/T.ICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 72y/F MRN:SH/LKO/007617/08/09 Lab No.:B-/08/1455 Date: 21.8.2009 REFERENCE RANGE

43.83 3.82

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

132.0 3.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sushma Pandey Pt. Location: IPD/SICU Referred By: Dr.Swadesh Singh Specimen: BLOOD PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007236/08/09 Lab No.:B-/08/1457 Date: 21.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

137.0 3.2

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Avadesh Narain Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 56y/M MRN:SH/LKO/007658/08/09 Lab No.:B-/08/1458 Date: 21.8.2009 REFERENCE RANGE

31 2.28

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

134.0 3.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shakuntla Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 85y/F MRN:SH/LKO/007538/08/09 Lab No.:B-/08/1459 Date: 21.8.2009 REFERENCE RANGE

38.05 2.13

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

124.0 3.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Anita Chatarjee Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 70y/F MRN:SH/LKO/006912/08/09 Lab No.:B-/08/1460 Date: 21.8.2009 REFERENCE RANGE

47.9 0.42

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

121.0 3.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ramesh Kumar Puri Age/Sex: 55y/M Pt. Location: IPD/CCU MRN:SH/LKO/007985/08/09 Referred By: Dr.S,K,Somani Lab No.:B-/08/1462 Specimen: BLOOD Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 18.83 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

14.46 4.38

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

106.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

174.5

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

144.5

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.43

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

1.98 3.54 0.57

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ramesh Kumar Puri Pt. Location: IPD/CCU Referred By: Dr.S,K,Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 55y/M MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1462 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

115 1.61

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sunanda Sudhir Pt. Location: OPD Referred By: Dr.Himani Negi Specimen: BLOOD Tr.No.19772 PARAMETER RESULT Age/Sex: 32y/F MRN:SH/LKO/007001/08/09 Lab No.:B-/08/1463 Date: 21.8.2009 REFERENCE RANGE

UNIT

Blood Sugar Fasting

77.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Safiya Begam Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD Tr.No.19963 PARAMETER RESULT Blood Sugar Random 137.3 Age/Sex: 65y/F MRN:SH/LKO/007132/08/09 Lab No.:B-/08/1478 Date: 21.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.02

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 4.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.23 PARAMETER RESULT Blood Sugar Fasting 80 Age/Sex: 41y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1465 Date: 21.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

7.4 0.8 8.9 3.9

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

3.5

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.15

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Age/Sex: 41y/F Pt. Location: OPD MRN:SH/LKO/007985/08/09 Referred By: MHC Lab No.:B-/08/1465 Specimen: BLOOD Tr.No.23 Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.42 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.12 0.3

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

20

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

18

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

66

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.2

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.2 3 1.4

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.23 PARAMETER RESULT
Total Serum Cholesterol

UNIT

Age/Sex: 41y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1465 Date: 21.8.2009 REFERENCE RANGE

146 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 93 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 35 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

92.4

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

18.6

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.17

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.64

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.23 PARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 112

UNIT

Age/Sex: 41y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1465 Date: 21.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

86.3

apo-A1/apo-B Ratio

1.29

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Ranjan Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.23 PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1465 Date: 21.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

5.6%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.24 PARAMETER RESULT Blood Sugar Fasting 83 Age/Sex: 49y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1466 Date: 21.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

16.1 0.84 8.66 3.82

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

5.2

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.14

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Age/Sex: 49y/F Pt. Location: OPD MRN:SH/LKO/007985/08/09 Referred By: MHC Lab No.:B-/08/1466 Specimen: BLOOD Tr.No.24 Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.03 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.2 0.83

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

53

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

45

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

99

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.45

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.1 3.35 1.22

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.24 PARAMETER RESULT
Total Serum Cholesterol

UNIT

Age/Sex: 49y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1466 Date: 21.8.2009 REFERENCE RANGE

160 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 117 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 44 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

92.6

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

24.4

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.63

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.1

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.24 PARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 149

UNIT

Age/Sex: 49y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1466 Date: 21.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

92

apo-A1/apo-B Ratio

1.61

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Poonam Saluja Pt. Location: OPD Referred By: MHC Specimen: BLOOD Tr.No.24 PARAMETER RESULT Age/Sex: 49y/F MRN:SH/LKO/007985/08/09 Lab No.:B-/08/1466 Date: 21.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.2%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Chandani Shukla Pt. Location: OPD Referred By: Dr.Manjusha Specimen: BLOOD Tr.No.19895 PARAMETER RESULT Blood Sugar Random 82.5 Age/Sex: 30y/F MRN:SH/LKO/007981/08/09 Lab No.:B-/08/1467 Date: 21.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Calcium
(Method: arsenazo III)

8.78 4.45

mg/dl mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Urea
Methodology- Urease- GLDH, Kinetic

23 0.75

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

138.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD)

Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Chandani Shukla Age/Sex: 30y/F Pt. Location: OPD MRN:SH/LKO/007981/08/09 Referred By: Dr.Manjusha Lab No.:B-/08/1467 Specimen: BLOOD Tr.No.19895 Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.53 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.14 0.39

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

29

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

25

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

46

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.61

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.30 3.31 1.29

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Chandani Shukla Pt. Location: OPD Referred By: Dr.Manjusha Specimen: BLOOD Tr.No.19895 PARAMETER RESULT
C reactive protein(C.R.P)

UNIT

Age/Sex: 30y/F MRN:SH/LKO/007981/08/09 Lab No.:B-/08/1467 Date: 21.8.2009 REFERENCE RANGE

<3.08

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER Blood Sugar Random Age/Sex: 57/M MRN:SH/LKO/006354/08/09 Lab No.:B-/08/1468 Date: 21.8.2009 REFERENCE RANGE 70 - 140

RESULT 97.8

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

92.5

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

6.54

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

123.0 4.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Gudiya Pt. Location: IPD/P.ICU Referred By: Dr.M.U.Hasan. Specimen: Blood PARAMETER Serum Calcium
(Method: arsenazo III)

RESULT 8.6 28 0.36

UNIT mg/dl mg/dl mg/dl

Age/Sex: NB/F MRN:SH/LKO/007666/09 Lab No.:B-/08/1469 Date: 21.8.2009 REFERENCE RANGE 8.4- 10.4 13 - 43 0.70 - 1.30

Serum Urea
Methodology- Urease- GLDH, Kinetic

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 5.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O.Subhdra Pt. Location: IPD/P.ICU Referred By: Dr.M.U.Hasan. Specimen: Blood PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)

RESULT 11.68 0.60 11.08

UNIT mg/dl mg/dl mg/dl

Age/Sex: NB/F MRN:SH/LKO/007784/09 Lab No.:B-/08/1470 Date: 21.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

q
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Prakash Lal Age/Sex: 84y/M Pt. Location: OPD MRN:SH/LKO/006773/09 Referred By: Dr.Swadesh Lab No.:B-/08/1471 Specimen: BLOOD Tr.No.19922 Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.19 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.50 0.69

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

29

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

33

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

125

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.70

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.90 3.80 1.0 101.7

g/dl 1.74 g/dl 2.56 ratio mg/dl

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1 70 - 140

Serum Globulin A/G Ratio Blood Sugar Random

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Subhash Chandra Pt. Location: IPD/G.W Referred By: Dr.S.Garg Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 99.3 Age/Sex: 51/M MRN:SH/LKO/007928/09 Lab No.:B-/08/1472 Date: 21.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

26 1

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Pt. Location: IPD/E.W Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 71 1.30

UNIT mg/dl mg/dl

Age/Sex: 47/F MRN:SH/LKO/008004/09 Lab No.:B-/08/1473 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Age/Sex: 47/F Pt. Location: IPD/E.W MRN:SH/LKO/008004/09 Referred By: Dr.S.K.Somani Lab No.:B-/08/1473 Specimen: Blood Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 13.43 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

10.14 3.10

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

51

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

105

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

358

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

4.35

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.10 2.25 0.93

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Shanti Singh Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 70y/F MRN:SH/LKO/007995/09 Lab No.:B-/08/1475 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

38 1.2

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Urine microalbumin Urine Microalbumin 2.81 mg/ L <20mg/L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Shanti Singh Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 70y/F MRN:SH/LKO/007995/09 Lab No.:B-/08/1475 Date: 21.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.4%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Ayub Khan Pt. Location: IPD/CTSTD Referred By: Dr.M.Husain Specimen: Blood PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)

UNIT mg/dl mg/dl mg/dl

Age/Sex: 12/M MRN:SH/LKO/006861/09 Lab No.:B-/08/1476 Date: 21.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

0.31 0.10 0.21

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

11

IU/I

0 - 42

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mr.Vikash Sinha Pt. Location: Dialysis Referred By: Dr.M.Ahamad Specimen: BLOOD PARAMETER RESULT
SERUM IRON 57.1

UNIT
g/dl

Age/Sex: 25y/M MRN:SH/LKO/006771/09 Lab No.:B-/08/1477 Date: 21.8.2009 REFERENCE RANGE


Male Female

59 - 158 37-145 112 - 346 250 - 450 13 - 45

U.I.B.C T.I.B.C % Saturation

76.3 133.4 42.82

g/dl g/dl %

Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sonika Mishra Pt. Location: IPD/G.W Referred By: Dr.S.N.Gupta Specimen: Blood PARAMETER RESULT Blood Sugar Random 82.9 Age/Sex: 37/F MRN:SH/LKO/007819/09 Lab No.:B-/08/1479 Date: 21.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

14.4 0.97

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sonika Mishra Pt. Location: IPD/G.W Referred By: Dr.S.N.Gupta Specimen: Blood PARAMETER RESULT Age/Sex: 37/F MRN:SH/LKO/007819/09 Lab No.:B-/08/1479 Date: 21.8.2009 REFERENCE RANGE

UNIT

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.86 mg/dl 0.36 0.50 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

13.2

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

29.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

66

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.20

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.10 2.10 1.95

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Avi Satija Pt. Location: IPD/Picu Referred By: Dr.M.U.Hasan Specimen: CSF PARAMETER C.S.F C.S.F Protein Glucose Age/Sex: MRN:SH/LKO/006693/09 Lab No.:B-/08/1481 Date: 21.8.2009 REFERENCE RANGE 15 - 45 40 - 80

RESULT 108 55.5

UNIT mg/dl mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Gulam Ashraf Pt. Location: IPD/N.ICU Referred By: Dr. Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex:42/M MRN:SH/LKO/007800/09 Lab No.:B-/08/1482 Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

22.2 0.95

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Laxmi Singh Age/Sex: 54y/M

Pt. Location: OPD Referred By: Dr.S.Dabadghao Specimen: BLOOD PARAMETER Serum LDH
Method: DGKC IFCC

Tr.No-19999 RESULT 309.5 0.26 0.07 0.19

UNIT U/I

MRN:SH/LKO/008000/09 Lab No.:B-/08/1483 Date: 21.8.2009 REFERENCE RANGE


135 - 225

Total Serum Bilirubin


(Method: Walter And Gerarde)

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Haptoglobin

0.629

g/L

0.3 to 2.0

Serum Haptoglobin is an acute phase reactant rises in response to stress,infection,acute inflammation and tissue necrosis. Levels increases after a hemolytic episode,which is dramatic following massive hemolytic episode in situations of hemolytic transfusion reaction,thermal burns,or autoimmune hemolytic anemia.It is also a useful measurement for serially monitoring patients who have a slow but steady rate of red cell breakdown such as by mechanical heart valves,,hemoglobinopathies,or exercise associated trauma Low Haptoglobin concentrations may be seen in liver diasese when hepatic synthetic capacity is impaired

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mrs.Taseem Fatima Pt. Location: IPD/G.W Referred By: Dr.Neelam Vinay Specimen: Blood PARAMETER RESULT
C reactive protein(C.R.P)

UNIT

Age/Sex:27/F MRN:SH/LKO/007908/09 Lab No.:B-/08/1484 Date: 21.8.2009 REFERENCE RANGE

15.3

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Surender Nath Pt. Location: OPD Age/Sex: 54y/M MRN:SH/LKO/008026/09

Referred By: Specimen: BLOOD PARAMETER Blood Sugar Random

Tr.No-21350 RESULT 191.4

UNIT mg/dl

Lab No.:B-/08/1485 Date: 21.8.2009 REFERENCE RANGE 70 - 140

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

35.5

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

2.56

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ram Bahadur Pt. Location: OPD Age/Sex: 48y/M MRN:SH/LKO/008020/09

Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER

Tr.No-20026 RESULT

UNIT

Lab No.:B-/08/1486 Date: 21.8.2009 REFERENCE RANGE

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.26

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Pt. Location: Referred By: Specimen: PARAMETER

Mr. K.K Singh IPD/G.W Dr. S.K Singh Blood RESULT UNIT

Age/Sex:50/M MRN:SH/LKO/006018/09 Lab No.:B-/08/1487 Date: 21.8.2009 REFERENCE RANGE

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.4

g/dl

3.2 - 5.0

Serum Sodium Serum Potassium

131.0 4.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Pt. Location: Referred By: Specimen: PARAMETER

Mrs. Saraswati Devi IPD/G.W Dr.H.N Tripathi Blood RESULT 21

UNIT mg/dl

Age/Sex:70/F MRN:SH/LKO/008042/09 Lab No.:B-/08/1488 Date: 21.8.2009 REFERENCE RANGE

Blood Urea Nitrogen


Method Urease GLDH Kinetic

6 to 20

Serum Calcium
(Method: arsenazo III)

9.66

mg/dl

8.4- 10.4

Serum Urea
Methodology- Urease- GLDH, Kinetic

45 2.38

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium Serum Calcium Ionized :

135.0 3.2 1.22

mmol/l mmol/l mmol/l

135 - 145 3.5 - 5.5 1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Pt. Location: Referred By: Specimen: PARAMETER

Mrs. Saraswati Devi Age/Sex:70/F IPD/G.W MRN:SH/LKO/008042/09 Dr.H.N Tripathi Lab No.:B-/08/1488 Blood Date: 21.8.2009 RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.23 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.07 0.16

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

9.3

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

13.9

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

46.8

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.67

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.31 2.36 1.4

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Pt. Location: Referred By: Specimen: PARAMETER Serum Sodium

Mrs. Vishi Devi IPD/ M.I.C.U Dr. M.Husain BLOOD RESULT 140.0 3.8 UNIT mmol/l mmol/l

Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1489 Date: 21.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5

Serum Potassium

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Mr. Anoop Bansal Pt. Location: IPD/ E/W Referred By: Dr. Mufazal Ahmed Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen 53.81
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 43y/M MRN:SH/LKO/008002/08/09 Lab No.:B-/08/1492 Date: 21.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

5.62

Serum Calcium
(Method: arsenazo III)

9.49

mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

5.76

mg/dl

2.5 - 4.5
2.5 6.8
135 - 225

Serum Uric Acid


(Method : Uricase-POD)

17.9

mg/dl U/I

Serum LDH
Method: DGKC IFCC

1048

Serum Sodium Serum Potassium Serum Calcium Ionized :

134.0 4.7 1.14

mmol/l mmol/l mmol/l

135 - 145 3.5 - 5.5 1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Age/Sex: 43y/M

Pt. Location: IPD/ E/W MRN:SH/LKO/008002/08/09 Referred By: Dr. Mufazal Ahmed Lab No.:B-/08/1492 Specimen: BLOOD Date: 21.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.88 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.26 0.62

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

75.8

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

58.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

80.8

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.24

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.61 2.63 1.0

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Age/Sex: 43y/M

Pt. Location: IPD/ E/W Referred By: Dr. Mufazal Ahmed Specimen: BLOOD PARAMETER RESULT

UNIT

MRN:SH/LKO/008002/08/09 Lab No.:B-/08/1492 Date: 21.8.2009 REFERENCE RANGE

Immunoglobulin (IgG,IgA,IgM) IgG IgA IgM


830 23.6 18.6 mg/dl mg/dl mg/dl

700-1600 mg/dl 70-400 mg/dl 40-230 mg/dl

*Quantitative determination of the immunoglobulins can provide important information on the humoral immune status of the body *Decreased serum immunoglobulin concentration occur in primary immunodeficiency conditions as well as in secondary immune insufficiencies ,e.g. in advanced malignant tumors, lymphatic leukemias etc. *Increased serum immunoglobulin concentration occur due to polyclonal proliferation ,eg.in hepatic diseases (hepatitis,viral cirrhosis),acute and chronic infections as well as in cord blood of neonates with intrauterine and perinatal infections. *Monoclonal immunoglobulin proliferation are seen in Plasmacytomas,Waldenstroms disease and heavy chain
disease.

Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Surender Kumar Pt. Location: IPD/ T.ICU Age/Sex: 65y/M MRN:SH/LKO/007690/08/09

Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER Serum Uric Acid
(Method : Uricase-POD)

RESULT

UNIT mg/dl

Lab No.:B-/08/1494 Date: 21.8.2009 REFERENCE RANGE 2.5 6.8

10

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rinku Bansal Pt. Location: IPD/ E/W Referred By: Dr. S.K Somani Age/Sex: 35y/M MRN:SH/LKO/008052/08/09 Lab No.:B-/08/1495

Specimen: BLOOD PARAMETER

RESULT

UNIT

Date: 21.8.2009 REFERENCE RANGE

Serum Calcium
(Method: arsenazo III)

9.89

mg/dl

8.4- 10.4

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

147.0 3.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Santosh Sahu Pt. Location: IPD/ G/W Referred By: Dr. M.Ahmed Age/Sex: 35y/M MRN:SH/LKO/007925/08/09 Lab No.:B-/08/1496

Specimen: BLOOD PARAMETER


Serum IRON

RESULT
186.8

UNIT
g/dl

Date: 21.8.2009 REFERENCE RANGE


Male Female 59 - 158 37-145

U.I.B.C T.I.B.C % Saturation

9.8 196.6 95.01

g/dl g/dl %

112 - 346

250 - 450 13 - 45

Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sanehi Sahi Pt. Location: IPD/ E/W Referred By: Dr. R.K Mishra Age/Sex: 65y/M MRN:SH/LKO/006839/08/09 Lab No.:B-/08/1501

Specimen: BLOOD PARAMETER Serum Urea


Methodology- Urease- GLDH, Kinetic

RESULT 119 1.58

UNIT mg/dl mg/dl

Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

128.0 6.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Subhash Chandra Pt. Location: IPD/ E/W Referred By: Dr. A.S Pandey Age/Sex: 51y/M MRN:SH/LKO/007928/08/09 Lab No.:B-/08/1502

Specimen: BLOOD PARAMETER Blood Sugar Post Prandial

RESULT 109

UNIT mg/dl

Date: 21.8.2009 REFERENCE RANGE 70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Rasna Devi Pt. Location: IPD/ MICU Referred By: Dr. H.N Triphati Age/Sex: 85y/F MRN:SH/LKO/006643/08/09 Lab No.:B-/08/1503

Specimen: BLOOD PARAMETER

RESULT

UNIT

Date: 21.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

137.0 3.50

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/ E/W Referred By: Dr. H.N Triphati Age/Sex: 55y/F MRN:SH/LKO/008075/08/09 Lab No.:B-/08/1504

Specimen: BLOOD PARAMETER Serum Urea


Methodology- Urease- GLDH, Kinetic

RESULT 126 3.11

UNIT mg/dl mg/dl

Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

140.0 8.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/ E/W Referred By: Dr. H.N Triphati Age/Sex: 55y/F MRN:SH/LKO/008075/08/09 Lab No.:B-/08/1504

Specimen: BLOOD PARAMETER Total Serum Bilirubin


(Method: Walter And Gerarde)

RESULT UNIT LIVER FUNCTION TEST 0.57 mg/dl 0.24 0.33 mg/dl mg/dl

Date: 21.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

12

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

16

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

274

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.16

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.18 3.98 0.80

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prem Bodh Pt. Location: IPD/ E/W Referred By: Dr. H.N Triphati Age/Sex: 87y/M MRN:SH/LKO/007258/08/09 Lab No.:B-/08/1507

Specimen: BLOOD PARAMETER Serum Urea


Methodology- Urease- GLDH, Kinetic

RESULT 37 1.49

UNIT mg/dl mg/dl

Date: 21.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

138.0 3.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. Alok Age/Sex: 54y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1508

Specimen: BLOOD PARAMETER

RESULT

UNIT

Date: 21.8.2009 REFERENCE RANGE

Serum Potassium

3.70

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Mukesh Shukla Pt. Location: OPD/Dialysis Referred By: Dr. M.Ahmed Specimen: BLOOD Tr.No-20088 PARAMETER RESULT Age/Sex: 33y/M MRN:SH/LKO/006048/09 Lab No.:B-/08/1505 Date: 21.8.2009 REFERENCE RANGE

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

75.73

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

5.52

mg/dl

0.70 - 1.30

Serum Calcium
(Method: arsenazo III)

8.78

mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

6.13

mg/dl

2.5 - 4.5

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 4.90

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

PRE HD

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Monika Mansani Pt. Location: OPD/Dialysis Referred By: Dr. M.Ahmed Specimen: BLOOD Tr.No-2408 PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007976/09 Lab No.:B-/08/1506 Date: 21.8.2009 REFERENCE RANGE

UNIT

Serum Alkaline Phosphatase


(Method: ALP - AMP)

82.4

IU/I

42 - 128

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.44

g/dl

3.2 - 5.0

Blood Urea Nitrogen


Method Urease GLDH Kinetic

56.21 8.94

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

8.81

mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

5.15

mg/dl

2.5 - 4.5

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

133.0 4.10

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer ) PRE HD
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Monika Mansani Pt. Location: OPD/Dialysis Referred By: Dr. M.Ahmed Specimen: BLOOD Tr.No-2408 PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007976/09 Lab No.:B-/08/1516 Date: 21.8.2009 REFERENCE RANGE

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

32.4 3.67

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

129.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

POST HD

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Aryan Mathur Pt. Location: IPD/ PICU Referred By: Dr. M.U Hasan Age/Sex: 1/1my/M MRN:SH/LKO/008076/08/09 Lab No.:B-/08/1512

Specimen: BLOOD PARAMETER Total Serum Bilirubin


(Method: Walter And Gerarde)

RESULT UNIT LIVER FUNCTION TEST 0.23 mg/dl 0.05 0.18 mg/dl mg/dl

Date: 21.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

16.8

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

47.5

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

114.1

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.72

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.3 4.42 0.97

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Aryan Mathur Pt. Location: IPD/ PICU Referred By: Dr. M.U Hasan Age/Sex: 1/1my/M MRN:SH/LKO/008076/08/09 Lab No.:B-/08/1512

Specimen: BLOOD PARAMETER Blood Urea Nitrogen


Method Urease GLDH Kinetic

RESULT 17.42 0.4

UNIT mg/dl mg/dl

Date: 21.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

10.24

mg/dl

8.4- 10.4

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

138.0 4.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

C reactive protein(C.R.P)

20.4

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mes.Susheela Devi Pt. Location: IPD/ G.W Referred By: Dr.Sunil Dabadghao Age/Sex: 43y/F MRN:SH/LKO/008030/08/09 Lab No.:B-/08/1514

Specimen: BLOOD PARAMETER

RESULT

UNIT

Date: 22.8.2009 REFERENCE RANGE

Serum Complement C3
Method-Immunonephalometric assay

109

mg/dl

90 - 180

Serum Complement C4
Method-Immunonephalometric assay

27.6

mg/dl

10 - 40

NOTE : *Complement proteins are acute phase reactants and their serum levels rises in inflammatory states and fall in autoimmune conditions as in S.L.E. *In SLE low levels are found in patients with active disease. *Patients with gram negative septicemia, and pyogenic infections aften have deficiency of C3 complement *Complement also appears to be a key importance in glomerular damage in may of the glomerulonephritis,

(Dr. Anju Shukla, MD) Associate Consultant


Checked by.

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Susheela Devi Pt. Location: IPD/ G.W Referred By: Dr.Sunil Dabadghao Specimen: BLOOD Age/Sex: 43y/F MRN:SH/LKO/008030/08/09 Lab No.:B-/08/1514 Date: 21.8.2009

PARAMETER
C reactive protein(C.R.P)

RESULT

UNIT

REFERENCE RANGE

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

(Dr. Anju Shukla, MD) Associate Consultant


Checked by.

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Susheela Devi Pt. Location: IPD/ G.W Referred By: Dr.Sunil Dabadghao Specimen: BLOOD Age/Sex: 43y/F MRN:SH/LKO/008030/08/09 Lab No.:B-/08/1514 Date: 21.8.2009

PARAMETER Serum Creatinine

RESULT 0.56 9.15 3.6

UNIT mg/dl mg/dl mg/dl

REFERENCE RANGE 0.70 - 1.30 8.4- 10.4

Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

14.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

20.8

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

65.8

IU/I

42 - 128

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.15

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

(Dr. Anju Shukla, MD) Associate Consultant


Checked by.

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Ankit Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 15y/M MRN:SH/LKO/007559/08/09 Lab No.:B-/08/1521 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

135.0 4.2

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sarswati Devi Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 70y/F MRN:SH/LKO/008042/08/09 Lab No.:B-/08/1523 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

20.7 0.83 9 3.0

mg/dl mg/dl mg/dl g/dl

13 - 43 0.70 - 1.30 8.4- 10.4 3.2 - 5.0

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Serum Albumin
(Method: Bromo Cresol Green BCG))

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium Serum Calcium Ionized :

136.0 4.4 1.17

mmol/l mmol/l mmol/l

135 - 145 3.5 - 5.5 1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Rasna Devi Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Age/Sex: 85y/F MRN:SH/LKO/006643/08/09 Lab No.:B-/08/1524 Date: 22.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

72.9 3.16

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 3.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Age/Sex: 62y/M MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1525 Date: 22.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

222.7 8.26

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 4.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sunita Malhotra Pt. Location: IPD/MICU Referred By: Dr.S.K.Somani Specimen: BLOOD PARAMETER RESULT Age/Sex: 54y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1526 Date: 22.8.2009 REFERENCE RANGE

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

126.9

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

2.31

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

151.0 4.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Jamila Begam Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 80y/F MRN:SH/LKO/007772/08/09 Lab No.:B-/08/1527 Date: 22.8.2009 REFERENCE RANGE

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

62.7

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.88

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

155.0 3.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kamlesh Kumari Pt. Location: IPD/MICU Referred By: Dr.Vaibhav Khanna Specimen: BLOOD PARAMETER RESULT Age/Sex: 35y/F MRN:SH/LKO/007860/08/09 Lab No.:B-/08/1528 Date: 22.8.2009 REFERENCE RANGE

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

11.71

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.49

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 3.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 38y/M MRN:SH/LKO/007836/08/09 Lab No.:B-/08/1530 Date: 21.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

150.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vishi Devi Pt. Location: IPD/ M.I.C.U Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1531 Date: 22.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Sodium Serum Potassium

140.0 3.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Ibtessam Anjum Pt. Location: IPD/ Gyne Referred By: Dr.Manjusha Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 105.6 Age/Sex: 28y/F MRN:SH/LKO/004719/09 Lab No.:B-/08/1533 Date: 22.8.2009 UNIT REFERENCE RANGE mg/dl 70 - 140

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

21.5 0.52

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

138.0 4.80

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Ibtessam Anjum Pt. Location: IPD/ Gyne Referred By: Dr.Manjusha Specimen: BLOOD PARAMETER RESULT UNIT LIVER FUNCTION TEST Age/Sex: 28y/F MRN:SH/LKO/004719/09 Lab No.:B-/08/1533 Date: 22.8.2009 REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

0.30 0.10 0.20

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

9.4

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

19.5

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

145.5

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.04

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.60 3.44 1.04

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.K.K.Singh Pt. Location: IPD/ CCU Referred By: Dr. Alok Specimen: BLOOD PARAMETER Age/Sex: 58y/M MRN:SH/LKO/006015/09 Lab No.:B-/08/1534 Date: 22.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Sodium Serum Potassium

143.0 3.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohad Farooq Pt. Location: IPD/E.W Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 55y/M MRN:SH/LKO/007979/09 Lab No.:B-/08/1537 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

132.0 5.70

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Kamla Kapoor Pt. Location: IPD/T.Icu Referred By: Dr. H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 72y/F MRN:SH/LKO/007647/09 Lab No.:B-/08/1538 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

134.0 4.10

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Blood Urea Nitrogen


Method Urease GLDH Kinetic

41.35

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

3.45

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Abhinandan Pt. Location: IPD/NICU Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER Age/Sex: 67y/M MRN:SH/LKO/007651/09 Lab No.:B-/08/1539 Date: 22.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

112.5 2.21

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

141.0 3.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Jagdish Pandey Pt. Location: IPD/SICU Referred By: Dr. M Ahamad Specimen: BLOOD PARAMETER RESULT Age/Sex: 72y/M MRN:SH/LKO/007761/09 Lab No.:B-/08/1540 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

135.0 3.60

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Blood Urea Nitrogen


Method Urease GLDH Kinetic

34.8

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

4.03

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Anita Chatterjee Pt. Location: IPD/S.Icu Referred By: Dr. V.K.Tewari Specimen: BLOOD PARAMETER RESULT Serum Sodium 125.0 Age/Sex: 70y/F MRN:SH/LKO/006912/09 Lab No.:B-/08/1541 Date: 22.8.2009 REFERENCE RANGE 135 - 145

UNIT mmol/l

Serum Potassium

2.80

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Blood Urea Nitrogen


Method Urease GLDH Kinetic

53.3

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

2.7

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Sushma Pandey Pt. Location: IPD/S.Icu Referred By: Dr. Swadesh Specimen: BLOOD PARAMETER RESULT Age/Sex: 41y/F MRN:SH/LKO/007236/09 Lab No.:B-/08/1542 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

125.0 2.80

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Shakuntala Pt. Location: IPD/S.Icu Referred By: Dr. M.Ahamad Specimen: BLOOD PARAMETER Age/Sex: 86y/F MRN:SH/LKO/007538/09 Lab No.:B-/08/1543 Date: 22.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Sodium Serum Potassium

129.0 3.70

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Bodh Mishra Pt. Location: IPD/E.W Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Age/Sex: 87y/M MRN:SH/LKO/007254/09 Lab No.:B-/08/1544 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

60.8

mg/dl

13 - 43

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

2.17

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

134.0 3.50

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G.W Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Age/Sex: 51y/M MRN:SH/LKO/006354/09 Lab No.:B-/08/1545 Date: 22.8.2009 REFERENCE RANGE

RESULT

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

100.4

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

6.59

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

123.0 4.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Devan Yadav Pt. Location: IPD/G.W Referred By: Dr.M.Ahamad Specimen: BLOOD PARAMETER RESULT Age/Sex: 75y/M MRN:SH/LKO/006934/09 Lab No.:B-/08/1546 Date: 22.8.2009 REFERENCE RANGE

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

74

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

3.33

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

133.0 5.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ambarish Arora Pt. Location: IPD/G.W Referred By: Dr.Abhishek Specimen: BLOOD PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
(Method-CHOD-PAP 194.9 mg/dl

UNIT

Age/Sex: 68y/M MRN:SH/LKO/007960/09 Lab No.:B-/08/1547 Date: 22.8.2009 REFERENCE RANGE

(Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 332 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 23.3 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

105.2

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

66.43

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

8.37

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

4.52

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Jamila Begum Age/Sex: 80y/F Pt. Location: IPD/MICU MRN:SH/LKO/007772/09 Referred By: Dr. M.Husain Lab No.:B-/08/1548 Specimen: BLOOD Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.31 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin

0.19

mg/dl

0 - 0.20

(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

0.12

mg/dl

0.08 - 0.75

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

20.7

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

56.4

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

37

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.63

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.3 3.33 0.69

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Ibtessam Anjum Pt. Location: IPD/Gyanee Referred By: Dr. M. U Hasan Specimen: BLOOD PARAMETER RESULT C reactive protein(C.R.P) 10.5 Age/Sex: y/ MRN:SH/LKO/008070/09 Lab No.:B-/08/1549 Date: 22.8.2009 REFERENCE RANGE

UNIT

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes

and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Asha Rawat Pt. Location: IPD/E/W Referred By: Dr. Sandeep Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 105 Age/Sex: 28y/F MRN:SH/LKO/007649/09 Lab No.:B-/08/1552 Date: 22.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl

According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

56 0.9

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Asha Rawat Age/Sex: 28y/F Pt. Location: IPD/E/W MRN:SH/LKO/007649/09 Referred By: Dr. Sandeep Lab No.:B-/08/1552 Specimen: BLOOD Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.52 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.20

mg/dl

0 - 0.20

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

0.32

mg/dl

0.08 - 0.75

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

44

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

30

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

105

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.98

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.20 2.78 1.15

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Balwant Singh Pt. Location: IPD/C.T Step Referred By: Dr. Abhishek Specimen: BLOOD PARAMETER RESULT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

UNIT mg/dl

Age/Sex: 30y/M MRN:SH/LKO/005726/09 Lab No.:B-/08/1569 Date: 22.8.2009 REFERENCE RANGE 0.70 - 1.30

0.62

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

134.0 4.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Subharda Pt. Location: IPD/PICU Referred By: Dr. M.U Hasan Specimen: BLOOD PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)

RESULT 6.67 0.47 6.19

UNIT mg/dl mg/dl mg/dl

Age/Sex: y/ MRN:SH/LKO/07784/09 Lab No.:B-/08/7784 Date: 22.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin

(Method: Walter And Gerarde)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Kusum Pt. Location: IPD/PICU Referred By: Dr. M.U Hasan Specimen: BLOOD PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)

RESULT 11.31 0.51 10.80

UNIT mg/dl mg/dl mg/dl

Age/Sex: y/ MRN:SH/LKO/07634/09 Lab No.:B-/08/1573 Date: 22.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin

(Method: Walter And Gerarde)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 79y/M MRN:SH/LKO/03660/09 Lab No.:B-/08/1574 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

198 4.38

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

24.7

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

31.9

IU/I

0 - 42

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER RESULT Age/Sex: 79y/M MRN:SH/LKO/03660/09 Lab No.:B-/08/1574 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

122.0 6.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/SICU Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Age/Sex: 55y/F MRN:SH/LKO/08075/09 Lab No.:B-/08/1577 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

142.0 8.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Amit Kushwaha Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)

UNIT mg/dl mg/dl mg/dl

Age/Sex: 24y/M MRN:SH/LKO/06223/09 Lab No.:B-/08/1579 Date: 22.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

3.12 2.58 0.54

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

774

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

1634

IU/I

0 - 42

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fakkruddin Pt. Location: IPD/E/W Referred By: Dr. M.Ahmed Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic

RESULT 83.83 7.62

UNIT mg/dl mg/dl

Age/Sex: 72y/F MRN:SH/LKO/07589/09 Lab No.:B-/08/1591 Date: 22.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

138.0 6.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Amar Jeet Singh Pt. Location: IPD/E/W Referred By: Dr. Sandeep Kapoor Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 30y/M MRN:SH/LKO/08137/09 Lab No.:B-/08/1605 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

31 0.78

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 4.90

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fakkruddin Pt. Location: IPD/E/W Referred By: Dr. M.Ahmed Specimen: BLOOD PARAMETER
Serum IRON

RESULT
44.7

UNIT
g/dl

Age/Sex: 72y/F MRN:SH/LKO/07589/09 Lab No.:B-/08/1591 Date: 22.8.2009 REFERENCE RANGE


Male Female 59 - 158 37-145

U.I.B.C T.I.B.C % Saturation

191 235.7 18.95

g/dl g/dl %

112 - 346

250 - 450 13 - 45

Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Dinesh Bajpai Pt. Location: IPD/G/W Referred By: Specimen: BLOOD PARAMETER RESULT Age/Sex: 60y/M MRN:SH/LKO/07336/09 Lab No.:B-/08/1592 Date: 22.8.2009 REFERENCE RANGE

UNIT

Serum Sodium

124.0

mmol/l

135 - 145

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Pt. Location: IPD/MICU Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)

RESULT 15.08 11.76 3.32

UNIT mg/dl mg/dl mg/dl

Age/Sex: 47/F MRN:SH/LKO/008004/09 Lab No.:B-/08/1593 Date: 22.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Alkaline Phosphatase


(Method: ALP - AMP)

207.7

IU/I

42 - 128

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Pt. Location: IPD/MICU Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER Age/Sex: 47/F MRN:SH/LKO/008004/09 Lab No.:B-/08/1606 Date: 22.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Sodium Serum Potassium

150.0 2.80

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vindhya Vashini Pt. Location: IPD/E/W Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER RESULT Serum Amylase Serum Lipase Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT U/L U/L mg/dl mg/dl

Age/Sex: 60/F MRN:SH/LKO/008139/09 Lab No.:B-/08/1595 Date: 22.8.2009 REFERENCE RANGE 28 - 100 13 - 60 13 - 43 0.70 - 1.30

53.5 20.6 95.8 1.17

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 5.20

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vindhya Vashini Age/Sex: 60/F Pt. Location: IPD/E/W MRN:SH/LKO/008139/09 Referred By: Dr.S.K.Somani Lab No.:B-/08/1595 Specimen: Blood Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.53 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.17 0.36

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)

13.5

IU/I

0 - 42

(Method: IFCC Without Pyridoxal Phosphate))

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

27.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

92

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.61

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.80 3.81 0.99

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Bhanumati Age/Sex: 50/F Pt. Location: IPD/E/W MRN:SH/LKO/001439/09 Referred By: Dr. Nitin Joshi Lab No.:B-/08/1596 Specimen: Blood Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.71 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.12 0.59

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)

17

IU/I

0 - 42

(Method: IFCC Without Pyridoxal Phosphate))

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

28

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

107

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.14

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.0 4.14 0.72

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Bhanumati Pt. Location: IPD/E/W Referred By: Dr. Nitin Joshi Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 67 1.75

UNIT mg/dl mg/dl

Age/Sex: 50/F MRN:SH/LKO/001439/09 Lab No.:B-/08/1596 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium

139.0

mmol/l

135 - 145

Serum Potassium

4.50

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mohd Rafeeq Pt. Location: IPD/G/W Referred By: Dr. R.K Mishra Specimen: Blood PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 119 2.36

UNIT mg/dl mg/dl

Age/Sex: 65/M MRN:SH/LKO/008127/09 Lab No.:B-/08/1597 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium

138.0

mmol/l

135 - 145

Serum Potassium

6.0

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Mamta Lal Pt. Location: IPD/E/W Referred By: Dr. Alok Specimen: Blood PARAMETER D-Dimer (Quantitative) Age/Sex: 48/F MRN:SH/LKO/005094/09 Lab No.:B-/08/1600 Date: 22.8.2009 REFERENCE RANGE

RESULT 1.11

UNIT

<0.5g fibrinogen equivalent unit/ml (g FEU/ml)

D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Raj Kumar Singh Pt. Location: OPD Referred By: Dr. Sandeep Kapoor Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 104.0 Age/Sex: 64y/M MRN:SH/LKO/008116/09 Lab No.:B-/08/1583 Date: 22.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

234

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Raj Kumar Singh Pt. Location: OPD Referred By: Dr. Sandeep Kapoor Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
124 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 64y/M MRN:SH/LKO/008116/09 Lab No.:B-/08/1583 Date: 22.8.2009 REFERENCE RANGE

Serum Triglycerides 79 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 40.3 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

67.9

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High;

160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

15.8

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.07

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.68

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Naresh Chandra Verma Pt. Location: OPD Referred By: Dr. S. K Somani Specimen: BLOOD Tr.NoPARAMETER RESULT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

UNIT mg/dl

Age/Sex: 68y/M MRN:SH/LKO/008103/09 Lab No.:B-/08/1568 Date: 22.8.2009 REFERENCE RANGE 0.70 - 1.30

1.44

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 5.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Naresh Chandra Verma Age/Sex: 68y/M Pt. Location: OPD MRN:SH/LKO/008103/09 Referred By: Dr. S. K Somani Lab No.:B-/08/1568 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.54 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.20 0.34

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

37

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

31

IU/I

0 - 42

Serum Alkaline Phosphatase

198

IU/I

42 - 128

(Method: ALP - AMP)

Serum Total Protein


(Method: Biuret)

7.66

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.80 3.86 0.98

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.K Agarwal Pt. Location: OPD Referred By: Dr. S. K. Singh Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 92.0 Age/Sex: 70y/M MRN:SH/LKO/008097/09 Lab No.:B-/08/1567 Date: 22.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

13.59

mg/dl

6 to 20

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

15

IU/I

0 - 42

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.93

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.K Agarwal Pt. Location: OPD Referred By: Dr. S. K. Singh Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
152.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 70y/M MRN:SH/LKO/008097/09 Lab No.:B-/08/1567 Date: 22.8.2009 REFERENCE RANGE

Serum Triglycerides 103 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 41.3 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

90.6

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density

20.61

mg/dl

10 to 40

Lipoprotein Cholesterol (VLDL-C) :

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.69

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.19

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ragini Pt. Location: OPD Referred By: Dr. Himani Negi Specimen: BLOOD PARAMETER Blood Sugar Random Age/Sex: 27y/F MRN:SH/LKO/007467/09 Lab No.:B-/08/1566 Date: 22.8.2009 REFERENCE RANGE 70 - 140

Tr.No- 21518 RESULT UNIT 83.9 mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Jitender Kumar Agarwal Pt. Location: OPD Referred By: Dr. Sunil Kumar Verma Specimen: BLOOD Tr.No- 21515 PARAMETER RESULT UNIT Blood Sugar Fasting 133.0 mg/dl Age/Sex: 62y/M MRN:SH/LKO/008081/09 Lab No.:B-/08/1565 Date: 22.8.2009 REFERENCE RANGE 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 7.7% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods

*ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 94 Age/Sex: 47y/M MRN:SH/LKO/008093/09 Lab No.:B-/08/1553 Date: 22.8.2009 UNIT REFERENCE RANGE mg/dl 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

106

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

9 0.89 8.81 3.66

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

6.21

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.18

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Age/Sex: 47y/M Pt. Location: OPD MRN:SH/LKO/008093/09 Referred By: M.H.C Lab No.:B-/08/1553 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.44 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.12 0.32

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

24

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

21

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

100

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.62

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0 3.62 1.10

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
152.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 47y/M MRN:SH/LKO/008093/09 Lab No.:B-/08/1553 Date: 22.8.2009 REFERENCE RANGE

Serum Triglycerides 163.4 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 24 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

95.9

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

32.68

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

6.35

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.95

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 47y/M MRN:SH/LKO/008093/09 Lab No.:B-/08/1553 Date: 22.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 6.0% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Rajender Prasad Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 76

UNIT

Age/Sex: 47y/M MRN:SH/LKO/008093/09 Lab No.:B-/08/1553 Date: 22.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

91.7

apo-A1/apo-B Ratio

0.82

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD)

Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 54y/M MRN:SH/LKO/008087/09 Lab No.:B-/08/1554 Date: 22.8.2009 REFERENCE RANGE 70 - 110

Tr.NoRESULT 96

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

107

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

9.08 0.72 8.99 3.89

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

4.68

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.2

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Age/Sex: 54y/M Pt. Location: OPD MRN:SH/LKO/008087/09 Referred By: M.H.C Lab No.:B-/08/1554 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.36 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.26

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

22

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

21

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

72

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.50

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0 3.50 1.14

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
Total Serum Cholesterol

Tr.NoRESULT
103

UNIT
mg/dl

Age/Sex: 54y/M MRN:SH/LKO/008087/09 Lab No.:B-/08/1554 Date: 22.8.2009 REFERENCE RANGE

LIPID PROFILE

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 113.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 28 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

52.7

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

22.78

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.72

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.9

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 107

Tr.NoRESULT

UNIT

Age/Sex: 54y/M MRN:SH/LKO/008087/09 Lab No.:B-/08/1554 Date: 22.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

53.3

apo-A1/apo-B Ratio

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.P Karan Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Age/Sex: 54y/M MRN:SH/LKO/008087/09 Lab No.:B-/08/1554 Date: 22.8.2009 REFERENCE RANGE

Tr.NoRESULT

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 6.1% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD)

Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 102 Age/Sex: 49y/M MRN:SH/LKO/008088/09 Lab No.:B-/08/1555 Date: 22.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

121.7

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

8.92 0.8 9.14 3.55

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

7.03

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.18

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Age/Sex: 49y/M Pt. Location: OPD MRN:SH/LKO/008088/09 Referred By: M.H.C Lab No.:B-/08/1555 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.36 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.30 1.06

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

72.5

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

44.4

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

97.6

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.47

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

3.47 1.15

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
180.9 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 49y/M MRN:SH/LKO/008088/09 Lab No.:B-/08/1555 Date: 22.8.2009 REFERENCE RANGE

Serum Triglycerides 181 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 35.3 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

109.4

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

36.24

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.12

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.1

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National

Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 120

UNIT

Age/Sex: 49y/M MRN:SH/LKO/008088/09 Lab No.:B-/08/1555 Date: 22.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

102

apo-A1/apo-B Ratio

1.17

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Veer Kureel Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 49y/M MRN:SH/LKO/008088/09 Lab No.:B-/08/1555 Date: 22.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 6.0% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 95 Age/Sex: 44y/M MRN:SH/LKO/008089/09 Lab No.:B-/08/1556 Date: 22.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

129

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

7.55 0.72 8.56 3.29

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

4.87

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.16

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Age/Sex: 44y/M Pt. Location: OPD MRN:SH/LKO/008089/09 Referred By: M.H.C Lab No.:B-/08/1556 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.0 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.32 0.68

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

28

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

45

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

105

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.44

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.80 4.6 0.82

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
114 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 44y/M MRN:SH/LKO/008089/09 Lab No.:B-/08/1556 Date: 22.8.2009 REFERENCE RANGE

Serum Triglycerides 46.4 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 35 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

70.1

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

9.29

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.27

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 96.9

UNIT

Age/Sex: 44y/M MRN:SH/LKO/008089/09 Lab No.:B-/08/1556 Date: 22.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

48.3

apo-A1/apo-B Ratio

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Kishore Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 44y/M MRN:SH/LKO/008089/09 Lab No.:B-/08/1556 Date: 22.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 6.5% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 43y/M MRN:SH/LKO/008090/09 Lab No.:B-/08/1557 Date: 22.8.2009 REFERENCE RANGE 70 - 110

Tr.NoRESULT 88

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

109

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

11.45 0.73 9.37 2.6

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

6.9

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.21

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Age/Sex: 43y/M Pt. Location: OPD MRN:SH/LKO/008090/09 Referred By: M.H.C Lab No.:B-/08/1557 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.43 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.13 0.30

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

56

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

36

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

65

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.12

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0 3.12 1.28

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
Total Serum Cholesterol

Tr.NoRESULT

UNIT

Age/Sex: 43y/M MRN:SH/LKO/008090/09 Lab No.:B-/08/1557 Date: 22.8.2009 REFERENCE RANGE

LIPID PROFILE
229 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 376 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 80 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

73.4

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

75.26

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.85

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

0.92

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 217

Tr.NoRESULT

UNIT

Age/Sex: 43y/M MRN:SH/LKO/008090/09 Lab No.:B-/08/1557 Date: 22.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

83.6

apo-A1/apo-B Ratio

2.59

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. M.P Mishra Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Age/Sex: 43y/M MRN:SH/LKO/008090/09 Lab No.:B-/08/1557 Date: 22.8.2009 REFERENCE RANGE

Tr.NoRESULT

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 5.5% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 80 Age/Sex: 16y/M MRN:SH/LKO/008079/09 Lab No.:B-/08/1558 Date: 22.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.47

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.91

mg/dl

0.70 - 1.30

Serum Calcium
(Method: arsenazo III)

9.38

mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

3.78

mg/dl

2.5 - 4.5
2.5 6.8

Serum Uric Acid


(Method : Uricase-POD)

5.51

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.24

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Age/Sex: 16y/M Pt. Location: OPD MRN:SH/LKO/008079/09 Referred By: M.H.C Lab No.:B-/08/1558 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.55 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.15 0.40

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

11

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

20

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

178

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.12

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.10 4.02 1.01

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
107 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 16y/M MRN:SH/LKO/008079/09 Lab No.:B-/08/1558 Date: 22.8.2009 REFERENCE RANGE

Serum Triglycerides 82.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 26 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

64.8

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

16.57

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.11

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.49

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 82

UNIT

Age/Sex: 16y/M MRN:SH/LKO/008079/09 Lab No.:B-/08/1558 Date: 22.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

53

apo-A1/apo-B Ratio

1.54

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashutosh Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 16y/M MRN:SH/LKO/008079/09 Lab No.:B-/08/1558 Date: 22.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 5.6% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Blood Sugar Fasting 85 Age/Sex: 42y/F MRN:SH/LKO/008080/09 Lab No.:B-/08/1559 Date: 22.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

9.67

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.67

mg/dl

0.70 - 1.30

Serum Calcium
(Method: arsenazo III)

9.1

mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

3.14

mg/dl

2.5 - 4.5
2.5 6.8

Serum Uric Acid


(Method : Uricase-POD)

5.24

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.2

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Age/Sex: 42y/F Pt. Location: OPD MRN:SH/LKO/008080/09 Referred By: M.H.C Lab No.:B-/08/1559 Specimen: BLOOD Tr.NoDate: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.63 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.16 0.47

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

10

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

16

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

98

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.23

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0 4.23 0.94

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
188.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 42y/F MRN:SH/LKO/008080/09 Lab No.:B-/08/1559 Date: 22.8.2009 REFERENCE RANGE

Serum Triglycerides 106.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 32.2 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

135.2

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

21.38

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.86

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

4.2

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 111

UNIT

Age/Sex: 42y/F MRN:SH/LKO/008080/09 Lab No.:B-/08/1559 Date: 22.8.2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

102

apo-A1/apo-B Ratio

1.08

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Pramila Pandey Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr.NoPARAMETER RESULT Age/Sex: 42y/F MRN:SH/LKO/008080/09 Lab No.:B-/08/1559 Date: 22.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 5.7% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ahmed Khan Pt. Location: IPD/E/W Referred By: Dr. S. Agarwal Specimen: Blood PARAMETER RESULT Blood Sugar Random 79 Age/Sex: 14/M MRN:SH/LKO/008141/09 Lab No.:B-/08/1602 Date: 22.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ahmed Khan Age/Sex: 14/M Pt. Location: IPD/E/W MRN:SH/LKO/008141/09 Referred By: Dr. S. Agarwal Lab No.:B-/08/1602 Specimen: Blood Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.55 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.20 0.35

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

106

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

212

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

195

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.10

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.10 3.0 1.03

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Murti Pt. Location: IPD/G/W Referred By: Dr. V.K Tiwari Specimen: Blood PARAMETER Blood Sugar Random Age/Sex: 65/M MRN:SH/LKO/001384/09 Lab No.:B-/08/1603 Date: 22.8.2009 REFERENCE RANGE 70 - 140

RESULT 127

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

44 1.23

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

118.0 4.40

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 66/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1604 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

66 1.39

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

132.0 5.70

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER RESULT Age/Sex: 66/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1604 Date: 22.8.2009 REFERENCE RANGE

UNIT

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 1.78 mg/dl 0.76 1.02 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

12

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

48

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

356

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.88

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.20 3.68 0.86

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER RESULT Age/Sex: 66/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1604 Date: 22.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 10.4% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/E/W Referred By: Dr. M.Ahmed Specimen: Blood PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl

Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1607 Date: 22.8.2009 REFERENCE RANGE

39.04

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

4.4

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium Serum Calcium Ionized :

131.0 4.3 1.22

mmol/l mmol/l mmol/l

135 - 145 3.5 - 5.5 1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Age/Sex: 70/M Pt. Location: IPD/E/W MRN:SH/LKO/001386/09 Referred By: Dr. M.Ahmed Lab No.:B-/08/1607 Specimen: Blood Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.98 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.47 0.51

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

50.7

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

110.1

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

60.9

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.48

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.9 3.58 0.81

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/E/W Referred By: Dr. M.Ahmed Specimen: Blood PARAMETER RESULT
Serum IRON 30.8

UNIT
g/dl

Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1607 Date: 22.8.2009 REFERENCE RANGE


Male Female 59 - 158 37-145

U.I.B.C T.I.B.C % Saturation

165.5 196.3 15.71

g/dl g/dl %

112 - 346

250 - 450 13 - 45

Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT 0.76 0.23 0.53 UNIT mg/dl mg/dl mg/dl

Age/Sex: 80Y/F MRN:Ex.001498 Lab No.:B-0/08/1642 Date: 23/8/2009


REFERENCE RANGE 0.30 - 1.0 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method:Diazo)

Direct Serum Bilirubin


(Method: Diazo)

Indirect Serum Bilirubin Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

15.1

IU/I

0 - 41

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

27.8

IU/I

0 - 40

Serum Alkaline Phosphate


(Method: ALP - AMP)

142.7

IU/I

40 - 129

Serum Total Protein


(Method: Biuret)

7.77

g/dl

6.6 - 8.7

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.80 3.97 0.95

g/dl

3.97 - 4.95

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

NOTE : Above test carried out by Cobas Integra 400 plus automated biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 80Y/F MRN:Ex.001498 Lab No.:B-0/08/1642 Date: 23/8/2009


REFERENCE RANGE

Total Serum Cholesterol

174.6 mg/dl (Method-CHOD-PAP) (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 92.3 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : (Low <40 mg/dl ;High 60 mg/dl) 69.1 mg/dl

(Method- Homogeneous enzymatic colorimetric assay)


Serum Low Density
87 mg/dl

Lipoprotein Cholesterol (LDL-C) :

(Method- Homogeneous enzymatic colorimetric assay)


(<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

18.46

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.53

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.56

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 80Y/F MRN:Ex.001498 Lab No.:B-0/08/1642 Date: 23/8/2009


REFERENCE RANGE

Blood Sugar Fasting

192

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

96 1.91 8.84 3.77

mg/dl mg/dl mg/dl mg/dl

13 - 43 0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5
2.5 6.8

Serum Uric Acid


(Method : Uricase-POD)

8.44

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 4.90 1.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

Serum Calcium Ionized :

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 80Y/F MRN:Ex.001498 Lab No.:B-0/08/1642 Date: 23/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

7.6%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Note : Above test carried out by D-10 Hb A1c analyzer.


Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD Dr.H.P.Kumar, MD Blood


RESULT 0.76 0.23 0.53 UNIT mg/dl mg/dl mg/dl

MRN:Ex.001498 Lab No.:B-0/08/1642 Date: 23/8/2009


REFERENCE RANGE 0.30 - 1.0 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method:Diazo)

Direct Serum Bilirubin


(Method: Diazo)

Indirect Serum Bilirubin Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

15.1

IU/I

0 - 41

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

27.8

IU/I

0 - 40

Serum Alkaline Phosphate


(Method: ALP - AMP)

142.7

IU/I

40 - 129

Serum Total Protein


(Method: Biuret)

7.77

g/dl

6.6 - 8.7

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.80 3.97 0.95

g/dl

3.97 - 4.95

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

NOTE : Above test carried out by Cobas Integra 400 plus automated biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD Dr.H.P.Kumar, MD Blood


RESULT LIPID PROFILE
174.6

MRN:Ex.001498 Lab No.:B-0/08/1642 Date: 23/8/2009


UNIT REFERENCE RANGE

Total Serum Cholesterol

mg/dl

(Method-CHOD-PAP) (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 92.3 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : (Low <40 mg/dl ;High 60 mg/dl) 69.1 mg/dl

(Method- Homogeneous enzymatic colorimetric assay)


Serum Low Density
87 mg/dl

Lipoprotein Cholesterol (LDL-C) :

(Method- Homogeneous enzymatic colorimetric assay)


(<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

18.46

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.53

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.56

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD Dr.H.P.Kumar, MD Blood


RESULT UNIT

MRN:Ex.001498 Lab No.:B-0/08/1642 Date: 23/8/2009


REFERENCE RANGE

Blood Sugar Fasting

192

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

96 1.91 8.84 3.77

mg/dl mg/dl mg/dl mg/dl

13 - 43 0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5
2.5 6.8

Serum Uric Acid


(Method : Uricase-POD)

8.44

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 4.90 1.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

Serum Calcium Ionized :

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Referred By: Dr.H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 80Y/F MRN:Ex.001498 Lab No.:B-0/08/1642 Date: 23/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

7.6%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Note : Above test carried out by D-10 Hb A1c analyzer.


Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.U.Siddiqui Age/Sex: 63Y/M

Pt. Location: Referred By: Specimen:


PARAMETER

OPD Dr.M.Husain Blood


RESULT UNIT

MRN:7992 Lab No.:B-0/08/1560 Date: 22/8/2009


REFERENCE RANGE

Blood Sugar Fasting

204.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

230

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.21

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

138.0 4.60

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.U.Siddiqui Pt. Location: OPD Age/Sex: 63Y/M MRN:7992

Referred By: Specimen:


PARAMETER

Dr.M.Husain Blood
RESULT UNIT

Lab No.:B-0/08/1560 Date: 22/8/2009


REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.62 mg/dl 0.18 0.44 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

22.8

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

23.2

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

38.5

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.4

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.30 3.1 1.38

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Sushma Agarwal Pt. Location: MHC Age/Sex: 54Y/F MRN: 0

Referred By: Specimen:


PARAMETER

SELF Blood
RESULT UNIT

Lab No.:B-0/08/1561 Date: 22/8/2009


REFERENCE RANGE

Blood Sugar Fasting

101

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

43

mg/dl

13 - 43

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.0

mg/dl

0.70 - 1.30

Serum Uric Acid


(Method : Uricase-POD)

7.3

mg/dl U/I

2.5 6.8
135 - 225

Serum LDH
Method: DGKC IFCC

187

CK-MB
Method- Immunoinhibition

12.2 68.6

U/L U/L

0-25 38 - 174

CPK

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Sushma Agarwal Pt. Location: MHC Age/Sex: 54Y/F MRN: 0

Referred By: Specimen:


PARAMETER

SELF Blood
RESULT UNIT

Lab No.:B-0/08/1561 Date: 22/8/2009


REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.45 mg/dl 0.12 0.33 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

36

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

33

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

77

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.45

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.4 4.05 1.08

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Sushma Agarwal Pt. Location: MHC Age/Sex: 54Y/F MRN: 0

Referred By: Specimen:


PARAMETER

SELF Blood
RESULT LIPID PROFILE UNIT

Lab No.:B-0/08/1561 Date: 22/8/2009


REFERENCE RANGE

Total Serum Cholesterol

245 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 93.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 51.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

174.9

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

18.75

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.74

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.38

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Devan Yadav Age/Sex: 75y/M

Pt. Location: IPD/G.W Referred By: Dr.M.Ahamad Specimen: URINE PARAMETER

RESULT

UNIT

MRN:SH/LKO/006934/09 Lab No.:B-/08/1576 Date: 22.8.2009 REFERENCE RANGE

URINARY PROTEIN (24 Hrs)


Total Urinary Volume 11.5 1340 Liter

ML mg/day 40-150 mg/day

Urinary protein (24 Hrs)

9299.6

*MINIMAL proteinuria (<1.0g/day) present in postural proteinuria and transient proteinuria.It is also
seen with inactive phase of glomerular disease ,nephrosclerosis,chronic interstitial nephritis,congenital diseases such as polycystic disease and medullary cystic disease ,and renal tubular diseases. *Moderate proteinuria (1.0-4.0 g/day) found in vast majority of renal diseases ,as well as nephrosclerosis,multiple myeloma,toxic nephropathies along with degenerative,malignant and inflammatory conditions of lower urinary tract. *Heavy proteinuria(>4 g/day) characteristically seen with the nephritic syndrome.

URINARY CREATININE(24 Hrs) Urinary Creatinine (24 Hrs) 417.3 mg/day M :- 1000-2000 mg/day F :- 800-1800 mg/day

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Age/Sex: 66/M

Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Pleural Fluid PARAMETER
Pleural fluid Protein Pleural fluid Glucose Pleural fluid lactate dehydrogenase(LDH)

RESULT
4.53 162

UNIT
g/dl mg/dl

MRN:SH/LKO/008138/09 Lab No.:B-/08/1598 Date: 22.8.2009 REFERENCE RANGE


<3.0 g/dl -Transudate >3.0 g/dl -Exudate 60-160 mg/dl -Normal

1465

U/L

> 300 U/L- Exudate

ADENOSINE DEAMINASE ADA (Pleural Fluid ) 44 U/L < 40

Comments- ADA is particularly abundant in T lymphocytes,which is increased in


tuberculosis.Its measurement hs been recommended in the diagnosis of pleural,peritoneal & meningeal tuberculosis ADA levels greater than 15 U/L was found to be a strong indicator of tubercular meningitis.Cut off value for tubercular peritonitis and tubercular pericarditis is 30 U/L .For tubercular pleuritis the value is 40 U/L.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Age/Sex: 70y/M

Pt. Location: IPD/E.W Referred By: Dr.Puneet Gupta Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 192.8 3.4 88 182.2 2.98 8.1

UNIT mg/dl mg/dl U/L U/L mg/dl mg/dl

MRN:SH/LKO/008142/09 Lab No.:B-/08/1601 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30 28 - 100 13 - 60 1.7 - 2.5 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Amylase Serum Lipase Magnesium Serum Calcium


(Method: arsenazo III)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium Serum Calcium Ionized :

135.0 4.50 1.1

mmol/l mmol/l mmol/l

135 - 145 3.5 - 5.5 1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Age/Sex: 70y/M

Pt. Location: IPD/E.W MRN:SH/LKO/008142/09 Referred By: Dr.Puneet Gupta Lab No.:B-/08/1601 Specimen: BLOOD Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.10 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.50 0.60

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

32

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

72

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

61

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.25

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.80 3.45 0.81

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Age/Sex: 6y/M

Pt. Location: IPD/SICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 467

UNIT mg/dl

MRN:SH/LKO/008142/09 Lab No.:B-/08/1613 Date: 22.8.2009 REFERENCE RANGE 70 - 140

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

452.9 3.31

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

188.0 4.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Age/Sex: 6y/M

Pt. Location: IPD/SICU MRN:SH/LKO/008142/09 Referred By: Dr.Mazhar Husain Lab No.:B-/08/1613 Specimen: BLOOD Date: 22.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.23 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.07 0.16

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

240.5

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

454

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

223.2

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.01

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.9 4.11 0.94

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.R.K.Bajpai Age/Sex: 63y/M

Pt. Location: IPD/E.W Referred By: Dr.Abhishek Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 27.5 0.65

UNIT mg/dl mg/dl

MRN:SH/LKO/008144/09 Lab No.:B-/08/1614 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

132.0 3.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.R.K.Bajpai Pt. Location: IPD/E.W Age/Sex: 63y/M MRN:SH/LKO/008144/09

Referred By: Dr.Abhishek Lab No.:B-/08/1614 Specimen: BLOOD Date: 23.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.53 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.13 0.40

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

29.2

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

27.3

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

77.6

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.55

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.5 4.05 0.86

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Malti Devi Pt. Location: IPD/CCU Age/Sex: 57y/F MRN:SH/LKO/007664/09

Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea


Methodology- Urease- GLDH, Kinetic

RESULT 25.4 0.64

UNIT mg/dl mg/dl

Lab No.:B-/08/1617 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vishi Devi Pt. Location: IPD/ M.I.C.U Age/Sex: 50y/F MRN:SH/LKO/007639/08/09

Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER

RESULT

UNIT

Lab No.:B-/08/1618 Date: 23.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

143.0 3.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Age/Sex: 38y/M MRN:SH/LKO/007836/08/09

Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Lab No.:B-/08/1619 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

107.9 2.54

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

147.0 3.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ketki Devi Pt. Location: IPD/NICU Age/Sex: 47/F MRN:SH/LKO/008004/09

Referred By: Dr.S.K.Somani Specimen: Blood PARAMETER

RESULT

UNIT

Lab No.:B-/08/1620 Date: 21.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

151.0 5.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast Ankit Age/Sex: 15y/M

Pt. Location: IPD/MICU Referred By: Dr.M..Husain. Specimen: Blood PARAMETER

RESULT

UNIT

MRN:SH/LKO/007559/09 Lab No.:B-/08/1621 Date: 23.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

137.0 3.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Hari Shanker Shukla Pt. Location: IPD/MICU Age/Sex: 70y/M MRN:SH/LKO/007921/08/09

Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Serum Urea


Methodology- Urease- GLDH, Kinetic

RESULT 117 3.5

UNIT mg/dl mg/dl

Lab No.:B-/08/1623 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

140.0 3.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Age/Sex: 62y/M

Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER

RESULT

UNIT

MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1622 Date: 23.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

132.0 4.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Age/Sex: 51y/F MRN:SH/LKO/007253/08/09

Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER Blood Urea Nitrogen
Method Urease GLDH Kinetic

RESULT 130.23 2.2

UNIT mg/dl mg/dl

Lab No.:B-/08/1624 Date: 23.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

150.0 3.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saraswati Devi Pt. Location: IPD/MICU Age/Sex:70/F MRN:SH/LKO/008042/09

Referred By: Dr.H.N Tripathi Specimen: Blood PARAMETER Serum Urea


Methodology- Urease- GLDH, Kinetic

RESULT 87.5 3.69

UNIT mg/dl mg/dl

Lab No.:B-/08/1625 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

139.0 2.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kamlesh Kumari Pt. Location: IPD/ MICU Age/Sex: 35y/F MRN:SH/LKO/007860/08/09

Referred By: Dr. R. Kohli Specimen: BLOOD PARAMETER

RESULT

UNIT

Lab No.:B-/08/1626 Date: 23.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

135.0 3.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Jamila Begam Pt. Location: IPD/N.ICU Age/Sex: 80y/F MRN:SH/LKO/007772/08/09

Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl

Lab No.:B-/08/1627 Date: 23.8.2009 REFERENCE RANGE

41.7

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.64

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

150.0 3.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sushma Pandey Pt. Location: IPD/SICU Age/Sex: 41y/F MRN:SH/LKO/007236/08/09

Referred By: Dr.Swadesh Singh Specimen: BLOOD PARAMETER RESULT Serum Albumin
(Method: Bromo Cresol Green BCG))

UNIT g/dl

Lab No.:B-/08/1628 Date: 23.8.2009 REFERENCE RANGE 3.2 - 5.0

2.2

Serum Urea
Methodology- Urease- GLDH, Kinetic

43.2 1.21

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohad Farooq Pt. Location: IPD/S.ICU Age/Sex: 55y/M MRN:SH/LKO/007979/09

Referred By: Dr. Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl

Lab No.:B-/08/1629 Date: 23.8.2009 REFERENCE RANGE

144.7

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

10.96

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

128.0 5.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohad Farooq Pt. Location: IPD/S.ICU Age/Sex: 55y/M MRN:SH/LKO/007979/09

Referred By: Dr. Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT

UNIT

Lab No.:B-/08/1629 Date: 23.8.2009 REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 6.7% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shakuntla Pt. Location: IPD/SICU Age/Sex: 85y/F MRN:SH/LKO/007538/08/09

Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Lab No.:B-/08/1630 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

67.4 1.43

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

130.0 3.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/SICU Age/Sex: 55y/F MRN:SH/LKO/008075/08/09

Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER

RESULT

UNIT

Lab No.:B-/08/1631 Date: 23.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

139.0 5.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Age/Sex: 79y/M MRN:SH/LKO/03660/09

Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER

RESULT

UNIT

Lab No.:B-/08/1632 Date: 23.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

119.0 5.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Jagdish Pandey Pt. Location: IPD/SICU Age/Sex: 72y/M MRN:SH/LKO/007761/09

Referred By: Dr. Mufazal Ahamad Specimen: BLOOD PARAMETER RESULT

UNIT

Lab No.:B-/08/1633 Date: 23.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

133.0 3.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Blood Urea Nitrogen


Method Urease GLDH Kinetic

40.95

mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

4.42

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Malti Srivastava Pt. Location: IPD/Ct.step Age/Sex: 59y/F MRN:SH/LKO/004852/09

Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Blood Sugar Fasting 75.7

UNIT mg/dl

Lab No.:B-/08/1634 Date: 23.8.2009 REFERENCE RANGE 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

88

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Abhinandan Swaroop Pt. Location: IPD/Ct.step Age/Sex: 67y/M MRN:SH/LKO/007651/09

Referred By: Dr.Mazhar Husain Specimen: Blood PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl mg/dl

Lab No.:B-/08/1635 Date: 23.8.2009 REFERENCE RANGE

44.94 96 1.69

6 to 20
13 - 43 0.70 - 1.30

Serum Urea
Methodology- Urease- GLDH, Kinetic

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

139.0 2.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs Kamla Kapoor Pt. Location: IPD/T.Icu Referred By: Dr. H.N.Tripathi Age/Sex: 72y/F MRN:SH/LKO/007647/09 Lab No.:B-/08/1637

Specimen: BLOOD PARAMETER

RESULT

UNIT

Date: 23.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

132.0 3.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fakkruddin Pt. Location: IPD/E/W Referred By: Dr. Mufazal Ahmad Age/Sex: 72y/M MRN:SH/LKO/07589/09 Lab No.:B-/08/1638

Specimen: BLOOD PARAMETER Serum Sodium Serum Potassium

RESULT 135.0 5.7

UNIT mmol/l mmol/l

Date: 23.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Age/Sex: 51/M MRN:SH/LKO/006354/08/09 Lab No.:B-/08/1639

Specimen: BLOOD PARAMETER Blood Urea Nitrogen


Method Urease GLDH Kinetic

RESULT 94.95 6.34

UNIT mg/dl mg/dl

Date: 23.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

125.0 4.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Avadesh Narain Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Age/Sex: 56y/M MRN:SH/LKO/007658/08/09 Lab No.:B-/08/1640

Specimen: BLOOD PARAMETER Blood Urea Nitrogen


Method Urease GLDH Kinetic

RESULT 26.16 2.08

UNIT mg/dl mg/dl

Date: 23.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mohd Rafeeq Pt. Location: IPD/G/W Referred By: Dr. R.K Mishra Age/Sex: 65/M MRN:SH/LKO/008127/09 Lab No.:B-/08/1641

Specimen: Blood PARAMETER Blood Sugar Fasting

RESULT 81.0

UNIT mg/dl

Date: 23.8.2009 REFERENCE RANGE 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Rawat Pt. Location: IPD/E.W Referred By: Dr.Sandeep Age/Sex: 28y/F MRN:SH/LKO/007649/09 Lab No.:B-/08/1643

Specimen: Blood PARAMETER Serum Calcium


(Method: arsenazo III)

RESULT 8.95

UNIT mg/dl

Date: 23.8.2009 REFERENCE RANGE 8.4- 10.4

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

142.0 4.10

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Pt. Location: IPD/ G/W Referred By: Dr.Sunil Dabadghao Specimen: BLOOD Age/Sex: 43y/M MRN:SH/LKO/008002/08/09 Lab No.:B-/08/1644 Date: 23.8.2009

PARAMETER Serum Uric Acid


(Method : Uricase-POD)

RESULT
11.64

UNIT mg/dl mg/dl mg/dl

REFERENCE RANGE 2.5 6.8 13 - 43 0.70 - 1.30

Serum Urea
Methodology- Urease- GLDH, Kinetic

93 4.45

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 4.2

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Kunwar Chand Pt. Location: IPD/ G/W Referred By: Dr.V.K.Tiwari Specimen: BLOOD PARAMETER RESULT Age/Sex: 57y/M MRN:SH/LKO/001428/08/09 Lab No.:B-/08/1645 Date: 23.8.2009 REFERENCE RANGE

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

23 1.0

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

134.0 4.10

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bhanu Mati Verma Pt. Location: IPD/ E/W Referred By: Dr.Nitin Joshi Specimen: BLOOD PARAMETER RESULT Age/Sex: 58y/F MRN:SH/LKO/001439/08/09 Lab No.:B-/08/1646 Date: 23.8.2009 REFERENCE RANGE

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

40 1.1

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

140.0 3.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shyama Kumari Pt. Location: IPD/ G/W Referred By: Dr.Sandeep Agarwal Specimen: BLOOD PARAMETER RESULT Age/Sex: 60y/F MRN:SH/LKO/008146/08/09 Lab No.:B-/08/1647 Date: 23.8.2009 REFERENCE RANGE

UNIT

Serum Urea
Methodology- Urease- GLDH, Kinetic

49 1.0

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shyama Kumari Pt. Location: IPD/ G/W Referred By: Dr.Sandeep Agarwal Specimen: BLOOD PARAMETER RESULT UNIT LIVER FUNCTION TEST Age/Sex: 60y/F MRN:SH/LKO/008146/08/09 Lab No.:B-/08/1647 Date: 23.8.2009 REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

0.74 0.24 0.50

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

25

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

23

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

66

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.40

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.10 3.30 1.32

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1648 Date: 23.8.2009 REFERENCE RANGE

UNIT

Serum Calcium
(Method: arsenazo III)

8.1

mg/dl

8.4- 10.4

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.08

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail:saharahospitals.com

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Dinesh Bajpai Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT Age/Sex: 65y/M MRN:SH/LKO/007336/09 Lab No.:B-/08/1649 Date: 23.8.2009 REFERENCE RANGE

UNIT

Serum Sodium

133.0

mmol/l

135 - 145

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Pt. Location: IPD/SICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea 333 Age/Sex: 6y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1651 Date: 23.8.2009 REFERENCE RANGE 13 - 43

UNIT mg/dl

Methodology- Urease- GLDH, Kinetic

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.84

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

172.0 4.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.C.L.Jaiswal Pt. Location: IPD/E.W Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER Total Serum Bilirubin Age/Sex: 57y/M MRN:SH/LKO/0088145/09 Lab No.:B-/08/1652 Date: 23.8.2009 REFERENCE RANGE 0.30 - 1.20

RESULT 5.48

UNIT mg/dl

(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

4.52 0.97

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

14

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

15

IU/I

0 - 42

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shaheeda Raza Pt. Location: IPD/G.W Referred By: Dr.V.K.Tiwari Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 104 Age/Sex: 40y/F MRN:SH/LKO/006819/09 Lab No.:B-/08/1657 Date: 23.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

16.9 0.63 25.7 46.4

mg/dl mg/dl U/L U/L

13 - 43 0.70 - 1.30 0-25 38 - 174

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

CK-MB
Method- Immunoinhibition

CPK

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

TROPONIN T (Qualitative

NEGATIVE

A positive result means that the concentration of troponin T in the sample is above the tests threshold value of 0.1ng/ml .This is evidence of cell damage to the myocardium. *Test performed by Troponin T Rapid test from Roche Diagnostics GmbH.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/11659 Date: 23.8.2009 UNIT REFERENCE RANGE

Ammonia
(Method: Enzymatic)

83.3

mol/l

Male 16 - 60 Female 11- 51

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/MICU Referred By: Dr. Mufazal Ahmad Specimen: Blood PARAMETER RESULT Serum Urea 99
Methodology- Urease- GLDH, Kinetic

Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1660 Date: 23.8.2009 UNIT REFERENCE RANGE mg/dl 13 - 43

Blood Urea Nitrogen


Method Urease GLDH Kinetic

46.3 4.75

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

137.0 4.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Chanchal Singh Pt. Location: IPD/N.ICU Referred By: Dr. Mazhar Husain Specimen: Blood PARAMETER RESULT Serum Urea 21.5 Age/Sex: 25/M MRN:SH/LKO/005975/09 Lab No.:B-/08/1661 Date: 23.8.2009 REFERENCE RANGE 13 - 43

UNIT mg/dl

Methodology- Urease- GLDH, Kinetic

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.7

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

142.0 3.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Chanchal Singh Age/Sex: 25/M Pt. Location: IPD/N.ICU MRN:SH/LKO/005975/09 Referred By: Dr. Mazhar Husain Lab No.:B-/08/1661 Specimen: Blood Date: 23.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.17 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.03 0.14

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

25.3

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

16.9

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

108

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.73

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.6 3.13 1.46

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Pt. Location: IPD/SICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 6y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1662 Date: 23.8.2009 REFERENCE RANGE

UNIT

Serum Sodium

181.0

mmol/l

135 - 145

Serum Potassium

4.0

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Virendra Kumar Pt. Location: IPD/Pvt.6 Referred By: Dr.(Col) S.Sablok Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl

Age/Sex: 57y/M MRN:SH/LKO/007953/09 Lab No.:B-/08/1663 Date: 23.8.2009 REFERENCE RANGE 13 - 43

21

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.25

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 3.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 169 6.52

UNIT mg/dl mg/dl

Age/Sex: 62y/M MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1665 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine

Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

131.0 4.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.S.N.Lal Pt. Location: IPD/E.W Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 136 1.39

UNIT mg/dl mg/dl

Age/Sex: 58y/M MRN:SH/LKO/008150/08/09 Lab No.:B-/08/1666 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 3.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.S.N.Lal Pt. Location: IPD/E.W Referred By: Dr.Alok Specimen: BLOOD PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)

RESULT UNIT LIVER FUNCTION TEST 4.82 mg/dl 3.81 mg/dl

Age/Sex: 58y/M MRN:SH/LKO/008150/08/09 Lab No.:B-/08/1666 Date: 23.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

1.01

mg/dl

0.08 - 0.75

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

59.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

220.4

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

1188.8

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.14

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.7 2.44 1.51

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Shadab Pt. Location: IPD/NICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 6y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1669 Date: 23.8.2009 REFERENCE RANGE
at.9;15pm

UNIT

Serum Sodium Serum Potassium

180.0 4.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Papia Mukherjee Pt. Location: IPD/E/W Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)

UNIT mg/dl mg/dl mg/dl

Age/Sex: 46y/F MRN:SH/LKO/004797/09 Lab No.:B-/08/1670 Date: 23.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

1.05 0.26 0.79

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin

(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

45.2

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

36.4

IU/I

0 - 42

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.89

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

129.0 3.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saraswati Devi Pt. Location: IPD/M.I.C.U Referred By: Dr.H.N Tripathi Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex:70/F MRN:SH/LKO/008042/09 Lab No.:B-/08/1672 Date: 23.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

60.6 2.81

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

139.0 3.6

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Vishi Devi Pt. Location: IPD/ M.I.C.U Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER Age/Sex: 50y/F MRN:SH/LKO/007639/08/09 Lab No.:B-/08/1677 Date: 24.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Sodium Serum Potassium

140.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kamlesh Kumari Pt. Location: IPD/MICU Referred By: Dr. V.Khanna Specimen: Blood PARAMETER RESULT Age/Sex: 35y/F MRN:SH/LKO/007840/09 Lab No.:B-/08/1680 Date: 24.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

136.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast Ankit Pt. Location: IPD/MICU Referred By: Dr.M..Husain. Specimen: Blood PARAMETER Age/Sex: 15y/M MRN:SH/LKO/007559/09 Lab No.:B-/08/1679 Date: 24.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Sodium Serum Potassium

135.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1674 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

316.5 2.49

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

152.0 3.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/MICU Referred By: Dr. M.Ahmed Specimen: Blood PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1675 Date: 24.8.2009 REFERENCE RANGE

52.26 5.14

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

134.0 4.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ashish Mital Pt. Location: IPD/MICU Referred By: Dr. Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 38/M MRN:SH/LKO/004836/09 Lab No.:B-/08/1676 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

131.2 2.36

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

151.0 3.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 226.6 7.83

UNIT mg/dl mg/dl

Age/Sex: 62y/M MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1678 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

129.0 4.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Hari Shanker Shukla Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 70y/M MRN:SH/LKO/007921/08/09 Lab No.:B-/08/1681 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

153.5 3.97

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

141.0 3.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sarswati Devi Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 70y/M MRN:SH/LKO/008042/08/09 Lab No.:B-/08/1682 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

66.8 3.2

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

137.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Pt. Location: IPD/E.W Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 70y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1685 Date: 24.8.2009 REFERENCE RANGE

107.76 3.29

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

139.0 4.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohad Farooq Pt. Location: IPD/SICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 55y/M MRN:SH/LKO/007979/09 Lab No.:B-/08/1686 Date: 24.8.2009 REFERENCE RANGE

94.2 8.27

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

126.0 4.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Jagdish Pandey Pt. Location: IPD/SICU Referred By: Dr. M Ahamad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 72y/M MRN:SH/LKO/007761/09 Lab No.:B-/08/1587 Date: 24.8.2009 REFERENCE RANGE

44.14 4.8

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

132.0 3.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER RESULT Age/Sex: 79y/M MRN:SH/LKO/03660/09 Lab No.:B-/08/1688 Date: 24.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

121.0 5.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/SICU Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 55y/F MRN:SH/LKO/008075/08/09 Lab No.:B-/08/1689 Date: 24.8.2009 REFERENCE RANGE

22.61 2.27

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

141.0 4.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.R.K.Bajpai Pt. Location: IPD/SICU Referred By: Dr.Abhishek Specimen: BLOOD PARAMETER Age/Sex: 63y/M MRN:SH/LKO/008144/09 Lab No.:B-/08/1690 Date: 24.8.2009 REFERENCE RANGE

RESULT

UNIT

Serum Sodium Serum Potassium

129.0 3.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Shakuntla Pt. Location: IPD/MICU Referred By: Dr.Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 85y/F MRN:SH/LKO/007538/08/09 Lab No.:B-/08/1691 Date: 24.8.2009 REFERENCE RANGE

75.2 2.13

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

128.0 5.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Mohd Sadab Pt. Location: IPD/NICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 6y/M MRN:SH/LKO/008143/09 Lab No.:B-/08/1692 Date: 24.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

179.0 4.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Ibtessam Anjum Pt. Location: IPD/Gyane Referred By: Dr.Manjusha Specimen: BLOOD PARAMETER RESULT Blood Sugar Fasting 88.4 Age/Sex: 28y/F MRN:SH/LKO/007953/09 Lab No.:B-/08/1693 Date: 24.8.2009 UNIT REFERENCE RANGE mg/dl 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Devan Yadav Pt. Location: IPD/G.W Referred By: Dr.M.Ahamad Specimen: BLOOD PARAMETER RESULT Age/Sex: 75y/M MRN:SH/LKO/006934/09 Lab No.:B-/08/1546 Date: 22.8.2009 REFERENCE RANGE

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

74 3.33

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium

133.0

mmol/l

135 - 145

Serum Potassium

5.0

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr.H.P.Kumar Pt. Location: OPD Referred By: Dr.Self Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 64y/M MRN:SH/LKO/002049/09 Lab No.:B-/08/1714 Date: 24.8.2009 REFERENCE RANGE 70 - 110

Tr. No.7461 RESULT 99.0

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

22.5 0.9
4.58

mg/dl mg/dl mg/dl

13 - 43 0.70 - 1.30 2.5 6.8

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Uric Acid


(Method : Uricase-POD)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr.H.P.Kumar Age/Sex: 64y/M Pt. Location: OPD MRN:SH/LKO/002049/09 Referred By: Dr.Self Lab No.:B-/08/1714 Specimen: BLOOD Tr. No.7461 Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 1.05 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.37 0.68

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

38.2

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)

28.7

IU/I

0 - 42

(Method: IFCC Without Pyridoxal Phosphate))

Serum Alkaline Phosphatase


(Method: ALP - AMP)

77.5

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.20

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.90 3.30 1.18

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr.H.P.Kumar Pt. Location: OPD Referred By: Dr.Self Specimen: BLOOD PARAMETER
Total Serum Cholesterol

Tr. No.7461 RESULT

UNIT

Age/Sex: 64y/M MRN:SH/LKO/002049/09 Lab No.:B-/08/1714 Date: 24.8.2009 REFERENCE RANGE

LIPID PROFILE
95 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 87.2 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 33 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

44.5

mg/dl

Lipoprotein Cholesterol (LDL-C) :

(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

17.44

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.87

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.35

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7460 PARAMETER RESULT Blood Sugar Fasting 118.0 Age/Sex: 55y/F MRN:SH/LKO/001542/09 Lab No.:B-/08/1715 Date: 24.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

21.8 0.69
4.13

mg/dl mg/dl mg/dl

13 - 43 0.70 - 1.30 2.5 6.8

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Uric Acid


(Method : Uricase-POD)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

139.0 5.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7460 PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
216.9 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 55y/F MRN:SH/LKO/001542/09 Lab No.:B-/08/1715 Date: 24.8.2009 REFERENCE RANGE

Serum Triglycerides 331.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 38.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

111.7

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High;

160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

66.37

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.59

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.88

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Asha Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7460 PARAMETER RESULT Age/Sex: 55y/F MRN:SH/LKO/001542/09 Lab No.:B-/08/1715 Date: 24.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 7.6% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment

goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Gunjan Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.6461 PARAMETER RESULT Blood Sugar Fasting 81.4 Age/Sex: 55y/F MRN:SH/LKO/002049/09 Lab No.B-08/1716 Date: 24-8-2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

21.4 0.87
4.49

mg/dl mg/dl mg/dl

13 - 43 0.70 - 1.30 2.5 6.8

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Uric Acid


(Method : Uricase-POD)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Gunjan Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7461 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.49 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)

Age/Sex: 55y/F MRN:SH/LKO/002049/09 Lab No.B-08/1716 Date: 24-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.39

mg/dl mg/dl

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

35.1

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

27.3

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

84.4

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.36

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.90 3.46 1.12

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Gunjan Kumar Pt. Location: OPD Referred By: Dr.H.P.Kumar MD Specimen: BLOOD Tr. No.7461 PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
168.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 55y/F MRN:SH/LKO/002049/09 Lab No.B-08/1716 Date: 24-8-2009 REFERENCE RANGE

Serum Triglycerides 114 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 31.5 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

114.22

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

22.88

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.35

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.62

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Rahmatullah Pt. Location: OPD Referred By: Dr.Manoj Mishra Specimen: BLOOD Tr. No.20602 PARAMETER RESULT Blood Sugar Random 84 Age/Sex: 62y/M MRN:SH/LKO/008171/09 Lab No.B-08/1742 Date: 24-8-2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

27.7 1.24

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Manish Singh Pt. Location: OPD Referred By: Dr.P.K.Samshrey Specimen: BLOOD Tr. No.20547 PARAMETER RESULT Blood Sugar Random 61.3 Age/Sex: 25y/M MRN:SH/LKO/008075/09 Lab No.B-08/1741 Date: 24-8-2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.32

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Surender Kumar Pt. Location: IPD/ T.ICU Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Serum Uric Acid
(Method : Uricase-POD)

UNIT mg/dl

Age/Sex: 65y/M MRN:SH/LKO/007690/08/09 Lab No.:B-/08/1700 Date: 24.8.2009 REFERENCE RANGE 2.5 6.8

7.34

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Bharat Lal Pt. Location: IPD/G/W Referred By: Dr. H.N Tripathi MD Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

Age/Sex: 51/M MRN:SH/LKO/006354/08/09 Lab No.:B-/08/1702 Date: 24.8.2009 REFERENCE RANGE

82.69 5.8

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

127.0 4.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Amit Kushwaha Pt. Location: IPD/G/W Referred By: Dr. H.N Tripathi MD Specimen: BLOOD PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)

UNIT mg/dl mg/dl mg/dl

Age/Sex: 24y/M MRN:SH/LKO/06223/09 Lab No.:B-/08/1703 Date: 24.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

5.77 5.09 0.68

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

811.6

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

555.4

IU/I

0 - 42

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT Blood Sugar Fasting 125 Age/Sex: 54y/M MRN:SH/LKO/008160/09 Lab No.B-08/1720 Date: 24-8-2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

157.3

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

11.2 0.91 8.99 3.7

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

6.36

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.2

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.70 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)

Age/Sex: 54y/M MRN:SH/LKO/008160/09 Lab No.B-08/1720 Date: 24-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.18 0.52

mg/dl mg/dl

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

15.7

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

19.4

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

124.2

IU/I

42 - 128

Serum Total Protein

8.18

g/dl

6.0 - 8.3

(Method: Biuret)

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.10 4.08 1.0

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
168.9 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 54y/M MRN:SH/LKO/008160/09 Lab No.B-08/1720 Date: 24-8-2009 REFERENCE RANGE

Serum Triglycerides 86.4 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 41 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

110.6

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

17.28

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.12

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.7

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 121

UNIT

Age/Sex: 54y/M MRN:SH/LKO/008160/09 Lab No.B-08/1720 Date: 24-8-2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

93.9

apo-A1/apo-B Ratio

1.28

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Girija Shankar Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No.78 PARAMETER RESULT Age/Sex: 54y/M MRN:SH/LKO/008160/09 Lab No.B-08/1720 Date: 24-8-2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 7.4% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 51y/M MRN:SH/LKO/008159/09 Lab No.B-08/1721 Date: 24-8-2009 REFERENCE RANGE 70 - 110

Tr. No. RESULT 157

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

195

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

9.35 0.87 9.08 3.27

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

6.58

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.21

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD Tr. No. PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.35 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)

Age/Sex: 51y/M MRN:SH/LKO/008159/09 Lab No.B-08/1721 Date: 24-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.25

mg/dl mg/dl

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

41

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

21

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

100

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.39

g/dl

6.0 - 8.3

Serum Albumin

4.20

g/dl

3.2 - 5.0

(Method: Bromo Cresol Green BCG))

Serum Globulin A/G Ratio

3.19 1.31

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
Total Serum Cholesterol

Tr. No. RESULT

UNIT

Age/Sex: 51y/M MRN:SH/LKO/008159/09 Lab No.B-08/1721 Date: 24-8-2009 REFERENCE RANGE

LIPID PROFILE
198 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 424 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 29.2 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

84.2

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

84.8

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

6.78

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.88

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 136

Tr. No. RESULT

UNIT

Age/Sex: 51y/M MRN:SH/LKO/008159/09 Lab No.B-08/1721 Date: 24-8-2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

100

apo-A1/apo-B Ratio

1.36

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Moti Lal Pt. Location: OPD Referred By: M.H.C Specimen: BLOOD PARAMETER Age/Sex: 51y/M MRN:SH/LKO/008159/09 Lab No.B-08/1721 Date: 24-8-2009 REFERENCE RANGE

Tr. No. RESULT

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 8.9% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. G.K Kumar Pt. Location: OPD Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

Tr. No. 21914 RESULT UNIT 24.4 1.22 mg/dl mg/dl

Age/Sex: 59y/M MRN:SH/LKO/007561/09 Lab No.B-08/1726 Date: 24-8-2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

124.0 5.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Ms. Anjali Maurya Pt. Location: OPD Referred By: Dr. Mufazal Ahmed Specimen: BLOOD Tr. No. 20543 PARAMETER RESULT UNIT Age/Sex: 12y/F MRN:SH/LKO/005403/09 Lab No.B-08/1735 Date: 24-8-2009 REFERENCE RANGE

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.6

g/dl

3.2 - 5.0

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.69

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Lata Pt. Location: OPD Referred By: Dr. Mufazal Ahmed Specimen: BLOOD Tr. No. 20569 PARAMETER RESULT UNIT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Age/Sex: 49y/F MRN:SH/LKO/008177/09 Lab No.B-08/1736 Date: 24-8-2009 REFERENCE RANGE 0.70 - 1.30 8.4- 10.4

2.37 9.4 3.85

mg/dl mg/dl mg/dl

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

144.0 4.2

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anil Kumar Jaishwal Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 8194 PARAMETER RESULT Age/Sex: 33y/M MRN:SH/LKO/008194/09 Lab No.B-08/1731 Date: 24-8-2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 6.4% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. A. K Singh Pt. Location: OPD Referred By: Dr. Abhishek Specimen: BLOOD PARAMETER CPK Serum Alkaline Phosphatase
(Method: ALP - AMP)

Tr. No. 20548 RESULT UNIT 47.9 439.6 1.77 U/L IU/I mg/dl

Age/Sex: 51y/M MRN:SH/LKO/008186/09 Lab No.B-08/1737 Date: 24-8-2009 REFERENCE RANGE 38 - 174 42 - 128

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5 1.12 1.32

Serum Calcium Ionized :

1.17

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Atul Kumar Pandey Pt. Location: OPD Referred By: Dr. Abhishek Specimen: BLOOD Tr. No. PARAMETER RESULT Serum Glutamic Pyruvic Transminase(SGPT/ALT)
(Method: IFCC Without Pyridoxal Phosphate))

UNIT

Age/Sex: 40y/M MRN:SH/LKO/008166/09 Lab No.B-08/1738 Date: 24-8-2009 REFERENCE RANGE

17.1

IU/I

0 - 42

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.9

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 4.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.K Chanda Pt. Location: OPD Referred By: Dr. S.K Singh Specimen: BLOOD PARAMETER Serum Amylase Serum Lipase Age/Sex: 60y/M MRN:SH/LKO/008200/09 Lab No.B-08/1739 Date: 24-8-2009 REFERENCE RANGE 28 - 100 13 - 60

Tr. No. RESULT 94.8 82.7

UNIT U/L U/L

Serum Urea
Methodology- Urease- GLDH, Kinetic

19.6 1.1

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Manisha Singh Pt. Location: OPD Referred By: Dr. I. Tyagi Specimen: BLOOD Tr. No. 20562 PARAMETER RESULT UNIT Blood Sugar Random 91 mg/dl Age/Sex: 18y/F MRN:SH/LKO/008185/09 Lab No.B-08/1740 Date: 24-8-2009 REFERENCE RANGE 70 - 140

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Ms. Hellan Kabla Cheti Pt. Location: OPD Referred By: Dr. Vaibh Khanna Specimen: BLOOD Tr. No. PARAMETER RESULT Blood Sugar Random 104 Age/Sex: 33y/F MRN:SH/LKO/001825/09 Lab No.B-08/1748 Date: 24-8-2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Total Serum Bilirubin


(Method: Walter And Gerarde)

0.30 0.10 0.20

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Urea
Methodology- Urease- GLDH, Kinetic

28 0.88

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Shakuntla Pandey Pt. Location: OPD Referred By: Dr. M.Ahmed Specimen: BLOOD Tr. No. PARAMETER RESULT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

UNIT mg/dl

Age/Sex: 55y/F MRN:SH/LKO/005188/09 Lab No.B-08/1749 Date: 24-8-2009 REFERENCE RANGE 0.70 - 1.30

1.44

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

136.0 5.60

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. R.B Gupta Pt. Location: IPD/G/W Referred By: Dr. P.Gupta Specimen: Blood PARAMETER Blood Sugar Random Age/Sex: 28/M MRN:SH/LKO/008099/09 Lab No.:B-/08/1745 Date: 24.8.2009 REFERENCE RANGE 70 - 140

RESULT 85

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bhullar Prasad Pt. Location: IPD/G/W Referred By: Dr. Sablok Specimen: Blood PARAMETER RESULT Blood Sugar Random 176 Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1746 Date: 24.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

35.6 1.17

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bhullar Prasad Pt. Location: IPD/G/W Referred By: Dr. Sablok Specimen: Blood PARAMETER RESULT Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1746 Date: 24.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 5.8% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bhullar Prasad Age/Sex: 62/M Pt. Location: IPD/G/W MRN:SH/LKO/008207/09 Referred By: Dr. Sablok Lab No.:B-/08/1746 Specimen: Blood Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.37 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.27

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

63

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

51

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

285

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.11

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.90 3.21 1.21

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. G.C Mehta Pt. Location: IPD/Neuro Referred By: Dr. M.Husain Specimen: Blood PARAMETER Blood Sugar Random Age/Sex: 80y/M MRN:SH/LKO/007405/09 Lab No.:B-/08/1743 Date: 24.8.2009 REFERENCE RANGE 70 - 140

RESULT 95

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

38 0.62

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

127.0 5.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. C.L Jaishwal Pt. Location: IPD/G/W Referred By: Dr.H.N Triphati Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 57y/M MRN:SH/LKO/008145/09 Lab No.:B-/08/1729 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

58 1.55

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr. Manish Tomar Pt. Location: IPD/E/W Referred By: Dr.H.N Triphati Specimen: Blood PARAMETER RESULT Age/Sex: y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1730 Date: 24.8.2009 REFERENCE RANGE

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 8.8% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr. Manish Tomar Pt. Location: IPD/E/W Referred By: Dr.H.N Triphati Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1730 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

67.8 0.72

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

113.0 4.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Urine PARAMETER RESULT Urine microalbumin Urine Microalbumin 8.17 mg/ L <20mg/L Age/Sex: 60y/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1732 Date: 24.8.2009 REFERENCE RANGE

UNIT

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER RESULT Blood Sugar Post Prandial 257.6 Age/Sex: 60y/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1732 Date: 24.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Karuna Srivastava Pt. Location: IPD/G/W Referred By: Dr. Specimen: Blood PARAMETER RESULT
Serum IRON 151

UNIT
g/dl

Age/Sex: 40y/F MRN:SH/LKO/001892/09 Lab No.:B-/08/1734 Date: 24.8.2009 REFERENCE RANGE


Male Female 59 - 158 37-145

U.I.B.C T.I.B.C % Saturation

170.4 321.5 47

g/dl g/dl %

112 - 346

250 - 450 13 - 45

Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast. Aleem Pt. Location: IPD/PICU Referred By: Dr. M.U Hasan Specimen: Blood PARAMETER Age/Sex: 6y/M MRN:SH/LKO/008084/09 Lab No.:B-/08/1723 Date: 24.8.2009 REFERENCE RANGE

RESULT 5.92

UNIT mg/dl

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Alkaline Phosphatase


(Method: ALP - AMP)

263.6

IU/I

42 - 128 1.12 1.32

Serum Calcium Ionized :

1.14

mmol/l

C reactive protein(C.R.P)

11

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Mamta Pt. Location: IPD/PICU Referred By: Dr. M.U Hasan Specimen: Blood PARAMETER Age/Sex: NB/ MRN:SH/LKO/007034/09 Lab No.:B-/08/1725 Date: 24.8.2009 REFERENCE RANGE

RESULT

UNIT

Blood Urea Nitrogen


Method Urease GLDH Kinetic

8.76 0.49 1.12

mg/dl mg/dl mmol/l

6 to 20
0.70 - 1.30 1.12 1.32

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium Ionized :

C reactive protein(C.R.P)

< 3.08

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O Mamta Age/Sex: NB/ Pt. Location: IPD/PICU MRN:SH/LKO/007034/09 Referred By: Dr. M.U Hasan Lab No.:B-/08/1725 Specimen: Blood Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.49 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.11 0.38

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

79.2

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

207.3

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

209

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.62

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.80 2.82 0.99

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rehman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 79/M MRN:SH/LKO/003660/09 Lab No.:B-/08/1727 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

149 3.58

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Laxmi Singh Pt. Location: IPD/G/W Referred By: Dr. S.Dabadghao Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 54/F MRN:SH/LKO/008000/09 Lab No.:B-/08/1747 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

18.7 0.61

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Laxmi Singh Age/Sex: 54/F Pt. Location: IPD/G/W MRN:SH/LKO/008000/09 Referred By: Dr. S.Dabadghao Lab No.:B-/08/1747 Specimen: Blood Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.20

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

17

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

16

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

54

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.8

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.20 3.6 0.88

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Jagdamba Prasad Pt. Location: IPD/E/W Referred By: Dr. M.Husain Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 57/M MRN:SH/LKO/008226/09 Lab No.:B-/08/1764 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

45.3 1.02

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

146.0 3.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Jagdamba Prasad Age/Sex: 57/M Pt. Location: IPD/E/W MRN:SH/LKO/008226/09 Referred By: Dr. M.Husain Lab No.:B-/08/1764 Specimen: Blood Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.73 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.17 0.56

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

41.3

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

63.4

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

130.1

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.73

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.0 3.73 0.80

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Pt. Location: IPD/E.W Referred By: Dr.Puneet Gupta Specimen: BLOOD PARAMETER RESULT Age/Sex: 70y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1752 Date: 24.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

140.0 4.10

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Aditya Gupta Pt. Location: IPD/G.W Referred By: Dr. Ramesh Kohli Specimen: BLOOD PARAMETER RESULT Age/Sex: 30y/M MRN:SH/LKO/006569/09 Lab No.:B-/08/1757 Date: 24.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

141.0 4.10

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ahmer Khan Pt. Location: IPD/G.W Referred By: Dr. S. Agarwal Specimen: c.s.f PARAMETER RESULT C.S.F C.S.F Protein Glucose 33 93 Age/Sex: y/M MRN:SH/LKO/008141/09 Lab No.:B-/08/1758 Date: 24.8.2009 REFERENCE RANGE 15 - 45 40 - 80

UNIT mg/dl mg/dl

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Mohd Sadab Pt. Location: IPD/PICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 6y/M MRN:SH/LKO/008143/09 Lab No.:B-/08/1759 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

130.6 0.76

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

182.0 4.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. J.P Srivastava Pt. Location: IPD/E/W Referred By: Dr. S.Agarwal Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 59y/M MRN:SH/LKO/008223/09 Lab No.:B-/08/1760 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

47.4 1.11

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

133.0 4.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. J.P Srivastava Age/Sex: 59y/M Pt. Location: IPD/E/W MRN:SH/LKO/008223/09 Referred By: Dr. S.Agarwal Lab No.:B-/08/1760 Specimen: BLOOD Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.65 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.20 0.45

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

21.3

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

23.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

72.3

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.32

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.6 4.72 0.76

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Manish Pt. Location: IPD/M.I.C.U Referred By: Dr. R.Kohli Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 70.1 0.84

UNIT mg/dl mg/dl

Age/Sex: 45y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1762 Date: 24.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

115.0 3.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Manish Tomar Pt. Location: IPD/M.I.C.U Referred By: Dr. R.Kohli Specimen: BLOOD PARAMETER RESULT Total Serum Bilirubin
(Method: Walter And Gerarde)

UNIT mg/dl mg/dl mg/dl

Age/Sex: 45y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1763 Date: 24.8.2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

1.17 0.87 0.30

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

20.4

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

43.5

IU/I

0 - 42

CK-MB
Method- Immunoinhibition

18.2 109.5 71.8 0.85

U/L U/L mg/dl mg/dl

0-25 38 - 174 13 - 43 0.70 - 1.30

CPK Serum Urea


Methodology- Urease- GLDH, Kinetic

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Kuldeep Kumar Pt. Location: IPD/C.T Step Referred By: Dr. M.Husain Specimen: BLOOD PARAMETER RESULT Blood Sugar Random 110 Age/Sex: 37y/M MRN:SH/LKO/008187/09 Lab No.:B-/08/1750 Date: 24.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

37 0.65

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

137.0 3.80

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Kuldeep Kumar Age/Sex: 37y/M Pt. Location: IPD/C.T Step MRN:SH/LKO/008187/09 Referred By: Dr. M.Husain Lab No.:B-/08/1750 Specimen: BLOOD Date: 24.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl 0.30 - 1.20
(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10 0.20

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

83.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

28.2

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

80

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.78

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.50 3.28 0.76

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bharat Lal Awasthi Pt. Location: IPD/G/W Referred By: Dr. H.N Triphati Specimen: Urine PARAMETER RESULT Spot Urine Protein Spot Urine Creatinine 5.5 22.5 Age/Sex: 51y/M MRN:SH/LKO/006354/09 Lab No.:B-/08/1751 Date: 24.8.2009 REFERENCE RANGE

UNIT mg/dl mg/dl

Spot Urine Protein/Creatnine Ratio

0.24

Ratio

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Raghuveer Kaur Pt. Location: IPD/Neuro Referred By: Dr. M.Husain Specimen: Blood PARAMETER RESULT Serum Calcium
(Method: arsenazo III)

UNIT mg/dl

Age/Sex: 55y/M MRN:SH/LKO/008155/09 Lab No.:B-/08/1744 Date: 24.8.2009 REFERENCE RANGE 8.4- 10.4

8.72

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 10.1% %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Raghuveer Kaur Pt. Location: IPD/Neuro Referred By: Dr. M.Husain Specimen: Blood PARAMETER RESULT Blood Sugar Fasting 174.1 Age/Sex: 55y/F MRN:SH/LKO/008155/09 Lab No.:B-/08/1777 Date: 25.8.2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Dularey Verma Pt. Location: IPD/E.W Referred By: Dr.Puneet Gupta Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 70y/M MRN:SH/LKO/008142/09 Lab No.:B-/08/1778 Date: 22.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

222.6 2.8

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Blood Urea Nitrogen


Method Urease GLDH Kinetic

104

mg/dl

6 to 20

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.6

g/dl

3.2 - 5.0

Blood Sugar Fasting

193.5

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Serum Sodium Serum Potassium

141.0 3.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Ubaidur Rahman Pt. Location: IPD/SICU Referred By: Dr. V.K Tiwari Specimen: BLOOD PARAMETER RESULT Serum Sodium Serum Potassium 126.0 4.3 Age/Sex: 79y/M MRN:SH/LKO/03660/09 Lab No.:B-/08/1776 Date: 25.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5

UNIT mmol/l mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Kiran Gupta Pt. Location: IPD/S.I.C.U Referred By: Dr. H.N Triphati Specimen: BLOOD PARAMETER RESULT Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

UNIT mg/dl

Age/Sex: 55y/F MRN:SH/LKO/008075/08/09 Lab No.:B-/08/1775 Date: 25.8.2009 REFERENCE RANGE 0.70 - 1.30

2.4

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

140.0 4.2

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Prahalad Rai Pt. Location: IPD/M.I.C.U Referred By: Dr. M.Ahmed Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1765 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

104 4.6

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

129.0 4.1

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Age/Sex: 38y/M MRN:SH/LKO/007836/08/09 Lab No.:B-/08/1767 Date: 25.8.2009 REFERENCE RANGE

UNIT

Serum Sodium Serum Potassium

144.0 3.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Saraswati Devi Pt. Location: IPD/ M.I.C.U Referred By: Dr.H.N Tripathi Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex:70/F MRN:SH/LKO/008042/09 Lab No.:B-/08/1768 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

99.4 4.12

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

134.0 4.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Hari Shanker Shukla Pt. Location: IPD/MICU Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl

Age/Sex: 70y/M MRN:SH/LKO/007921/08/09 Lab No.:B-/08/1769 Date: 25.8.2009 REFERENCE RANGE

87.15

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

4.12

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

142.0 3.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.N.Shukla Pt. Location: IPD/MICU Referred By: Dr.Alok Specimen: BLOOD PARAMETER Serum Urea
Methodology- Urease- GLDH, Kinetic

RESULT 260.1 8.38

UNIT mg/dl mg/dl

Age/Sex: 62y/M MRN:SH/LKO/007845/08/09 Lab No.:B-/08/1770 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

124.0 4.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Manish Tomar Pt. Location: IPD/M.I.C.U Referred By: Dr. R.Kohli Specimen: BLOOD PARAMETER RESULT TROPONIN T (Qualitative NEGATIVE Age/Sex: 45y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1763 Date: 24.8.2009 REFERENCE RANGE

UNIT

A positive result means that the concentration of troponin T in the sample is above the tests threshold value of 0.1ng/ml .This is evidence of cell damage to the myocardium. *Test performed by Troponin T Rapid test from Roche Diagnostics GmbH.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Sunita Malhotra Pt. Location: IPD/ MICU Referred By: Dr. S.K Somani Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 51y/F MRN:SH/LKO/007253/08/09 Lab No.:B-/08/1771 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

344.7 3.06

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

141.0 4.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Dr. Manish Tomar Pt. Location: IPD/M.I.C.U Referred By: Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1772 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

77.6 0.86

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

116.0 4.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Jagdish Pandey Pt. Location: IPD/SICU Referred By: Dr. M Ahamad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl

Age/Sex: 72y/M MRN:SH/LKO/007761/09 Lab No.:B-/08/1773 Date: 25.8.2009 REFERENCE RANGE

48.23

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

4.91

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

131.0 2.9

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Mohd Farooq Pt. Location: IPD/SICU Referred By: Dr. Ravi Dubey Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl

Age/Sex: 55y/M MRN:SH/LKO/007979/09 Lab No.:B-/08/1774 Date: 25.8.2009 REFERENCE RANGE

99.59

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

8.81

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

126.0 4.8

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Pt. Location: Referred By: Specimen: PARAMETER

Mrs. Hero Rani Rastogi OPD Dr. S.K Singh BLOOD Tr. No. 20488 RESULT UNIT 115.0 mg/dl

Age/Sex: y/F MRN:SH/LKO/008162/09 Lab No.B-08/1722 Date: 24-8-2009 REFERENCE RANGE 70 - 110

Blood Sugar Fasting

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

201.9

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.71

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Hero Rani Rastogi Age/Sex: y/F

Pt. Location: OPD Referred By: Dr. S.K Singh Specimen: BLOOD PARAMETER

Tr. No. 20488 RESULT UNIT

MRN:SH/LKO/008162/09 Lab No.B-08/1722 Date: 24-8-2009 REFERENCE RANGE

LIPID PROFILE
Total Serum Cholesterol
80.1 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 52.6 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 28.4 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

40.9

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

10.52

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.81

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.44

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 38y/M MRN:SH/LKO/007836/08/09 Lab No.:B-/08/1779 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

112.4 1.92

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Pt. Location: Referred By: Specimen: PARAMETER

Mr.Bharat Lal IPD/G/W Dr. H.N Triphati BLOOD RESULT 74.6 UNIT mg/dl

Age/Sex: 51/M MRN:SH/LKO/006354/08/09 Lab No.:B-/08/1780 Date: 25.8.2009 REFERENCE RANGE

Blood Urea Nitrogen


Method Urease GLDH Kinetic

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

5.4

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

130.0 4.2

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Pt. Location: Referred By: Specimen: PARAMETER

Mr. Bhullar Prasad IPD/G/W Dr. Sablok Blood RESULT 127.0 UNIT mg/dl

Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1781 Date: 25.8.2009 REFERENCE RANGE 70 - 110

Blood Sugar Fasting

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY

Name: Pt. Location: Referred By: Specimen: PARAMETER

Mr. Bhullar Prasad IPD/G/W Dr. Sablok Blood RESULT UNIT

Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1781 Date: 25.8.2009 REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Fakkruddin Age/Sex: 72y/F

Pt. Location: IPD/E/W Referred By: Dr. Mufazal Ahmad Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl

MRN:SH/LKO/07589/09 Lab No.:B-/08/1782 Date: 25.8.2009 REFERENCE RANGE

67.48 5.95

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

135.0 4.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Shiv Balak Singh Age/Sex: 66/M

Pt. Location: IPD/G/W Referred By: Dr. Alok Specimen: Blood PARAMETER Blood Sugar Fasting

RESULT 185.2

UNIT mg/dl

MRN:SH/LKO/008138/09 Lab No.:B-/08/1783 Date: 25.8.2009 REFERENCE RANGE 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Age/Sex: 43y/M

Pt. Location: IPD/ E/W Referred By: Dr. Mufazal Ahmed Specimen: BLOOD PARAMETER RESULT Serum Uric Acid
(Method : Uricase-POD)

UNIT mg/dl mg/dl

MRN:SH/LKO/008002/08/09 Lab No.:B-/08/1784 Date: 25.8.2009 REFERENCE RANGE 2.5 6.8 0.70 - 1.30

10.61
4.85

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

137.0 3.4

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Mohd Sadab Age/Sex: 6y/M

Pt. Location: IPD/NICU Referred By: Dr.Mazhar Husain Specimen: BLOOD PARAMETER RESULT

UNIT

MRN:SH/LKO/008143/09 Lab No.:B-/08/1786 Date: 25.8.2009 REFERENCE RANGE

Serum Sodium Serum Potassium

168.0 4.5

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Maneesh Kumar Pt. Location: OPD Referred By: Dr. Self Age/Sex: 38 y/M MRN:SH/LKO/008230/09 Lab No.B-08/1788

Specimen: BLOOD PARAMETER

Tr. No. RESULT

UNIT

Date: 25-8-2009 REFERENCE RANGE

LIPID PROFILE
Total Serum Cholesterol
203.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 166.2 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 43.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

126.6

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

33.24

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.65

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.89

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Maneesh Kumar Pt. Location: OPD Referred By: Dr. Self Specimen: BLOOD Tr. No. Age/Sex: 38 y/M MRN:SH/LKO/008230/09 Lab No.B-08/1788 Date: 25-8-2009

PARAMETER Blood Sugar Fasting

RESULT 101.1

UNIT mg/dl

REFERENCE RANGE 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

86.4

IU/I

0 - 42

Blood Urea Nitrogen


Method Urease GLDH Kinetic

17.08 0.91

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Justic O.P Srivastava Pt. Location: OPD Referred By: Dr. Mahesh Chandra Specimen: BLOOD Tr. No. PARAMETER RESULT Age/Sex: 65 y/M MRN:SH/LKO/008228/09 Lab No.B-08/1789 Date: 25-8-2009 REFERENCE RANGE

UNIT

Blood Sugar Fasting

100.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

15.7

IU/I

0 - 42

Blood Urea Nitrogen


Method Urease GLDH Kinetic

12.31 0.88

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Justic O.P Srivastava Pt. Location: OPD Referred By: Dr. Mahesh Chandra Specimen: BLOOD Tr. No. PARAMETER RESULT
LIPID PROFILE

UNIT

Age/Sex: 65 y/M MRN:SH/LKO/008228/09 Lab No.B-08/1789 Date: 25-8-2009 REFERENCE RANGE

Total Serum Cholesterol

213.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 176.1 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 66.9 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

111.8

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

35.21

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.2

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.67

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Vaibhav Kumar Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 22065 PARAMETER RESULT UNIT Age/Sex: 31 y/M MRN:SH/LKO/004815/09 Lab No.B-08/1790 Date: 25-8-2009 REFERENCE RANGE

Serum Uric Acid


(Method : Uricase-POD)

7.08

mg/dl

2.5 6.8

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Paras Ram Agarwal Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 22067 PARAMETER RESULT UNIT Blood Sugar Fasting 110.0 mg/dl Age/Sex: 65y/M MRN:SH/LKO/00820/09 Lab No.B-08/1791 Date: 25-8-2009 REFERENCE RANGE 70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

185

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kaushlya Devi Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 20714 PARAMETER RESULT UNIT Blood Sugar Fasting
(Method: - GOD-POD)

Age/Sex: 64y/F MRN:SH/LKO/008219/09 Lab No.B-08/1792 Date: 25-8-2009 REFERENCE RANGE 70 - 110

167.5

mg/dl

(Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

264

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

33.9 0.78

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Kaushlya Devi Pt. Location: OPD Referred By: Dr. H.N Triphati Specimen: BLOOD Tr. No. 20714 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.48 Total Serum Bilirubin mg/dl Age/Sex: 64y/F MRN:SH/LKO/008219/09 Lab No.B-08/1792 Date: 25-8-2009 REFERENCE RANGE 0.30 - 1.20

(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.13 0.32

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

16.6

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

14.2

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

81

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.24

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.39 2.85 1.54

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Surender Kumar Age/Sex: 65y/M Pt. Location: IPD/ T.ICU MRN:SH/LKO/007690/08/09 Referred By: Dr. H.N Triphati Lab No.:B-/08/1815 Specimen: BLOOD Date: 25.8.2009 PARAMETER RESULT UNIT REFERENCE RANGE LIVER FUNCTION TEST 0.55 Total Serum Bilirubin mg/dl 0.30 - 1.20

(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.20 0.35

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

64

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

45

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

92

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.37

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.5 2.87 0.87

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sabir Khan Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD PARAMETER
Total Serum Cholesterol

Tr. No. 20716 RESULT UNIT

Age/Sex: 32y/M MRN:SH/LKO/001589/09 Lab No.B-08/1793 Date: 25-8-2009 REFERENCE RANGE

LIPID PROFILE
190.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 243.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 28.6 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

113.4

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

48.76

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

6.68

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.97

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sunil Agarwal Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD Tr. No. 072 PARAMETER RESULT Blood Sugar Fasting 65.8 Age/Sex: 56y/M MRN:SH/LKO/008083/09 Lab No.B-08/1835 Date: 22-8-2009 REFERENCE RANGE 70 - 110

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen

28.3

mg/dl

6 to 20

Method Urease GLDH Kinetic

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.02

mg/dl

0.70 - 1.30

Serum Calcium
(Method: arsenazo III)

9.59

mg/dl mg/dl

8.4- 10.4 2.5 6.8

Serum Uric Acid


(Method : Uricase-POD)

5.4

CK-MB
Method- Immunoinhibition

18 39.6 137

U/L U/L U/I

0-25 38 - 174
135 - 225

CPK Serum LDH


Method: DGKC IFCC

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sunil Agarwal Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD Tr. No. 072 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.30 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)

Age/Sex: 56y/M MRN:SH/LKO/008083/09 Lab No.B-08/1835 Date: 22-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.13 0.17

mg/dl mg/dl

Indirect Serum Bilirubin

(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

25.5

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

18.7

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

56.7

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.95

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.20 2.75 1.52

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Sunil Agarwal Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: BLOOD Tr. No. 072 PARAMETER RESULT
LIPID PROFILE
Total Serum Cholesterol
130.7 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

UNIT

Age/Sex: 56y/M MRN:SH/LKO/008083/09 Lab No.B-08/1835 Date: 22-8-2009 REFERENCE RANGE

Serum Triglycerides 83.6 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl)

Serum High Density Lipoprotein Cholesterol (HDL-C) :

43.8

mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

70.2

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

16.71

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.98

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.6

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Alok Swaroop Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD PARAMETER RESULT Blood Sugar Post Prandial 353.7 Age/Sex: 44y/M MRN:SH/LKO/008269/09 Lab No.B-08/1828 Date: 25-8-2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD Tr.No.20298 PARAMETER RESULT Blood Sugar Post Prandial 81.4 Age/Sex: 43y/M MRN:SH/LKO/008260/09 Lab No.B-08/1822 Date: 25-8-2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Manish Singh Pt. Location: OPD Referred By: Dr.Farah Arshad Specimen: BLOOD Tr.No.20802 PARAMETER RESULT UNIT LIVER FUNCTION TEST 1.10 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)

Age/Sex: 25y/M MRN:SH/LKO/008015/08/09 Lab No.B-08/1823 Date: 25-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.29 0.81

mg/dl mg/dl

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)

16

IU/I

0 - 42

(Method: IFCC Without Pyridoxal Phosphate))

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

18.8

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

56.2

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.29

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0 3.79 1.05

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Syed Aliwahid Zaidi Pt. Location: OPD Referred By: Dr.H.N.Tripathi Specimen: BLOOD Tr.No.20 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.40 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)

Age/Sex: 54y/M MRN:SH/LKO/008259/08/09 Lab No.B-08/1827 Date: 25-8-2009 REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.16 0.25

mg/dl mg/dl

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

14.7

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

28

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

135.3

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.56

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.15 2.41 1.74

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.John Christophar Pt. Location: OPD Referred By: Dr.P.K.Samshrey Specimen: BLOOD PARAMETER RESULT Serum Uric Acid
(Method : Uricase-POD)

UNIT mg/dl

Age/Sex: 27y/M MRN:SH/LKO/00/08/09 Lab No.B-08/1831 Date: 25-8-2009 REFERENCE RANGE 2.5 6.8

10.51

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. C reactive protein(C.R.P)

<3.08

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases.

Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Sonal Agarwal Pt. Location: OPD Referred By: Dr. Specimen: BLOOD Tr.No.881 PARAMETER RESULT Blood Sugar Random 72.3 Age/Sex: 29y/F MRN:SH/LKO/00138/08/09 Lab No.B-08/1831 Date: 25-8-2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Tek Narayan Pt. Location: OPD Referred By: Dr.P.K.Samshrey Specimen: BLOOD Tr.No.20 PARAMETER RESULT
C reactive protein(C.R.P)

UNIT

Age/Sex: 47y/M MRN:SH/LKO/00138/08/09 Lab No.B-08/1829 Date: 25-8-2009 REFERENCE RANGE

94.2

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Tek Narayan Pt. Location: OPD Referred By: Dr.P.K.Samshrey Specimen: Fluid Tr.No.20 PARAMETER RESULT Age/Sex: 47y/M MRN:SH/LKO/00138/08/09 Lab No.B-08/1829 Date: 25-8-2009 REFERENCE RANGE

UNIT

Synovial fluid Uric Acid

4.2

mg/dl

Synovial fluid Glucose Synovial fluid Protein

79.6 6.71

mg/dl g/dl

70-110 mg/dl 1-3 g/dl

Interpretation of SF glucose values requires comparision with serum levels,preceded by 8 hours to allow glucose to equilibrate across the synovial membrane.The serum - synovial differential is less than 10 mg/dl in normal and many non inflammatory conditions.In septic arthritis,this difference ranges from 20-

60 mg/dl. Measurement of SF protein is non specific:the sensitivity is about 52% and the specificity 56% for inflammatory conditions.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Qasim Pt. Location: OPD Referred By: Dr. H,N,Tripathi Specimen: BLOOD PARAMETER Blood Sugar Fasting Age/Sex: 49y/M MRN:SH/LKO/008262/08/09 Lab No.B-08/1826 Date: 25-8-2009 REFERENCE RANGE 70 - 110

Tr.No.20832 RESULT 145.6

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

37.7 1.3

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Qasim Pt. Location: OPD Referred By: Dr. H,N,Tripathi Specimen: BLOOD PARAMETER
Total Serum Cholesterol

Tr.No.20832 RESULT

UNIT

Age/Sex: 49y/M MRN:SH/LKO/008262/08/09 Lab No.B-08/1826 Date: 25-8-2009 REFERENCE RANGE

LIPID PROFILE
206 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 184.6 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 35.6 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

133.6

mg/dl

Lipoprotein Cholesterol (LDL-C) :

(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

36.91

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.8

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.76

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Mohd Qasim Pt. Location: OPD Referred By: Dr. H,N,Tripathi Specimen: URINE PARAMETER Age/Sex: 49y/M MRN:SH/LKO/008262/08/09 Lab No.B-08/1826 Date: 25-8-2009 REFERENCE RANGE

Tr.No.20832 RESULT

UNIT

Urine microalbumin Urine Microalbumin 7.69 mg/ L <20mg/L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mast.Mohd Sadab Pt. Location: IPD/PICU Referred By: Dr.M.U.Hasan Specimen: BLOOD PARAMETER RESULT
C reactive protein(C.R.P)

UNIT

Age/Sex: 6y/M MRN:SH/LKO/008143/09 Lab No.:B-/08/1821 Date: 25.8.2009 REFERENCE RANGE

<3.08

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr. Bhullar Prasad Pt. Location: IPD/G/W Referred By: Dr. Sablok Specimen: Blood PARAMETER RESULT Blood Sugar Post Prandial 232.2 Age/Sex: 62/M MRN:SH/LKO/008207/09 Lab No.:B-/08/1820 Date: 25.8.2009 REFERENCE RANGE 70 - 140

UNIT mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Blood Sugar Fasting Age/Sex: 42y/F MRN:SH/LKO/008279/08/09 Lab No.B-08/1832 Date: 25-8-2009 REFERENCE RANGE 70 - 110

Tr.No.93 RESULT 85.8

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.69 0.78 8.51 3.14

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

5.23

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.21

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE Tr.No.93 PARAMETER RESULT UNIT LIVER FUNCTION TEST 0.41 Total Serum Bilirubin mg/dl
(Method: Walter And Gerarde)

Age/Sex: 42y/F MRN:SH/LKO/008279/08/09 Lab No.B-08/1832 Date: 25-8-2009 REFERENCE RANGE


0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.10. 0.32

mg/dl mg/dl

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

34

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

26.7

IU/I

0 - 42

Serum Alkaline Phosphatase

82.2

IU/I

42 - 128

(Method: ALP - AMP)

Serum Total Protein


(Method: Biuret)

7.48

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.6 2.88 1.59

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER
Total Serum Cholesterol

Tr.No.93 RESULT

UNIT

Age/Sex: 42y/F MRN:SH/LKO/008279/08/09 Lab No.B-08/1832 Date: 25-8-2009 REFERENCE RANGE

189.3 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 186.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 30.6 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

121.3

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density

37.37

mg/dl

10 to 40

Lipoprotein Cholesterol (VLDL-C) :

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

6.19

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.97

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 119

Tr.No.93 RESULT

UNIT

Age/Sex: 42y/F MRN:SH/LKO/008279/08/09 Lab No.B-08/1832 Date: 25-8-2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

99

apo-A1/apo-B Ratio

1.2

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Bharti Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Age/Sex: 42y/F MRN:SH/LKO/008279/08/09 Lab No.B-08/1832 Date: 25-8-2009 REFERENCE RANGE

Tr.No.93 RESULT

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.2%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended.

* Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Blood Sugar Fasting Age/Sex: 47y/M MRN:SH/LKO/008275/08/09 Lab No.B-08/1833 Date: 25-8-2009 REFERENCE RANGE 70 - 110

Tr.No.92 RESULT 102.6

UNIT mg/dl

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.91 0.98 8.46 2.94

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

8.42

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.14

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)

Tr.No.92 RESULT UNIT LIVER FUNCTION TEST


0.77 0.2 0.56 mg/dl mg/dl mg/dl

Age/Sex: 47y/M MRN:SH/LKO/008275/08/09 Lab No.B-08/1833 Date: 25-8-2009 REFERENCE RANGE


0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

49.2

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

23

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

98

IU/I

42 - 128

Serum Total Protein

7.24

g/dl

6.0 - 8.3

(Method: Biuret)

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.56 2.68 1.7

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER
Total Serum Cholesterol

Tr.No.92 RESULT

UNIT

Age/Sex: 47y/M MRN:SH/LKO/008275/08/09 Lab No.B-08/1833 Date: 25-8-2009 REFERENCE RANGE

142.3 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 155.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 28.3 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

82.8

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

31.16

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.03

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.93

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER
ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 104

Tr.No.92 RESULT

UNIT

Age/Sex: 47y/M MRN:SH/LKO/008275/08/09 Lab No.B-08/1833 Date: 25-8-2009 REFERENCE RANGE

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

76.5

apo-A1/apo-B Ratio

1.35

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.A.B.Lal Pt. Location: OPD Referred By: M.H.C Specimen: URINE PARAMETER Age/Sex: 47y/M MRN:SH/LKO/008275/08/09 Lab No.B-08/1833 Date: 25-8-2009 REFERENCE RANGE

Tr.No.92 RESULT

UNIT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

7.0%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Shiv Balak Singh Pt. Location: IPD/G/W Referred By: Dr.Alok Specimen: Blood PARAMETER RESULT Age/Sex: 66/M MRN:SH/LKO/008138/09 Lab No.:B-/08/1842 Date: 25.8.2009 REFERENCE RANGE

UNIT

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

0.63 0.35 0.28

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

12.3

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

19.2

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

265.7

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.38

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.1 4.28 0.49

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: B/O.Salma Pt. Location: IPD/PICU Referred By: Dr.M.U.Hasan Specimen: Blood PARAMETER Total Serum Bilirubin
(Method: Walter And Gerarde)

RESULT
22.38 1.27 21.11

UNIT
mg/dl mg/dl mg/dl

Age/Sex: / MRN:SH/LKO/007613/09 Lab No.:B-/08/1848 Date: 25.8.2009 REFERENCE RANGE


0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs.Nidhi Sharma Pt. Location: IPD/E.W Referred By: Dr.Swadesh Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 20y/F MRN:SH/LKO/003293/09 Lab No.:B-/08/1848 Date: 25.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

138.0 4.3

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 42y/M MRN:008248/09 Lab No.:B-0/08/1977 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

110.7

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

127

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

11.89 0.74 9.31 3.07

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid

6.1

mg/dl

2.5 6.8

(Method : Uricase-POD)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.21

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.43 0.12 0.3 UNIT mg/dl mg/dl mg/dl

Age/Sex: 42y/M MRN:008248/09 Lab No.:B-0/08/1977 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

27.2

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

18

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

95.8

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.08

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.8

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

4.28 0.88

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 42y/M MRN:008248/09 Lab No.:B-0/08/1977 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

165.8 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 121.2 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 33.4 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

90

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

42.44

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.97

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.7

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 42y/M MRN:008248/09 Lab No.:B-0/08/1977 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 124

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

92

apo-A1/apo-B Ratio

1.34

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jeet Bahadur Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 42y/M MRN:008248/09 Lab No.:B-0/08/1977 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.9%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 41y/M MRN:004882/09 Lab No.:B-0/08/1800 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

117

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

156.2

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

7.17 0.76 8.68 3.26

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

4.48

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.24

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.37 0.11 0.27 UNIT mg/dl mg/dl mg/dl

Age/Sex: 41y/M MRN:004882/09 Lab No.:B-0/08/1800 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

36.8

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

31.4

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

58.7

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.78

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4 3.48 1.14

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 41y/M MRN:004882/09 Lab No.:B-0/08/1800 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

220.2 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 214.6 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 39.9 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

137.4

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

42.92

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.51

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.44

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 41y/M MRN:004882/09 Lab No.:B-0/08/1800 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 128

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

116

apo-A1/apo-B Ratio

1.1

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Kumar Dixit Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 41y/M MRN:004882/09 Lab No.:B-0/08/1800 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.3%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56y/M MRN:008236/09 Lab No.:B-0/08/1801 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

83

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

104

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.14 1.05 8.9 3.49

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

4.9

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.23

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.55 0.15 0.4 UNIT mg/dl mg/dl mg/dl

Age/Sex: 56y/M MRN:008236/09 Lab No.:B-0/08/1801 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

59.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

44.9

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

79

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4 4 1

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 56y/M MRN:008236/09 Lab No.:B-0/08/1801 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

177.4 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 125.4 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 40.2 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

112

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

25.08

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.41

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.79

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56y/M MRN:008236/09 Lab No.:B-0/08/1801 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 122

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

91.1

apo-A1/apo-B Ratio

1.33

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Chhote Lal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56y/M MRN:008236/09 Lab No.:B-0/08/1801 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

5.8%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 46y/M MRN:008249/09 Lab No.:B-0/08/1802 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

160

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

178.5

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

14.6 0.69 8.88 3.61

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

4.6

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.23

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.68 0.17 0.51 UNIT mg/dl mg/dl mg/dl

Age/Sex: 46y/M MRN:008249/09 Lab No.:B-0/08/1802 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

22.8

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

19

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

108

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

8.18

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.1 4.08 1

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD)

Checked by..

Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 46y/M MRN:008249/09 Lab No.:B-0/08/1802 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

215 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 127.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 46 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

143.3

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

25.58

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.66

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.11

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 46y/M MRN:008249/09 Lab No.:B-0/08/1802 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 129

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

114

apo-A1/apo-B Ratio

1.13

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Laxmi Narayan Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 46y/M MRN:008249/09 Lab No.:B-0/08/1802 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

9.9%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 45y/M MRN:008246/09 Lab No.:B-0/08/1803 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

83.4

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

105.8

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

9.59 0.94 8.9 3.86

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

7.15

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.24

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD)

Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.55 0.13 0.42 UNIT mg/dl mg/dl mg/dl

Age/Sex: 45y/M MRN:008246/09 Lab No.:B-0/08/1803 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

80.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

47.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

104.5

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.47

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4 3.47 1.15

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 45y/M MRN:008246/09 Lab No.:B-0/08/1803 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

165.2 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 167.1 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 29.5 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

102.2

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

33.41

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.59

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.46

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 45y/M MRN:008246/09 Lab No.:B-0/08/1803 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 114

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

97.3

apo-A1/apo-B Ratio

1.17

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.H.R.Verma Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 45y/M MRN:008246/09 Lab No.:B-0/08/1803 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.1%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 40y/M MRN:008237/09 Lab No.:B-0/08/1804 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

88.5

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

106.5

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

12.64 0.91 9.0 3.16

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

6.14

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.15

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.35 0.06 0.29 UNIT mg/dl mg/dl mg/dl

Age/Sex: 40y/M MRN:008237/09 Lab No.:B-0/08/1804 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

26.4

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

25.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

98.5

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.02

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0 3.02 1.32

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 40y/M MRN:008237/09 Lab No.:B-0/08/1804 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

184.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 206.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 38.2 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

105.1

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

41.37

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.83

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.75

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 40y/M MRN:008237/09 Lab No.:B-0/08/1804 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 127

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

92

apo-A1/apo-B Ratio

1.38

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Mahipal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 40y/M MRN:008237/09 Lab No.:B-0/08/1804 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

5.8%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 40y/M MRN:008244/09 Lab No.:B-0/08/1805 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

85.1

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

109

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.9 0.93 8.6 2.62

mg/dl mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

6.02

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.24

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.45 0.12 0.33 UNIT mg/dl mg/dl mg/dl

Age/Sex: 40y/M MRN:008244/09 Lab No.:B-0/08/1805 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

25.7

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

23.7

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

73

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.79

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0 3.79 1.05

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE
137.9

Age/Sex: 40y/M MRN:008244/09 Lab No.:B-0/08/1805 Date: 25/8/2009


UNIT REFERENCE RANGE

Total Serum Cholesterol

mg/dl

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 124.7 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 24.6 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

88.3

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

24.95

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.66

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.58

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 40y/M MRN:008244/09 Lab No.:B-0/08/1805 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 97

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

80.2

apo-A1/apo-B Ratio

1.2

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.R.N.Thakur Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 40y/M MRN:008244/09 Lab No.:B-0/08/1805 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

5.6%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 62y/M MRN:008240/09 Lab No.:B-0/08/1806 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

94

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

17.4

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.33 9.18 2.85

mg/dl mg/dl mg/dl

0.70 - 1.30 8.4- 10.4

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

8.44

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.21

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.54 0.16 0.38 UNIT mg/dl mg/dl mg/dl

Age/Sex: 62y/M MRN:008240/09 Lab No.:B-0/08/1806 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

16.6

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

23.1

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

72.3

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.25

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.9 3.35 1.16

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 62y/M MRN:008240/09 Lab No.:B-0/08/1806 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

139 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 92.8 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 45.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

74.6

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

18.56

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.03

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.63

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 62y/M MRN:008240/09 Lab No.:B-0/08/1806 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 146

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

62.2

apo-A1/apo-B Ratio

2.34

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajesh Kumar Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 62y/M MRN:008240/09 Lab No.:B-0/08/1806 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.0%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56y/F MRN:008238/09 Lab No.:B-0/08/1807 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

88.3

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

15.54

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.63 9.05 4.51

mg/dl mg/dl mg/dl

0.70 - 1.30 8.4- 10.4

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

5.41

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.22

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.28 0.06 0.22 UNIT mg/dl mg/dl mg/dl

Age/Sex: 56y/F MRN:008238/09 Lab No.:B-0/08/1807 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

14.4

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

18.1

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

78.2

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.43

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.9 3.53 1.10

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 56y/F MRN:008238/09 Lab No.:B-0/08/1807 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

292.6 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 234.1 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 53.3 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

192.4

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

46.81

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.49

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.61

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56y/F MRN:008238/09 Lab No.:B-0/08/1807 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 159

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

158

apo-A1/apo-B Ratio

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Mrs.Madhu Agarwal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56y/F MRN:008238/09 Lab No.:B-0/08/1807 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

6.1%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Pushpa Bansal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 38y/F MRN:008239/09 Lab No.:B-0/08/1808 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

77.2

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.35

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.75 9.01 3.46

mg/dl mg/dl mg/dl

0.70 - 1.30 8.4- 10.4

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

3.4

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.21

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Mrs.Pushpa Bansal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT 0.66 0.16 0.5 UNIT mg/dl mg/dl mg/dl

Age/Sex: 38y/F MRN:008239/09 Lab No.:B-0/08/1808 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

11.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

15.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

81.8

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.66

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.1 3.56 1.15

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Mrs.Pushpa Bansal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 38y/F MRN:008239/09 Lab No.:B-0/08/1808 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

206.7 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 122.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 45.6 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

136.6

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

24.59

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.54

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.0

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry

Name: Pt. Location: Referred By: Specimen:


PARAMETER

Mrs.Pushpa Bansal OPD M.H.C Blood


RESULT UNIT

Age/Sex: 38y/F MRN:008239/09 Lab No.:B-0/08/1808 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 138

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

100

apo-A1/apo-B Ratio

1.38

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry

Name: Pt. Location: Referred By: Specimen:


PARAMETER

Mrs.Pushpa Bansal OPD M.H.C Blood


RESULT UNIT

Age/Sex: 38y/F MRN:008239/09 Lab No.:B-0/08/1808 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

5.7%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Mrs.Anju Bansal Pt. Location: OPD Referred By: M.H.C Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 32y/F MRN:008242/09 Lab No.:B-0/08/1809 Date: 25/8/2009


REFERENCE RANGE

Blood Sugar Fasting

91.1

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

11.63

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.59 8.90 3.68

mg/dl mg/dl mg/dl

0.70 - 1.30 8.4- 10.4

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5

Serum Uric Acid


(Method : Uricase-POD)

4.13

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.22

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry

Name: Pt. Location: Referred By: Specimen:


PARAMETER

Mrs.Anju Bansal OPD M.H.C Blood


RESULT 0.71 0.19 0.52 UNIT mg/dl mg/dl mg/dl

Age/Sex: 32y/F MRN:008242/09 Lab No.:B-0/08/1809 Date: 25/8/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

15.2

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

16.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

59

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.58

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.0 3.58 1.11

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry

Name: Pt. Location: Referred By: Specimen:


PARAMETER

Mrs.Anju Bansal OPD M.H.C Blood


RESULT LIPID PROFILE UNIT

Age/Sex: 32y/F MRN:008242/09 Lab No.:B-0/08/1809 Date: 25/8/2009


REFERENCE RANGE

Total Serum Cholesterol

186.4 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 88 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 51 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

117.9

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

17.59

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.66

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.31

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Anju Bansal Age/Sex: 32y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD M.H.C Blood


RESULT UNIT

MRN:008242/09 Lab No.:B-0/08/1809 Date: 25/8/2009


REFERENCE RANGE

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 147

142 105 1.35

mg/d mg/dl mg/d mg/dl Ratio Ratio

115 115210 210 55 135 0.91 0.91 2.63 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

87

apo-A1/apo-B Ratio

1.68

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Anju Bansal Age/Sex: 32y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD M.H.C Blood


RESULT UNIT

MRN:008242/09 Lab No.:B-0/08/1809 Date: 25/8/2009


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

5.3%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mr. Manish Pt. Location: IPD/MICU Referred By: Dr. R.Kohli Specimen: Blood PARAMETER Serum Sodium Serum Potassium

RESULT 115.0 3.90

UNIT mmol/l mmol/l

Age/Sex: 45/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1851 Date: 24.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mr.Ashish Mitra Pt. Location: IPD/MICU Referred By: Dr. M.Husain Specimen: Blood PARAMETER Serum Sodium Serum Potassium

RESULT 138.0 2.80

UNIT mmol/l mmol/l

Age/Sex: 38/M MRN:SH/LKO/007836/09 Lab No.:B-/08/1852 Date: 25.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mr.Prahlad Rai Pt. Location: IPD/MICU Referred By: Dr. M.Husain Specimen: Blood PARAMETER Serum Sodium Serum Potassium

RESULT 131.0 4.10

UNIT mmol/l mmol/l

Age/Sex: 70/M MRN:SH/LKO/001386/09 Lab No.:B-/08/1855 Date: 25.8.2009 REFERENCE RANGE 135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mrs.Kailashi Devi Pt. Location: IPD/E.W Referred By: Dr. H.N.Tripathi Specimen: Blood PARAMETER RESULT Serum Calcium
(Method: arsenazo III)

UNIT mg/dl

Age/Sex: 58/F MRN:SH/LKO/008295/09 Lab No.:B-/08/1854 Date: 25.8.2009 REFERENCE RANGE 8.4- 10.4

8.38

Serum Urea
Methodology- Urease- GLDH, Kinetic

42.1 0.78

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

130.0 4.30

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mrs.Kailashi Devi Pt. Location: IPD/E.W Referred By: Dr. H.N.Tripathi Specimen: Blood PARAMETER RESULT

UNIT

Age/Sex: 58/F MRN:SH/LKO/008295/09 Lab No.:B-/08/1854 Date: 25.8.2009 REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.68 mg/dl 0.10 0.58 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

56

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

47.7

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

148

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.52

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.61 3.91 0.92

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Dr. Manish Tomar Pt. Location: IPD/MICU Referred By: Dr.Vaibhav Khanna Specimen: Blood PARAMETER RESULT Serum Urea
Methodology- Urease- GLDH, Kinetic

UNIT mg/dl mg/dl

Age/Sex: 45y/M MRN:SH/LKO/008184/09 Lab No.:B-/08/1870 Date: 26.8.2009 REFERENCE RANGE 13 - 43 0.70 - 1.30

97 0.89

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

125.0 3.7

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mrs. Nidhi Mishra Pt. Location: IPD/G.W Referred By: Dr.Swadesh Singh Specimen: Blood PARAMETER RESULT
SERUM IRON 245

UNIT
g/dl

Age/Sex: 20y/F MRN:SH/LKO/008293/09 Lab No.:B-/08/1871 Date: 26.8.2009 REFERENCE RANGE


Male Female

59 - 158 37-145 112 - 346 250 - 450 13 - 45

U.I.B.C T.I.B.C % Saturation 255

10

g/dl g/dl %

96.07

Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

SAHARA HOSPITAL
VIRAJ KHAND, GOMTI NAGAR, LUCKNOW -226010 e-mail: hospital@hqsimil.sahara.co.in

DEPARTMENT OF PATHOLOGY

UNIT : BIOCHEMISTRY Name: Mr. Anoop Bansal Pt. Location: IPD/ G/W Referred By: Dr.Sunil Dabadghao Specimen: BLOOD PARAMETER RESULT Blood Urea Nitrogen 57.05
Method Urease GLDH Kinetic

UNIT mg/dl mg/dl mg/dl

Age/Sex: 43y/M MRN:SH/LKO/008002/08/09 Lab No.:B-/08/1872 Date: 26.8.2009 REFERENCE RANGE

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

5.11 9.02

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5
2.5 6.8

Serum Uric Acid

10.53

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

137.0 3.10

mmol/l mmol/l

135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD Dr.H.P.Kumar, MD Blood


RESULT LIPID PROFILE
147.5

MRN:Ex.001498 Lab No.:B-0/08/1887 Date: 26/8/2009


UNIT REFERENCE RANGE

Total Serum Cholesterol

mg/dl

(Method-CHOD-PAP) (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 107 mg/dl (Method-GPO-PAP) (Desirabl <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : (Low <40 mg/dl ;High 60 mg/dl) 62.5 mg/dl

(Method- Homogeneous enzymatic colorimetric assay)


Serum Low Density
63.6 mg/dl

Lipoprotein Cholesterol (LDL-C) :

(Method- Homogeneous enzymatic colorimetric assay)


(<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

21.4

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.36

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.02

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD Dr.H.P.Kumar, MD Blood


RESULT UNIT

MRN:Ex.001498 Lab No.:B-0/08/1887 Date: 26/8/2009


REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.90 mg/dl 0.28 0.62 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

13.7

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

27.6

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

125.7

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.62

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.7 3.92 0.94

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Age/Sex: 80Y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD Dr.H.P.Kumar, MD Blood


RESULT UNIT

MRN:Ex.001498 Lab No.:B-0/08/1887 Date: 26/8/2009


REFERENCE RANGE

Blood Sugar Random

160

mg/dl

70 - 140

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

135.5 63.3

mg/dl mg/dl

13 - 43

Blood Urea Nitrogen


Method Urease GLDH Kinetic

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

2.37 8.73 4.5

mg/dl mg/dl mg/dl

0.70 - 1.30 8.4- 10.4

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

2.5 - 4.5
2.5 6.8

Serum Uric Acid


(Method : Uricase-POD)

8.97

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Mata Ji (Smt.Chhabi Roy) Pt. Location: OPD Age/Sex: 80Y/F MRN:Ex.001498

Referred By: Specimen:


PARAMETER

Dr.H.P.Kumar, MD Blood
RESULT UNIT

Lab No.:B-0/08/1887 Date: 26/8/2009


REFERENCE RANGE

Serum Sodium Serum Potassium

135.0 5.1 1.03

mmol/l mmol/l

135 - 145 3.5 - 5.5

Serum Calcium Ionized :

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Lakshmi Pt. Location: OPD Age/Sex: 70Y/F MRN:SH/LKO/008268/08/09

Referred By: Specimen:


PARAMETER

Dr.R.K.Mishra MD Blood
RESULT

Tr.No.20973 UNIT

Lab No.:B-0/08/1880 Date: 26/8/2009


REFERENCE RANGE

Blood Sugar Fasting

226.4

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

77

mg/dl

13 - 43

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Lakshmi Pt. Location: OPD Referred By: Dr.R.K.Mishra MD Specimen: Blood
PARAMETER RESULT LIPID PROFILE

Tr.No.20973 UNIT

Age/Sex: 70Y/F MRN:SH/LKO/008268/08/09 Lab No.:B-0/08/1880 Date: 26/8/2009


REFERENCE RANGE

Total Serum Cholesterol

284 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 153 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 49.4 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

204

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

30.61

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.75

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

4.13

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Rani Seth Age/Sex: 52Y/F

Pt. Location: Referred By: Specimen:


PARAMETER

OPD MHC Blood


RESULT LIPID PROFILE
150

MRN:SH/LKO/010671/09 Lab No.:B-0/08/1880 Date: 10/14/2009


UNIT REFERENCE RANGE

Total Serum Cholesterol

mg/dl

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 91 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 44.5 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

87.49

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

18.23

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.38

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.97

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Rani Seth Pt. Location: OPD Age/Sex: 52Y/F MRN:SH/LKO/010671/09

Referred By: Specimen:


PARAMETER

MHC Blood
RESULT UNIT

Lab No.:B-0/08/1880 Date: 10/14/2009


REFERENCE RANGE

Blood Sugar Fasting

131.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

238

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

8.51

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.67

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Rani Seth Pt. Location: OPD Referred By: MHC Age/Sex: 52Y/F MRN:SH/LKO/010671/09 Lab No.:B-0/08/1880

Specimen:
PARAMETER

Blood
RESULT UNIT

Date:

10/14/2009

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.8 %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Kamini Singh Pt. Location: OPD Age/Sex: y/F52 MRN:11002616/11

Referred By: Specimen:


PARAMETER

Dr. M Ahamad Blood


RESULT UNIT

Lab No.:B-0/08/1809 Date: 11/3/2011


REFERENCE RANGE

Serum Sodium Serum Potassium

143.0 3.0

mmol/l mmol/l

135 - 145 3.5 - 5.5

Blood Urea Nitrogen


Method Urease GLDH Kinetic

15.48

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

2.17

mg/dl

0.70 - 1.30

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Sanno Srivastava Pt. Location: OPD Referred By: Dr. G.Swaroop Age/Sex: y/F MRN:11003011/11 Lab No.:B-0/08/1809

Specimen:
PARAMETER

Blood
RESULT UNIT

Date: 0.54 mg/dl

11/1/2011 0.70 - 1.30

REFERENCE RANGE

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Blood Sugar Random

279

mg/dl

70 - 140

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Trisha Neogi Pt. Location: OPD Referred By: Dr. Neelam Vinay Specimen: Blood Age/Sex: 35y/F MRN:11009379/11 Lab No.:B-0/08/905 Date: 11/4/2011

PARAMETER

RESULT

UNIT

REFERENCE RANGE

ORAL GLUCOSE TOLERANACE TEST G.T.T (after 75 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 86 106 176 mg/dl mg/dl mg/dl 95 180 155

*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.C.P.Shukla Age/Sex: 41y/M

Pt. Location: Referred By: Specimen:


PARAMETER

OPD Dr. Self Blood


RESULT UNIT

MRN:11037967/11 Lab No.:B-0/08/1809 Date: 11/2/2011


REFERENCE RANGE

Blood Sugar Post Prandial

395

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Nirmala Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex:

65Y/F

Lab No.:B-0/08/1880 Date: 11/22/2011


REFERENCE RANGE

Blood Sugar Fasting

98.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

24 0.7

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mona Mishra Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex:

34Y/F

Lab No.:B-0/08/1880 Date: 11/20/2011


REFERENCE RANGE

Blood Sugar Fasting

82.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

118

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Homocysteine (HCY)

29.5

mol/L

5-15 mol/L

Homocysteine is an amino acid derived from methionine ,requiring ,vitamin B6 ,vitamin B12 and folic acid for further metabolizing.Mutation of the gene coding for homocysteine metabolism ,e.g.MTHFR ,result in hyperhomocysteinemia.Deficiency of folic acid ,vitamin B6,vitamin B12 are associated with increased plasma levels of homocysteine. Hyperhomocysteinemia is found to be associated with an increased risk for ischemic heart disease,stroke,peripherial arterial disease, and deep vein thrombosis,as well as neural tube defect and preeclampsia of pregnancy.An increased frequency of hyperhomocysteinemia is observed especially in elderly,smokers,patients with renal disease,diabetes ,or on a strict vegetarian diet

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Gupta Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 61Y/M MRN-11013088 Lab No.:B-0/08/1880 Date: 11/22/2011


REFERENCE RANGE

Blood Sugar Fasting

313.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.77

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Gupta Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 61Y/M MRN-11013088 Lab No.:B-0/08/1880 Date: 11/22/2011


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

10.9 %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ashok Gupta Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 61Y/M MRN-11013088 Lab No.:B-0/08/1889 Date: 11/28/2011


REFERENCE RANGE

Blood Sugar Post Prandial

273

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Dutt Dwivedi Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Total Serum Cholesterol
(Method-CHOD-PAP 186 mg/dl

Age/Sex:

67Y/

Lab No.:B-0/12/1880 Date: 12/12/2011


UNIT REFERENCE RANGE

(Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 135 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 42 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

117

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

27

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

4.42

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.78

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Dutt Dwivedi Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex:

67Y/

Lab No.:B-0/12/1880 Date: 12/12/2011


REFERENCE RANGE

Blood Sugar Fasting

86.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Uric Acid


(Method : Uricase-POD)

7.4

mg/dl

2.5 6.8

NOTE : Above test carried out by EM 360 automated biochemistry analyzer.

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.86 8.96

mg/dl mg/dl

0.70 - 1.30 8.4- 10.4

Serum Calcium
(Method: arsenazo III)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Dutt Dwivedi Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER C reactive protein(C.R.P) RESULT UNIT

Age/Sex:

67Y/

Lab No.:B-0/12/1880 Date: 12/12/2011


REFERENCE RANGE

2.9

mg/L

less than 3

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions

CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.C.Somani Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Total Serum Cholesterol
137 mg/dl

Age/Sex:

Y/

Lab No.:B-0/12/1880 Date: 1/16/2012


UNIT REFERENCE RANGE

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 132 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 39.7 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

70.61

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

26.46

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.45

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.78

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.C.Somani Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex:

Y/

Lab No.:B-0/12/1880 Date: 1/16/2012


REFERENCE RANGE

Serum Urea
Methodology- Urease- GLDH, Kinetic

22 0.88

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine

Method- Modified Jaffe"s, no deproteinization

Blood Sugar Fasting

118.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Uric Acid


(Method : Uricase-POD)

4.8

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.C.Somani Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex:

Y/

Lab No.:B-0/12/1880 Date: 1/16/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.1 %

EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Pandey Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 70 Yrs/M

Date: 142 mg/dl

1/18/2012 70 - 140

REFERENCE RANGE

Blood Sugar Random

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

30 1.03

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

29.0

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

26.0

IU/I

0 - 42

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Rukhsar Husain Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT

Age/Sex: 32 Yrs/F MRN-11016806 Date: 1/18/2012


REFERENCE RANGE 0 hour

Peritoneal fluid Glucose

1552

mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

8 0.91

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Rukhsar Husain Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT

Age/Sex: 32 Yrs/F MRN-11016806 Date: 1/18/2012


REFERENCE RANGE 2 hour

Peritoneal fluid Glucose

1332

mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

43 3.53

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Rukhsar Husain Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT

Age/Sex: 32 Yrs/F MRN-11016806 Date: 1/18/2012


REFERENCE RANGE 4 hour

Peritoneal fluid Glucose

962

mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

66 5.5

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Preeti Sabarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 55 Yrs/F MRN-11016806 Lab No.-1302 Date: 1/30/2012


REFERENCE RANGE

Total Serum Cholesterol

185 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) 138 mg/dl

Serum Triglycerides

(Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 34.1 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

123.29

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

27.67

mg/dl

10 to 40

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Santosh Sharma Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 37 Yrs/M

Date: 1.7 mg/dl

1/28/2012 0.70 - 1.30

REFERENCE RANGE

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Uric Acid


(Method : Uricase-POD)

4.35

mg/dl

2.5 6.8

Phosphorus
(Method: phosphomolybdate UV

4.35 9.12 37

mg/dl mg/dl mg/dl

2.5 - 4.5 8.4- 10.4 13 - 43

Serum Calcium
(Method: arsenazo III)

Serum Urea
Methodology- Urease- GLDH, Kinetic

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Preeti Sabarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/F MRN-11016806 Lab No.-1302 Date: #######


REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.8 mg/dl 0.2 0.6 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin

(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

16

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

20

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

148

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.8 3.8

g/dl g/dl 1.74 g/dl 2.56 ratio

6.0 - 8.3 3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Albumin
(Method: Bromo Cresol Green BCG))

Serum Globulin A/G Ratio

3.0 1.2:1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Sidhart Dixit Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 23 Yrs/M

Date:

1/28/2012

REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 2.01 mg/dl 1.44 mg/dl

0.30 - 1.20 0 - 0.20

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

0.56

mg/dl

0.08 - 0.75

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

210.0

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

58.0

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

263.0

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.75

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.99 2.77 1.44

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.N. Pandey Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 76 Yrs/M

Date:

1/28/2012

REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.54 mg/dl 0.30 0.24 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

73.3

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

53.0

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

431.0

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.66 3.45 2.20 1.57

g/dl g/dl 1.74 g/dl 2.56 ratio

6.0 - 8.3 3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Albumin
(Method: Bromo Cresol Green BCG))

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. S.N. Pandey Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 76 Yrs/M

Date: 30.0 0.86 mg/dl mg/dl

1/28/2012 13 - 43 0.70 - 1.30

REFERENCE RANGE

Serum Urea
Methodology- Urease- GLDH, Kinetic

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. O.P. Bansal Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT

Age/Sex: 70 Yrs/M MRN-11018527 Date: 2/13/2012


REFERENCE RANGE 0 hour

Peritoneal fluid Glucose Serum Urea


Methodology- Urease- GLDH, Kinetic

2137 10

mg/dl mg/dl 13 - 43

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.62

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. O.P. Bansal Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT

Age/Sex: 70 Yrs/M MRN-11018527 Date: 2/13/2012


REFERENCE RANGE 2 hour

Peritoneal fluid Glucose Serum Urea


Methodology- Urease- GLDH, Kinetic

1228 77

mg/dl mg/dl 13 - 43

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

2.92

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. O.P. Bansal Pt. Location: OPD Referred By: Dr .M.Ahmad Specimen: P.D.Fluid
PARAMETER RESULT UNIT

Age/Sex: 70 Yrs/M MRN-11018527 Date: 2/13/2012


REFERENCE RANGE 4 hour

Peritoneal fluid Glucose Serum Urea


Methodology- Urease- GLDH, Kinetic

2129 10

mg/dl mg/dl 13 - 43

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.62

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Rajendra Shukla Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 53 Yrs/M

Date: 71.0 mg/dl

14.02.2012 70 - 110

REFERENCE RANGE

Blood Sugar Fasting

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :

7.7 %

EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Anjum Khatoon Pt. Location: OPD Referred By: Dr.S.Verma Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 48 Yrs/F MRN-12004401 Lab No.-1302 Date: 2/14/2012


REFERENCE RANGE

Total Serum Cholesterol

258 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 165 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 50.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

174.2

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

32.9

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.08

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.43

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Simranjeet Kaur Pt. Location: OPD Referred By: Dr.M.Ahamad Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 33 Yrs/F MRN-11029687 Lab No.-1303 Date: 2/14/2012


REFERENCE RANGE

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.66

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Rajendra Singh Pt. Location: OPD Referred By: Dr.M.Ahamad Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 70Yrs/M MRN-11028063 Lab No.-1304 Date: 2/14/2012


REFERENCE RANGE

Serum Uric Acid


(Method : Uricase-POD)

4.06

mg/dl

2.5 6.8

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Mahaveer Prasad Agrawal Pt. Location: OPD Referred By: Dr.Naveen Jamwal Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 69 Yrs/M MRN-12003373 Lab No.-0662 Date: 2/3/2012


REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.27 mg/dl 0.08 0.19 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)

20

IU/I

0 - 42

(Method: IFCC Without Pyridoxal Phosphate))

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

27

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

64

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

5.97

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

2.62 3.35 0.78

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Amita Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 26 Yrs/F MRN-12003373 Lab No.-0662 Date: 2/18/2012


REFERENCE RANGE

Serum Urea
Methodology- Urease- GLDH, Kinetic

24.0 0.65

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Blood Sugar Random


(Method: - GOD-POD)

80.0

mg/dl

70 - 140

(Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Amita Pt. Location: OPD Referred By: Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 26 Yrs/F MRN-12003373 Lab No.-0662 Date: 2/18/2012


REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.26 mg/dl 0.11 0.15 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)

20.4

IU/I

0 - 42

(Method: IFCC Without Pyridoxal Phosphate))

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

26.0

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

231.0

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.0

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.08 2.95 1.05

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Pt. Location: OPD Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 69 Yrs/M MRN-12003373 Lab No.-0662 Date: 2/3/2012


REFERENCE RANGE

Serum Urea
Methodology- Urease- GLDH, Kinetic

47.8 4.16

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Raj Narayan Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 62 Yrs/M MRN-GN003096/2009 Lab No.-0662 Date: 2/24/2012


REFERENCE RANGE

Blood Sugar Fasting

132.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

141

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.5

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.8

mg/dl

0.70 - 1.30

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Raj Narayan Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 62 Yrs/M MRN-GN003096/2009 Lab No.-0662 Date: 2/24/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

7.6 %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months.

* Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Raj Narayan Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE
122

Age/Sex: 62 Yrs/M MRN-GN003096/2009 Lab No.-0662 Date: 2/24/2012


UNIT REFERENCE RANGE

Total Serum Cholesterol

mg/dl

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 74 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 52.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

54.66

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

14.88

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.32

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.04

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Bhupendra Nath Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 63 Yrs/M MRN-GN009393/2009 Lab No.-0662 Date: 2/24/2012


REFERENCE RANGE

Blood Sugar Fasting

127.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

148

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

29.64

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.59

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Bhupendra Nath Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 63 Yrs/M MRN-GN009393/2009 Lab No.-0662 Date: 2/24/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 6.6 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months.

* Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Bhupendra Nath Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 63 Yrs/M MRN-GN009393/2009 Lab No.-0662 Date: 2/24/2012


REFERENCE RANGE

Total Serum Cholesterol

86 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 82 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 36.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

32.47

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

16.42

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

2.33

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

0.88

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ram Bujharat Pt. Location: OPD Referred By: Dr.Alok Srivastava Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 47 Yrs/M MRN-GN009393 Lab No.-0665 Date: 2/25/2012


REFERENCE RANGE

Blood Sugar Random

73

mg/dl

70 - 140

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl

According to Amercian diabetes association, 2004

Serum Urea
Methodology- Urease- GLDH, Kinetic

43 0.77

mg/dl mg/dl mg/dl U/L U/L

13 - 43 0.70 - 1.30 2.5 6.8 28 - 100 13 - 60

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Uric Acid


(Method : Uricase-POD)

5.2
63 26

Serum Amylase Serum Lipase

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ram Bujharat Pt. Location: OPD Referred By: Dr.Alok Srivastava Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 47 Yrs/M MRN-GN009393 Lab No.-0665 Date: 2/25/2012


REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.49 mg/dl 0.13 mg/dl

0.30 - 1.20 0 - 0.20

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

0.36

mg/dl

0.08 - 0.75

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

31

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

26

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

195

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.60

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.53 3.11 1.13

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ram Bujharat Pt. Location: OPD Referred By: Dr.Alok Srivastava Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 47 Yrs/M MRN-GN009393 Lab No.-0665 Date: 2/25/2012


REFERENCE RANGE

Serum Calcium Ionized :

1.1

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Serum Sodium

132.0

mmol/l

135 - 145

Serum Potassium

4.1

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shahida Khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/F MRN-11031263 Lab No.-01 Date: 3/12/2012


REFERENCE RANGE

Blood Sugar Fasting

224.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

287

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

9.85 0.59

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shahida Khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/F MRN-11031263 Lab No.-01 Date: 3/12/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 10.3 %

EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shahida Khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/F MRN-11031263 Lab No.-01 Date: 3/12/2012


REFERENCE RANGE

Urine microalbumin Urine Microalbumin 30.3 mg/ L <20mg/L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 52 Yrs/F MRN-11002515 Lab No.-01 Date: 3/14/2012


REFERENCE RANGE

Blood Sugar Fasting

103.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

202

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

11.19 0.55

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Total Serum Cholesterol
(Method-CHOD-PAP 121 mg/dl

Age/Sex: 52 Yrs/F MRN-11002515 Lab No.-01 Date: 3/14/2012


UNIT REFERENCE RANGE

(Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 145 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 38.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

53.28

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

29.09

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.12

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

1.37

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 52 Yrs/F MRN-11002515 Lab No.-01 Date: 3/14/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 6.3 %

EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56 Yrs/M MRN-11002515 Lab No.-02 Date: 3/14/2012


REFERENCE RANGE

Blood Sugar Fasting

108.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

155

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

11.03 0.56

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE
Total Serum Cholesterol
(Method-CHOD-PAP 156 mg/dl

Age/Sex: 56 Yrs/M MRN-11002515 Lab No.-02 Date: 3/14/2012


UNIT REFERENCE RANGE

(Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 127 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 40.5 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

89.7

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

25.31

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.84

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.22

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56 Yrs/M MRN-11002515 Lab No.-02 Date: 3/14/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 6.6 %

EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 54 Yrs/M MRN-11029325 Lab No.-03 Date: 3/14/2012


REFERENCE RANGE

Blood Sugar Fasting

302.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

399

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.69

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 54 Yrs/M MRN-11029325 Lab No.-03 Date: 3/14/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 13.7 %

EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jitendra Srivastava Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 46 Yrs/M MRN-11016506 Lab No.-03 Date: 3/24/2012


REFERENCE RANGE

Blood Sugar Fasting

161.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

199

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.68

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Jitendra Srivastava Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 46 Yrs/M MRN-11016506 Lab No.-03 Date: 3/24/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 8.1 %

EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajendra Kumar Agrahari Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 39 Yrs/M MRN-12045 Lab No.-03 Date: 4/23/2012


REFERENCE RANGE

Blood Sugar Fasting


(Method: - GOD-POD)

124.0

mg/dl

70 - 110

(Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

214

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.02

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Rajendra Kumar Agrahari Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 39 Yrs/M MRN-12045 Lab No.-03 Date: 4/23/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 8.6 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: Yrs/M MRN-12001550 Lab No.-04 Date: 4/23/2012


REFERENCE RANGE

Blood Sugar Fasting

157.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

214

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.63

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: Yrs/M MRN-12001550 Lab No.-04 Date: 4/23/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.5 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Deepshikha Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: ... Yrs/F MRN-GN00202 Lab No.-0665 Date: 4/25/2012


REFERENCE RANGE

LIVER FUNCTION TEST

Total Serum Bilirubin


(Method: Walter And Gerarde)

0.38 0.11 0.27

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

22.9

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

27

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

125

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

7.61

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.55 3.05 1.49

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Deepshikha Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: ... Yrs/F MRN-GN00202 Lab No.-0665 Date: 4/25/2012


REFERENCE RANGE

Serum Urea
Methodology- Urease- GLDH, Kinetic

16 0.57

mg/dl mg/dl

13 - 43 0.50 - 1.20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Subroto Roy Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 42 Yrs/M MRN-24872 Lab No.-1 Date: 5/3/2012


REFERENCE RANGE

Blood Sugar Fasting

138.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

13.49

mg/dl

6 to 20

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.83

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Subroto Roy Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 42 Yrs/M MRN-24872 Lab No.-1 Date: 5/3/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.8 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Subroto Roy Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: 42 Yrs/M MRN-24872 Lab No.-1 Date: 5/3/2012


REFERENCE RANGE

Total Serum Cholesterol

236 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 118 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 66.2 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

146.43

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

23.6

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

3.57

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

2.21

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/M MRN-11029325 Lab No.-1 Date: 5/8/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 12.1 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/M MRN-11029325 Lab No.-1 Date: 5/8/2012


REFERENCE RANGE

Blood Urea Nitrogen


Method Urease GLDH Kinetic

9.24 0.7 168.0

mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 70 - 110

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Blood Sugar Fasting

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

256

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Vishnu Vijay Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/M MRN-11029325 Lab No.-1 Date: 5/8/2012


REFERENCE RANGE

Urine Microalbumin

65.7

mg/ L

<20mg/L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Jas Agarwal Pt. Location: MHC Referred By: Dr. Specimen: Blood Age/Sex: 56Yrs/M MRN-12004319 Lab No.-05 Date: 5/14/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

Blood Sugar Fasting

127.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

189

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.94

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Jas Agarwal Pt. Location: MHC Referred By: Dr. Specimen: Blood Age/Sex: 56Yrs/M MRN-12004319 Lab No.-05 Date: 5/14/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.0 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Krishna Agarwal Pt. Location: MHC Referred By: Dr. Specimen: Blood Age/Sex: 58Yrs/M MRN-11016777 Lab No.-05 Date: 5/16/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 9.6 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

13800

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.P.Pathak Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 79 Yrs/M MRN1 Lab No.-1 Date: 5/21/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

Blood Urea Nitrogen


Method Urease GLDH Kinetic

11.1 0.76 79.0

mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 70 - 110

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Blood Sugar Fasting

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Calcium
(Method: arsenazo III)

9.0 3.1

mg/dl mg/dl

8.4- 10.4 2.5 6.8

Serum Uric Acid


(Method : Uricase-POD)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium Serum Calcium Ionized :

132.0 4.4 1.09

mmol/l mmol/l mmol/l

135 - 145 3.5 - 5.5 1.12 1.32

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.P.Pathak Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 79 Yrs/M MRN1 Lab No.-1 Date: 5/21/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.40 mg/dl 0.16 0.24 mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

13.3

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

21.8

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

83

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.49

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.12 2.38 1.73

g/dl 1.74 g/dl 2.56 ratio

3.2 - 5.0 g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.S.P.Pathak Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 79 Yrs/M MRN1 Lab No.-1 Date: 5/21/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

5.6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-4760 Date: 5/21/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

7.2

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Shalini Bhalla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-4760 Date: 5/21/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

Blood Sugar Fasting

147.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

315.0

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Checked by..

(Dr. Shalini Bhlla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shamida khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/F MRN-100815 Lab No.-1 Date: 6/12/2012


REFERENCE RANGE

LIPID PROFILE
Total Serum Cholesterol
231 mg/dl

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl) Serum Triglycerides 191 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 45.8 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

146.78

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

38.28

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

5.04

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.21

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Shalini Bhalla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shamida khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 55 Yrs/F MRN-100815 Lab No.-1 Date: 6/12/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.3 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Shalini Bhalla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shamida khatoon Pt. Location: MHC Referred By: Dr. Specimen: Blood Age/Sex: 55 Yrs/F MRN-100815 Lab No.-1 Date: 6/12/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

Blood Urea Nitrogen


Method Urease GLDH Kinetic

20.42 0.72 117.0

mg/dl mg/dl mg/dl

6 to 20
0.70 - 1.30 70 - 110

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Blood Sugar Fasting

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

221

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Shalini Bhalla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 71 Yrs/M MRN-12001550 Lab No.-01 Date: 7/18/2012


REFERENCE RANGE

Blood Sugar Fasting

163.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

245.0

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

15.81 1.09

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 71 Yrs/M MRN-12001550 Lab No.-01 Date: 7/18/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.6 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Babu Ram Yadav Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 71 Yrs/M MRN-12001550 Lab No.-01 Date: 7/18/2012


REFERENCE RANGE

Urine microalbumin Urine Microalbumin 7.9 mg/ L <20mg/L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. M.A.Khan Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: Yrs/M MRN-12009019 Lab No.-01 Date: 7/27/2012


REFERENCE RANGE

Blood Sugar Fasting

127.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.61 0.77

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. M.A.Khan Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: Yrs/M MRN-12009019 Lab No.-01 Date: 7/27/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 6.4 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Brijesh Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: Yrs/M MRN-12004535 Lab No.-01 Date: 8/1/2012


REFERENCE RANGE

Blood Sugar Fasting

147.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

242

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.67

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Brijesh Singh Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: Yrs/M MRN-12004535 Lab No.-01 Date: 8/1/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 5.2 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-1 Date: 8/3/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.1

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-1 Date: 8/3/2012

PARAMETER

RESULT

UNIT

REFERENCE RANGE

Blood Sugar Fasting

153.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

243.0

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

6.08 0.59

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Shri Prakash Mishra Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 54 Yrs/M MRN:12001747 Lab No.-1 Date: 8/3/2012


REFERENCE RANGE

Urine microalbumin Urine Microalbumin 5.2 mg/ L <20mg/L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Age/Sex: 56 Yrs/M MRN:12004319 Lab No.-1 Date: 8/13/2012
UNIT REFERENCE RANGE

Unit: Biochemistry Name: Mr.Ramjas Agarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 6.9


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ramjas Agarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56 Yrs/M MRN:12004319 Lab No.-1 Date: 8/13/2012


REFERENCE RANGE

Blood Sugar Fasting

110.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

189.0

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

10.84 0.88

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ramjas Agarwal Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56 Yrs/M MRN:12004319 Lab No.-1 Date: 8/13/2012


REFERENCE RANGE

Urine microalbumin Urine Microalbumin 4.1 mg/ L <20mg/L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 57y/M

UNIT

Date: 20.8.2012 REFERENCE RANGE

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

0.27 0.05 0.22

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

27

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

18

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

83

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.58

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.14 2.45 1.69

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT CK-MB
Method- Immunoinhibition

Age/Sex:

57y/M

UNIT U/L

Date: 20.8.2012 REFERENCE RANGE 0-25

25.9

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.1 %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Serum Calcium
(Method: arsenazo III)

Age/Sex:

57y/M

UNIT mg/dl

Date: 20.8.2012 REFERENCE RANGE 8.4- 10.4

8.9

Serum Urea
Methodology- Urease- GLDH, Kinetic

19 0.8

mg/dl mg/dl

13 - 43 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized : Serum Sodium Serum Potassium

1.16 137.0 3.20

mmol/l mmol/l mmol/l

1.12 1.32 135 - 145 3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT CK-MB
Method- Immunoinhibition

Age/Sex:

57y/M

UNIT U/L

Date: 20.8.2012 REFERENCE RANGE 0-25

25.9

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.1 %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 57y/M

UNIT

Date: 20.8.2012 REFERENCE RANGE

LIVER FUNCTION TEST Total Serum Bilirubin


0.27 mg/dl 0.30 - 1.20

(Method: Walter And Gerarde)

Direct Serum Bilirubin


(Method: Walter And Gerarde)

0.05 0.22

mg/dl mg/dl

0 - 0.20 0.08 - 0.75

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

27

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

18

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

83

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.58

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.14 2.45 1.69

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.O.P.Srivastava Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 57y/M

UNIT

Date: 20.8.2012 REFERENCE RANGE

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

0.27 0.05 0.22

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

27

IU/I

0 - 42

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

18

IU/I

0 - 42

Serum Alkaline Phosphatase


(Method: ALP - AMP)

83

IU/I

42 - 128

Serum Total Protein


(Method: Biuret)

6.58

g/dl

6.0 - 8.3

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.14 2.45 1.69

g/dl

3.2 - 5.0

Serum Globulin A/G Ratio

1.74 g/dl 2.56 ratio

g/dl 2.0 - 3.5 2.0- 3.5 ratio >1

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Mini Srivastava Pt. Location: OPD Referred By: Self Specimen: food particles PARAMETER RESULT Age/Sex: 48y/F

UNIT

Date: 26.8.2012 REFERENCE RANGE

Gastric aspirate
Total Bilirubin
(Method: Walter And Gerarde)

1.00 0.68 0.32

mg/dl mg/dl mg/dl

0.30 - 1.20 0 - 0.20 0.08 - 0.75

Direct Bilirubin
(Method: Walter And Gerarde)

Indirect Bilirubin
(Method: Walter And Gerarde)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Ram Shankar Rathore Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: 50y/M MRN:11038556 Lab No.-1 Date: 04.09.2012 REFERENCE RANGE

UNIT

Blood Sugar Fasting

113.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

220.0

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

8.59 0.84

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Shalini Bhalla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Ram Shankar Rathore Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 50y/M MRN:11038556 Lab No.-1 Date: 04.09.2012


REFERENCE RANGE

Urine microalbumin Urine Microalbumin 20.6 mg/ L <20mg/L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods. Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Shalini Bhalla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Age/Sex: 50y/M MRN:11038556 Lab No.-1 Date: 04.09.2012
UNIT REFERENCE RANGE

Unit: Biochemistry Name: Mr.Ram Shankar Rathore Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.8 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Shalini Bhalla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 52 Yrs/F MRN-11002515 Lab No.-01 Date: 9/17/2012


REFERENCE RANGE

Blood Sugar Fasting

116.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

291

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.71

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Method- Modified Jaffe"s, no deproteinization

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs. Shalini Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 52 Yrs/F MRN-11002515 Lab No.-01 Date: 9/17/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 6.6 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56 Yrs/M MRN-11002513 Lab No.-02 Date: 9/17/2012


REFERENCE RANGE

Blood Sugar Fasting

107.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

169

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.75

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Method- Modified Jaffe"s, no deproteinization

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Girish Chandra Manchanda Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 56 Yrs/M MRN-11002513 Lab No.-02 Date: 9/17/2012


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 6.5 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Hon'ble Saharashri Ji Pt. Location: OPD Referred By: Dr. H.P.Kumar, MD Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 63 Yrs/M MRN-2009/008180 Lab No.-02/2012 Date:08/10/2012


REFERENCE RANGE

Serum Copper
(Method: 3,5-Di Br Paesa)

91.0

g/dl

70- 140

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Ram Teerath Verma Pt. Location: MHC Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 50 Yrs/M MRN-12023762 Lab No.-02 Date: 10/30/2012


REFERENCE RANGE

Blood Sugar Fasting

160.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

262

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.81

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Method- Modified Jaffe"s, no deproteinization

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Joysuna Verma Pt. Location: Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Date:

2/2/2013

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.7 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Blood Sugar Fasting

147.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Dr.B P Gupta Pt. Location: OPD Referred By: Self Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: 70 Yrs/M MRN-1301930 Lab No.BMA04861 Date: 1/21/2013


REFERENCE RANGE

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

1.38

mg/dl

0.70 - 1.30

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Method- Modified Jaffe"s, no deproteinization

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Joysuna Verma Pt. Location: Referred By: Dr. Specimen: Blood
PARAMETER RESULT UNIT

Date:

2/2/2013

REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 7.7 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr. Joysuna Verma Pt. Location: Referred By: Dr. Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Date:

2/2/2013

REFERENCE RANGE

Total Serum Cholesterol

256 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 501 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 36 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

219.8

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

100.1

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

7.2

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.4

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002)

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Lee Sashi Pt. Location: OPD Referred By: National Pathology(48732) Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: F Lab No.BMA04861 Date: 3/20/2013


REFERENCE RANGE

Serum Calcium Ionized :

1.22

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Inam Zahra Pt. Location: OPD Referred By: National Pathology(48745) Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex:F Lab No.BMA04862 Date: 3/20/2013


REFERENCE RANGE

Serum Calcium Ionized :

1.18

mmol/l

1.12 1.32

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Brijesh Singh Pt. Location: OPD Referred By: MHC Specimen: Blood PARAMETER RESULT Age/Sex: y/M MRN:12004535 Lab No.-204187 Date: 24.04.2013 REFERENCE RANGE

UNIT

Blood Sugar Fasting

115.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

140

mg/dl

70 - 140

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

6.57 0.89

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mr.Brijesh Singh Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT LIPID PROFILE UNIT

Age/Sex: y/M MRN:12004535 Lab No.-204187 Date: 24.04.2013


REFERENCE RANGE

Total Serum Cholesterol

156 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 170 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 25 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

96.2

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

34

mg/dl

10 to 40

Total Cholesterol/ Serum High Density


Lipoproteins Cholesterol Ratio

6.1

mg/dl

Less 4.5

Low Density Lipoproteins/High


Density Lipoproteins Cholesterol Ratio

3.8

mg/dl

Less 3.0

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Age/Sex: y/M MRN:12004535 Lab No.-204187 Date: 24.04.2013
RESULT UNIT REFERENCE RANGE

Unit: Biochemistry Name: Mr.Brijesh Singh Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) : 5.5 %


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mr.Brijesh Singh Pt. Location: OPD Referred By: MHC Specimen: Blood
PARAMETER RESULT UNIT

Age/Sex: y/M MRN:12004535 Lab No.-204187 Date: 24.04.2013


REFERENCE RANGE

Blood Sugar Fasting

111.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

According to Amercian diabetes association, 2004

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

15.7

IU/I

0 - 42

Blood Urea Nitrogen


Method Urease GLDH Kinetic

12.31 0.88

mg/dl mg/dl

6 to 20
0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Blood Sugar Post Prandial

313.4

mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Sugar Fasting

97.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Serum Urea
Methodology- Urease- GLDH, Kinetic

47.8 4.16

mg/dl mg/dl 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Sodium Serum Potassium

130.0 6.2

mmol/l mmol/l

135 - 145

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Total Serum Bilirubin


(Method: Walter And Gerarde)

LIVER FUNCTION TEST 0.44 0.10 0.34

mg/dl mg/dl mg/dl

0.30 - 1.20

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

0.08 - 0.75

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

14.5

IU/I

Serum Glutamic Oxaloacetate

Transminase(SGOT/AST)
(Method: IFCC Without Pyridoxal Phosphate))

19.8

IU/I

Serum Alkaline Phosphatase


(Method: ALP - AMP)

65.7

IU/I

Serum Total Protein


(Method: Biuret)

7.71

g/dl

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.39 3.32 1.32

g/dl 1.74 g/dl g/dl 2.56 ratio ratio 2.0- 3.5 >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant Checked by..

Serum Calcium
(Method: arsenazo III)

10.1

mg/dl mg/dl

8.4- 10.4

Serum Uric Acid


(Method : Uricase-POD)

5.2

NOTE : Above test carried out by EM 360 automated biochemistry analyzer.

Serum Calcium Ionized :

1.3

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Blood Urea Nitrogen


Method Urease GLDH Kinetic

16.9

mg/dl

LIPID PROFILE
Total Serum Cholesterol
159.7 mg/dl

(Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 112.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 21.2 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

115.9

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

22.58

mg/dl

Total Cholesterol/ Serum High Density

7.54 Lipoproteins Cholesterol Ratio

mg/dl

Low Density Lipoproteins/High

5.48 Density Lipoproteins Cholesterol Ratio

mg/dl

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Blood Sugar Random

359

mg/dl

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004 NOTE : Above test carried out by EM 360 automated biochemistry analyzer.

CK-MB
Method- Immunoinhibition

8.4

U/L

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 %

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

C.S.F C.S.F C.S.F

Protein Glucose Chloride

35.7 58.7 102 1.86 3.5

mg/dl mg/dl

nmol/l
mg/dl mg/dl

116 - 127

Magnesium

Phosphorus
(Method: phosphomolybdate UV

Serum LDH
Method: DGKC IFCC

392.5

U/I

Serum Amylase Serum Lipase

66 54.7

U/L U/L

Serum Calcium Ionized :

1.16

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Spot Urine Protein Spot Urine Creatinine

2.8 35

mg/dl mg/dl

Spot Urine Protein/Creatnine Ratio

0.8

Ratio

Magnesium

2.16

mg/dl

NOTE : Above test carried out by EM 360 automated biochemistry analyzer.

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 145

142 105 1.35

mg/dl mg/d mg/dl mg/d Ratio Ratio

115 210 55 135 0.91 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

68

apo-A1/apo-B Ratio

2.13

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD) Lipoprotein (LP-a)
(Method :Immunonephelometric assay (Values of Lp-a >0.3g/L are associated with two fold increase of MI. If both LDL and Lp-a are raised the risk of 10

mg/d

MI is increased five folds)

Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer.

Haptoglobin

0.639

g/L

Serum Haptoglobin is an acute phase reactant rises in response to stress,infection,acute inflammation and tissue necrosis. Levels increases after a hemolytic episode,which is dramatic following massive hemolytic episode in situations of hemolytic transfusion reaction,thermal burns,or autoimmune hemolytic anemia.It is also a useful measurement for serially monitoring patients who have a slow but steady rate of red cell breakdown such as by mechanical heart valves,,hemoglobinopathies,or exercise associated trauma Low Haptoglobin concentrations may be seen in liver diasese when hepatic synthetic capacity is impaired

Serum Glutamic Oxaloacetate

18

IU/I

Hemoglobin variant analysis by HPLC

Concentration Hb- F Hb A2

<0.8 % 2.70%

Reference Range in normal adult%HbA2: 1.5-3.5% %HbF: <1%

HbA2 estimation is principally used in the diagnosis of -thalassemia trait (Heterzygous -thalassemia), in which it is elevated up to 7%. Co-existence of - thalassemia trait with iron deficiency may show normal HbA2 levels. In this case, retesting should be performed after the iron deficiency is corrected. Similarly, if the individual with - thalassemia trait has coexisting

thalassemia, the increase in HbA2 might be dampened down and appear equivocal. Elevated HbF is also found in cases of Hereditary Persistence of Fetal Hemoglobin, homozygous and thalassemia. The Tests carried out on automated D-10,Bio-Rad HLC analyser

CK-MB
Method- Immunoinhibition

26.4 452

U/L U/L 38 - 174

CPK

Serum IRON

57.5

g/dl

Male Female

U.I.B.C T.I.B.C % Saturation

197.7 255.2 22.53

g/dl g/dl %

Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

Serum LDH

351 U/I

Method: DGKC

CPK

495

U/L

38 - 174

TROPONIN T (Qualitative

POSITIVE

A positive result means that the concentration of troponin T in the sample is above the tests threshold value of 0.1ng/ml .This is evidence of cell damage to the myocardium. *Test performed by Troponin T Rapid test from Roche Diagnostics GmbH.

Rheumatoid Factor(RF) Assay


Mehod-Immunonephalometric assay

8.0

IU/m

Note : Rheumatoid factor (RF) is an antibody directed against the Fe portion of the IgG molecule Rheumatoid factor is not specific for Rheumatoid arthritis and is often seen in cases of chronic infections and other systemic inflammatory conditions

Note :Test carried out by BN ProSpec Nephlometer fully automated analyzer.

URINARY PROTEIN (24 Hrs) Urinary protein (24 Hrs) 329.6 mg/day

*MINIMAL proteinuria (<1.0g/day) present in postural proteinuria and transient proteinuria.It is also
seen with inactive phase of glomerular disease ,nephrosclerosis,chronic interstitial nephritis,congenital diseases such as polycystic disease and medullary cystic disease ,and renal tubular diseases. *Moderate proteinuria (1.0-4.0 g/day) found in vast majority of renal diseases ,as well as nephrosclerosis,multiple myeloma,toxic nephropathies along with degenerative,malignant and inflammatory conditions of lower urinary tract. *Heavy proteinuria(>4 g/day) characteristically seen with the nephritic syndrome.

Blood Sugar Fasting

111

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

13 1.27

mg/dl mg/dl 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

8.6

mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

2.93

mg/dl

Serum Uric Acid


(Method : Uricase-POD)

3.98

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.13

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Serum Albumin Peritoneal fluid Albumin Serum ascites albumin gradient

1.8g/dl 0.7 g/dl 1.1g/dl

g/dl g/dl g/dl Transudates >1.1g/dl Exudates<1.1g/dl

Peritoneal fluid Glucose

85

mg/dl

*The serum ascitis albumin gradient ,defind as the serum albumin concentration minus ascetic fluid albumin concentration is widely considered as the most reliable method to differentiate peritoneal transudates from exudates .Transudates has gradient >1.1g/dl while exudates has gradient < 1.1g/dl. *Recent study have found decreased glucose levels in most cases of tubercular ascites and about 50% of patients with abdominal carcinomatosis.Nevertheless ,glucose measurement are of little value since the sensitivity and specificity are generally too low to be of practical value.

High-Sensitivity C Reactive Protein (hs-CRP) :

2.4

mg/l

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions *Recent studies have established that individuals with higher base line levels of plasma CRP are at increased risk for CHD and stroke.

Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

C reactive protein(C.R.P)

23.1

mg/L

*CRP is an acute phase reactant appeared in plasma during many infectious or inflammatory conditions CRP assay provides useful information for the diagnosis,therapy and monitoring of inflammatory processes and associated diseases. Increase in CRP values are non specific and should not be interpreted without a complete clinical history.
Note : above test carried out by BN ProSpec Nephlometer Automated Analyzer .

Urine microalbumin Urine Microalbumin 225.4 mg/ L

Microalbuminuria is the presence of albumin in the urine above the normal levels bu below the detectable range of conventional methods.

Urine albumin levels from 20-200 mg/L are an indicator of early or possibly reversible glomerular damage.In diabetic patients ,microalbulinemia is associated with a four to six fold increase in cardiovascular mortality,and an independent risk factor for renal mortality.It is also more prevelant in hypertensive subjects Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

CERULOPLASMIN

CERULOPLASMIN

25.1

mg/dl

Ceruloplasmin ,a late acute phase reactant is the prinicipal Copper containing protein of plasma.The most important clinical application of Ceruloplasmin is in the diagnosis of Wilsons disease,where typically concentration of Ceruloplasmin are reduced.Low levels of Ceruloplasmin may also be found in malnutrition,malabsorption,nephrosis and severe liver disese
Note :Test carried out by BN ProSpec Nephlometer fully automated analyzer

URINARY PROTEIN (24 Hrs)


Total Urinary Volume 2550ml 11.5 Liter

Urinary protein (24 Hrs)

3434.8

mg/day

*MINIMAL proteinuria (<1.0g/day) present in postural proteinuria and transient proteinuria.It is also
seen with inactive phase of glomerular disease ,nephrosclerosis,chronic interstitial nephritis,congenital diseases such as polycystic disease and medullary cystic disease ,and renal tubular diseases. *Moderate proteinuria (1.0-4.0 g/day) found in vast majority of renal diseases ,as well as nephrosclerosis,multiple myeloma,toxic nephropathies along with degenerative,malignant and inflammatory conditions of lower urinary tract.

*Heavy proteinuria(>4 g/day) characteristically seen with the nephritic syndrome. URINARY CREATININE(24 Hrs) Urinary Creatinine (24 Hrs) 413.8 mg/day

M :- 1000-2000 mg/da F :- 800-1800 mg/day

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Homocysteine (HCY)

mol/L

Homocysteine is an amino acid derived from methionine ,requiring ,vitamin B6 ,vitamin B12 and folic acid for further metabolizing.Mutation of the gene coding for homocysteine metabolism ,e.g.MTHFR ,result in hyperhomocysteinemia.Deficiency of folic acid ,vitamin B6,vitamin B12 are associated with increased plasma levels of homocysteine. Hyperhomocysteinemia is found to be associated with an increased risk for ischemic heart disease,stroke,peripherial arterial disease, and deep vein thrombosis,as well as neural tube defect and preeclampsia of pregnancy.An increased frequency of hyperhomocysteinemia is observed especially in elderly,smokers,patients with renal disease,diabetes ,or on a strict vegetarian diet

Anti-Streptolysin O(ASL)

IU/ml

Quantitative determination of Anti-Streptolysin O (ASL) provides valuable information regarding post streptococcal infection (rheumatic fever,scarlet fever ,tonsillitis,glomerulonephritis,etc. As upper limit of the reference interval 200 IU/ml is accepted internationally ,however ASL concentration depends upon the age of the patients,on the geographical location,and on the local frequency of streptoicoccal infections.Since an individual result provides no information about a change of the ASL concentration ,an appropriate assessment is only possible if the assay is repeated after 1 or 2 week. Vanillylmandelic acid (VMA),Urine Volume,24 Hrs urine 10.7 2250 mg/24 hrs ml/24 hrs

Metanephrine,urine

128

g/24 hrs

*VMA is the end product of both adrenaline (epinephrine) & noradrenaline (norepinephrine) catabolism and reflect catecholamine production by chromaffin cells of the adrenal medulla and sympathetic nervous system.Quantitation of urinary VMA is valuable in the diagnosis and follow up of patients with Pheochromocytoma and related neurogenic tumors(Neuroblastoma,ganglioblastoma) *Metanephrine are metabolites of catecholamines and include metanephrine and normetanephrine .urine metanephrine determination is considered to be the most accurate single screening method for pheochromocytoma .Further ,in suspected cases of Pheochromocytoma ,where VMA and catecholamines are normal determination of urnary metanephrine is advisable.

SOLUBLE TRANSFERRIN RECEPTOR (sTfR)


sTfR 1.26 mg/L 0.76-1.76 mg/L

* Transferrin receptor (TRs) also exist in a soluble form in the circulation.Iron deficiency causes rise in the levels of soluble TRs,which is proportional to the extent of iron deficiency in the tissue(= functional iron deficiency).Soluble TRs are usually not increased in anemia of chronic disease.Soluble TRs also vary with the rate of erythropoiesis .Its level is lower in patients with aplastic anemia,while patients with hemolytic anemia have higher values

Note :Test carried out by BN ProSpec Nephlometer fully automated analyzer

URINARY CALCIUM(24 Hrs) Urinary Calcium (24 Hrs) 249.6 mg/day

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

GLUCOSE CHALLENGE TEST


Plasma glucose
(After 50 gram of glucose)

103

InterpretationIt is an initial screening test for Average risk women for the early diagnosis of Gestational diabetes mellitus.

1-h plasma glucose level (after 50-g glucose load) >130 mg/dl >140 mg/dl

Detection of Gestational diabetes 90% 80%

*( According to American diabetes Association ,2004 b) Pleural fluid Protein Pleural fluid albumin Serum pleural fluid albumin gradient Pleural fluid Glucose Pleural fluid lactate dehydrogenase(LDH) Pleural fluid /serum protein ratio Pleural fluid /serum LDH ratio 0.5 Ratio 3.6 1.94 g/dl g/dl

1.14 145

g/dl mg/dl

117

U/L

Ratio

*Laboratory criteria for pleural fluid exudate (Light 1997)

Pleural fluid/serum protein ratio 0.50;(2) Pleural fluid serum LD ratio 0.60;(3)Pleural fluid LD 2/3 upper limit of normal serum LD;(3)Pleural fluid cholesterol >45 mg/dl;(4) Pleural fluid serum cholesterol ratio 0.30;(5)Serum- pleural fluid protein gradient 1.2 g/dl (5)Pleural fluid serum bilirubin ratio 0.60

ADENOSINE DEAMINASE ADA (Pleural Fluid ) 38.6 U/L

Comments- ADA is particularly abundant in T lymphocytes,which is increased in


tuberculosis.Its measurement hs been recommended in the diagnosis of pleural,peritoneal & meningeal tuberculosis ADA levels greater than 15 U/L was found to be a strong indicator of tubercular meningitis.Cut off value for tubercular peritonitis and tubercular pericarditis is 30 U/L .For tubercular pleuritis the value is 40 U/L. g/dl

SERUM IRON

33.7

Male Female

U.I.B.C T.I.B.C % Saturation

201.1 234.8 14.35

g/dl g/dl %

Iron is transported as Fe(111) bound to the plasma protein apotransferrin.Normally only about one third of the iron binding sites of transferrin are occupied by Fe(111).The additional amount of iron that can be bound is the unsaturated iron binding capacity (UIBC). The sum of the serum iron and UIBC represents TIBC.TIBC is a measurement for the maximum iron concentration that transferrin can bind. The serum TIBC varies in disorders of iron metabolism .In iron dediciency anemia the TIBC is elevated and the transferring saturation is lowered to 15% or less. Low serum iron associated with low TIBC is characteristic of the anemia of chronic disorders,malignant tumors,and infections. Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

Ammonia
(Method: Enzymatic)

56.5

mol/l

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

. Gamma Glutayml Transpeptidase (GGT) :

858.7

92

IU/l U/L

11 - 50 10-7I

URINARY CREATININE(24 Hrs)

Total Urinary Volume - 11.5 Liter

Urinary Creatinine (24 Hrs)

0.76

g/day

URINARY PROTEIN (24 Hrs)


Total Urinary Volume 1.2 LITER 11.5 Liter

Urinary protein (24 Hrs)

484.8

mg/day

*MINIMAL proteinuria (<1.0g/day) present in postural proteinuria and transient proteinuria.It is also

seen with inactive phase of glomerular disease ,nephrosclerosis,chronic interstitial nephritis,congenital diseases such as polycystic disease and medullary cystic disease ,and renal tubular diseases. *Moderate proteinuria (1.0-4.0 g/day) found in vast majority of renal diseases ,as well as nephrosclerosis,multiple myeloma,toxic nephropathies along with degenerative,malignant and inflammatory conditions of lower urinary tract. *Heavy proteinuria(>4 g/day) characteristically seen with the nephritic syndrome.

URINARY CREATININE(24 Hrs) Urinary Creatinine (24 Hrs) 5200 mg/day

M :- 1000-2000 mg/day F :- 800-1800 mg/day

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
UNIT : BIOCHEMISTRY Name: Mrs. Nupur Soni Pt. Location: OPD Referred By: Dr. Manjusha Specimen: Blood Tra. No - 5584 PARAMETER RESULT

Age/Sex: MRN:SH/LKO/0005075/08 Lab No.:B-/06/856 Date: UNIT REFERENCE RANG

DEPARTMENT OF PATHOLOGY

Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER RESULT

Tr.No-6826
UNIT

Age/Sex: MRN:006523/08/09 Lab No.:B-0/07/1206 Date:


REFERENCE RANGE

Blood Sugar Fasting

87.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Urea Nitrogen


Method Urease GLDH Kinetic

8.23 0.69

mg/dl mg/dl mg/dl 0.70 - 1.30

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Phosphorus
(Method: phosphomolybdate UV

3.28
9.39

Serum Calcium
(Method: arsenazo III)

mg/dl mg/dl

8.4- 10.4

Serum Uric Acid


(Method : Uricase-POD)

6.35

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.24

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER RESULT

Tr.No-6826
UNIT mg/dl mg/dl mg/dl

Age/Sex: MRN:006523/08/09 Lab No.:B-0/07/1206 Date:


REFERENCE RANGE 0.30 - 1.20

LIVER FUNCTION TEST Total Serum Bilirubin


(Method: Walter And Gerarde)

0.91 0.17 0.74

Direct Serum Bilirubin


(Method: Walter And Gerarde)

Indirect Serum Bilirubin


(Method: Walter And Gerarde)

0.08 - 0.75

Serum Glutamic Pyruvic Transminase(SGPT/ALT)


(Method: IFCC Without Pyridoxal Phosphate))

25.5

IU/I

Serum Glutamic Oxaloacetate Transminase(SGOT/AST)


(Method: IFCC Without Pyridoxal Phosphate))

26.6

IU/I

Serum Alkaline Phosphatase


(Method: ALP - AMP)

97.4

IU/I

Serum Total Protein


(Method: Biuret)

7.46

g/dl

Serum Albumin
(Method: Bromo Cresol Green BCG))

4.36 3.1 1.41

g/dl 1.74 g/dl g/dl 2.56 ratio ratio 2.0- 3.5 >1

Serum Globulin A/G Ratio

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer. (Dr. Anju Shukla, MD) Associate Consultant

Checked by..

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER
Total Serum Cholesterol

Tr.No-6826
UNIT

Age/Sex: MRN:006523/08/09 Lab No.:B-0/07/1206 Date:


REFERENCE RANGE

RESULT

159.7 mg/dl (Method-CHOD-PAP (Desirable <200 mg/dl; Borderline High 200 239 mg/dl; High 240 mg/dl)

Serum Triglycerides 112.9 mg/dl (Method-GPO-PAP) (Desirable <150 mg/dl;Borderline High 150 199 mg/dl; High 200 - 499 mg/dl;Very High 500 mg/dl) Serum High Density Lipoprotein Cholesterol (HDL-C) : 21.2 mg/dl

(Method-,Immunoinhibition
(Low <40 mg/dl ;High 60 mg/dl)

Serum Low Density

115.9

mg/dl

Lipoprotein Cholesterol (LDL-C) :


(Method-Direct enzymaticCHE&CO) (<100 optimal, 100 129 near optimal/ above optimal; 130 -159 mg/dl Border line High; 160 -189 mg/dl High, 190= very high)

Serum Very Low Density


Lipoprotein Cholesterol (VLDL-C) :

22.58

mg/dl

Total Cholesterol/ Serum High Density

7.54 Lipoproteins Cholesterol Ratio

mg/dl

Low Density Lipoproteins/High

5.48 Density Lipoproteins Cholesterol Ratio

mg/dl

Reference ranges are according to ATP III (Adult Treatment Panel 3), based on third report of the National Cholesterol Education Programmed (NCEP, 2002) Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER RESULT

Tr.No-6826
UNIT

Age/Sex: MRN:006523/08/09 Lab No.:B-0/07/1206 Date:


REFERENCE RANGE

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C )


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

5.5%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods

*ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

DEPARTMENT OF PATHOLOGY
Unit: Biochemistry Name: Mrs.Mary Ghosh Hazra Pt. Location: OPD Referred By: Dr.S.K.Singh Specimen: Blood
PARAMETER ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)
(Method :Immunonephelometric assay) 145

Tr.No-6826
UNIT

Age/Sex: MRN:006523/08/09 Lab No.:B-0/07/1206 Date:


REFERENCE RANGE

RESULT

142 105 1.35

mg/dl mg/d mg/dl mg/d Ratio Ratio

115 210 55 135 0.91 2.63

Apolipoprotein B (Apo-B)
(Method :Immunonephelometric assay)

68

apo-A1/apo-B Ratio

2.13

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Serum Calcium
(Method: arsenazo III)

8.3

mg/dl

8.4- 10.4

Blood Urea Nitrogen


Method Urease GLDH Kinetic

61.68

mg/dl

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

8.23

mg/dl

0.70 - 1.30

Phosphorus
(Method: phosphomolybdate UV

6.08

mg/dl

Serum Albumin
(Method: Bromo Cresol Green BCG))

3.9

g/dl

3.2 - 5.0

Serum Alkaline Phosphatase


(Method: ALP - AMP)

89 139.0

IU/I mmol/l

42 - 128 135 - 145

Serum Sodium

Serum Potassium

4.50

mmol/l

3.5 - 5.5

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Pree HD

Blood Sugar Post Prandial

313.4

mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Sugar Fasting

97.0

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Random

359

mg/dl

70 - 140

(Method: - GOD-POD) (Normal 140mg/dl, Impaired glucose tolerance 140-199 mg/dl, Diabetes mellitus 200mg/dl According to Amercian diabetes association, 2004

Ascitic fluid Albumin Ascitic fluid Protein Serum Ascitic fluid albumin gradient

1.81 3.82

g/dl g/dl

>3.0 g/dl -Exudate

0.93

g/dl

Ascitic fluid Glucose Ascitic fluid Amylase

81.9 177.2

mg/dl U/L

60-160 mg/dl -Norm

*Laboratory criteria for Ascitic fluid exudate (Light 1997) Ascitic fluid/serum protein ratio 0.50;(2) Ascitic fluid serum LD ratio 0.60;(3)Pleural fluid LD 2/3 upper limit of normal serum LD;(3)Ascitic fluid cholesterol >45 mg/dl;(4) Ascitic fluid serum cholesterol ratio 0.30;(5)Serum- Ascitic fluid protein gradient 1.2 g/dl (5)Ascitic fluid serum bilirubin ratio 0.60

G-6-PD 263.89 (Glucose -6-Phosphate Dehydrogenase)

mU/10

Interference:Reticulocytes have higher G-6-PDH levels than mature red cells.Therfore ,it is not recommended that this assay be performed after a severe hemolytic crisis ,since G6-PDH levels may appear falsely elevated .Testing may be more helpful after the level of mature red cells have retured to normal.

ADA (Ascitic fluid )

7.4

U/L

Comments - ADA is particularly abundant in T lymphocytes,which is increased in


tuberculosis.Its measurement hs been recommended in the diagnosis of pleural,peritoneal & meningeal tuberculosis ADA levels greater than 15 U/L was found to be a strong indicator of tubercular meningitis.Cut off value for tubercular peritonitis and tubercular pericarditis is 30 U/L .For tubercular pleuritis the value is 40 U/L.

Ascitic fluid Protein Ascitic fluid Albumin

6.46

g/dl g/dl

<3.0 g/dl -Transudat

Ascitic fluid Glucose

79.6

mg/dl

60-160 mg/dl -Norm

STONE ANALYSIS
Chemically the stone consists of following
Calcium (Stone) Oxalate (Stone) Uric acid (stone)

+++ +++ ++

FDP (D-Dimer) (Quantitative)

12.06 <0.5g fibrinogen <0.5g equivalent fibrinogen unit/ml equivalent unit/ml (g FEU/ml)

D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Blood Sugar Fasting

95

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

313.4

mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

7.2 0.69 8.7 3.25

mg/dl mg/dl mg/dl mg/dl 0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

Serum Uric Acid


(Method : Uricase-POD)

7.92

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.1

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

D-Dimer (Quantitative)

5.02

<0.5g fibrinogen equivalent unit/ml (g FEU/ml)

D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

FDP (D-Dimer) (Quantitative)

1.14<0.5g fibrinogen <0.5g equivalent fibrinogen unit/ml equivalent unit/ml (g FEU/ml)

D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 1 hour plasma glucose 2 hour plasma glucose 2 hour plasma glucose 79.8 97.2 90.6 90.6 mg/dl mg/dl mg/dl mg/dl

*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Serum Copper
(Method: 3,5-Di Br Paesa)

91.0

g/dl

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 %

6.4%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended. * Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Blood Sugar Fasting

95

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

313.4

mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

7.2 0.69 8.7 3.25

mg/dl mg/dl mg/dl mg/dl 0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

Serum Uric Acid


(Method : Uricase-POD)

7.92

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.1

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

D-Dimer (Quantitative)

5.02

<0.5g fibrinogen equivalent unit/ml (g FEU/ml)

D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

FDP (D-Dimer) (Quantitative)

1.14<0.5g fibrinogen <0.5g equivalent fibrinogen unit/ml equivalent unit/ml (g FEU/ml)

D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

. Gamma Glutayml Transpeptidase (GGT) :

858.7

92

IU/l U/L

11 - 50 10-7I

ORAL GLUCOSE TOLERANACE TEST G.T.T (after 100 gram of glucose) Fasting plasma glucose 79.8 mg/dl

1 hour plasma glucose 2 hour plasma glucose 2 hour plasma glucose

97.2 90.6 90.6

mg/dl mg/dl mg/dl

*Gestational diabetes mellitus diagnosed if 2 plasma glucose levels are exceeded (American Diabetes Association ,2004b).

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

70 - 140

70 - 110

13 - 43 0.70 - 1.30

135 - 145 3.5 - 5.5

0.30 - 1.20 0 - 0.20 0.08 - 0.75

0 - 42

0 - 42

42 - 128

6.0 - 8.3

3.2 - 5.0 2.0 - 3.5

(Dr. Anju Shukla, MD) Associate Consultant

8.4- 10.4 2.5 6.8

1.12 1.32

6 to 20

High 500 mg/dl)

10 to 40

Less 4.5

Less 3.0

hird report of the National

Anju Shukla, MD) ssociate Consultant

70 - 140

s 200mg/dl

0-25

he past 2-4 months.

ople with diabetes mellitus. by NGSP certified methods

n patients meeting treatment when patients are not meeting

lications such as retinopathy,

15 - 45 40 - 80 116 - 127 1.7 - 2.5

2.5 - 4.5

135 - 225

28 - 100 13 - 60

1.12 1.32

1.7 - 2.5

115 210 55 135 0.91 2.63

Less than 30

aised the risk of

mated Analyzer.

0.3 to 2.0

0 - 42

-thalassemia), in which it is

n this case, retesting should be semia trait has coexisting

zygous and thalassemia. The

0-25 38 - 174

59 - 158 37-145

112 - 346

250 - 450 13 - 45

only about one third of the iron that can be bound is the

the maximum iron the TIBC is elevated and the

c disorders,malignant

(Dr. Anju Shukla, MD) Associate Consultant

38 - 174

< 15.0

IgG molecule s of chronic infections and other

40-150 mg/day

ansient proteinuria.It is also nephritis,congenital diseases

eases ,as well as lignant and inflammatory

70 - 110

6 to 20
0.70 - 1.30

8.4- 10.4

2.5 - 4.5
2.5 6.8

ochemistry analyzer.

1.12 1.32

Anju Shukla, MD) ssociate Consultant

Transudates >1.1g/dl Exudates<1.1g/dl

minus ascetic fluid albumin toneal transudates from

tes and about 50% of patients ue since the sensitivity and

Less than 3

flammatory conditions

asma CRP

less than 3

flammatory conditions f inflammatory processes

omplete clinical history.

<20mg/L

20-60

ining protein of he diagnosis of duced.Low levels rosis and severe

40-150 mg/day

t proteinuria.It is also nephritis,congenital diseases

s well as lignant and inflammatory

M :- 1000-2000 mg/day F :- 800-1800 mg/day

5-15 mol/L

up to 200 IU/ml

0.00 to 13.60

25-312

inephrine) catabolism and mpathetic nervous patients with

ormetanephrine .urine method for A and catecholamines are

0.76-1.76 mg/L

ses rise in the levels of soluble ency).Soluble TRs are usually not ts level is lower in patients with

100 -240 mg/day

(Dr. Anju Shukla, MD) Associate Consultant

tational diabetes mellitus.

<3.0 g/dl -Transudate >3.0 g/dl -Exudate

1.2g/dl- Exudate 60-160 mg/dl -Normal

> 300 U/L- Exudate

>0.5-- Exudate

>0.6 -Exudate

0;(3)Pleural fluid LD 2/3 ural fluid serum cholesterol serum bilirubin ratio 0.60

< 40

increased in pleural,peritoneal

ditis is 30 U/L

59 - 158 37-145 112 - 346 250 - 450 13 - 45

only about one third of the iron that can be bound is the

the maximum iron the TIBC is elevated and the

c disorders,malignant

(Dr. Anju Shukla, MD) Associate Consultant

Male 16 - 60 Female 11- 51

1-2 g/day

40-150 mg/day

ansient proteinuria.It is also

nephritis,congenital diseases

eases ,as well as lignant and inflammatory

M :- 1000-2000 mg/day F :- 800-1800 mg/day

(Dr. Anju Shukla, MD) Associate Consultant

Y
27y/F MRN:SH/LKO/0005075/08/09 Lab No.:B-/06/856 17.6.2009 REFERENCE RANGE

46y/F MRN:006523/08/09 Lab No.:B-0/07/1206 23/7/2009


REFERENCE RANGE

70 - 110

6 to 20
0.70 - 1.30

2.5 - 4.5
8.4- 10.4 2.5 6.8

1.12 1.32

Anju Shukla, MD) ssociate Consultant

46y/F MRN:006523/08/09 Lab No.:B-0/07/1206 23/7/2009


REFERENCE RANGE 0.30 - 1.20 0 - 0.20 0.08 - 0.75

0 - 42

0 - 42

42 - 128

6.0 - 8.3

3.2 - 5.0 2.0 - 3.5

(Dr. Anju Shukla, MD) Associate Consultant

46y/F MRN:006523/08/09 Lab No.:B-0/07/1206 23/7/2009


REFERENCE RANGE

High 500 mg/dl)

10 to 40

Less 4.5

Less 3.0

hird report of the National

Anju Shukla, MD) ssociate Consultant

46y/F MRN:006523/08/09 Lab No.:B-0/07/1206 23/7/2009


REFERENCE RANGE

he past 2-4 months.

ople with diabetes mellitus. by NGSP certified methods

n patients meeting treatment when patients are not meeting

lications such as retinopathy,

Anju Shukla, MD) ssociate Consultant

46y/F MRN:006523/08/09 Lab No.:B-0/07/1206 23/7/2009


REFERENCE RANGE

115 210 55 135 0.91 2.63

Anju Shukla, MD) ssociate Consultant

8.4- 10.4

6 to 20

0.70 - 1.30

2.5 - 4.5

3.2 - 5.0

42 - 128 135 - 145

3.5 - 5.5

(Dr. Anju Shukla, MD) Associate Consultant

70 - 140

70 - 110

70 - 140

s 200mg/dl

>3.0 g/dl -Exudate >3.0 g/dl -Exudate

1.2g/dl- Exudate

60-160 mg/dl -Normal

(3)Pleural fluid LD 2/3 itic fluid serum cholesterol erum bilirubin ratio 0.60

245-299

< 40

increased in

pleural,peritoneal

rditis is 30 U/L

<3.0 g/dl -Transudate >3.0 g/dl -Exudate

60-160 mg/dl -Normal

nogen equivalent unit/ml (g FEU/ml)

(Dr. Anju Shukla, MD) Associate Consultant

70 - 110

70 - 140

6 to 20
0.70 - 1.30 8.4- 10.4

2.5 - 4.5

2.5 6.8

ochemistry analyzer.

1.12 1.32

Anju Shukla, MD) ssociate Consultant

nogen equivalent unit/ml (g FEU/ml)

nogen equivalent unit/ml (g FEU/ml)

95 180 155 140

(Dr. Anju Shukla, MD) Associate Consultant

70- 140

he past 2-4 months.

ople with diabetes mellitus. by NGSP certified methods

n patients meeting treatment when patients are not meeting

lications such as retinopathy,

Anju Shukla, MD) ssociate Consultant

70 - 110

70 - 140

6 to 20
0.70 - 1.30 8.4- 10.4

2.5 - 4.5

2.5 6.8

ochemistry analyzer.

1.12 1.32

Anju Shukla, MD) ssociate Consultant

nogen equivalent unit/ml (g FEU/ml)

nogen equivalent unit/ml (g FEU/ml)

95

180 155 140

(Dr. Anju Shukla, MD) Associate Consultant

Blood Sugar Fasting

95

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

7.2

mg/dl

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

0.69

mg/dl

0.70 - 1.30

Serum Calcium
(Method: arsenazo III)

8.7

mg/dl

8.4- 10.4

Phosphorus
(Method: phosphomolybdate UV

3.25

mg/dl

Serum Uric Acid


(Method : Uricase-POD)

7.92

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.1

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )
Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

ApolipoProtein Estimation Apolipoprotein A1 (Apo-A1)


(Method :Immunonephelometric assay) 145

142 105

mg/dl mg/d mg/dl mg/d

115 210 55 135

Apolipoprotein B (Apo-B)

68

(Method :Immunonephelometric assay)

apo-A1/apo-B Ratio

2.13

1.35

Ratio Ratio

0.91 2.63

( Elevation of apo B (present in chylomicrons, VLDL, HDL and LDL), decrease in apo A-1 (present mostly in HDL), and decrease in the apo A -1/apo B ratio have been associated with increased risk of CHD)

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

GLYCOSYLATED HAEMOGLOBIN ESTIMATION BY (HPLC)

Glycosylated Haemoglobin (HbA 1C ) :


EXPECTED VALUES : Hemoglobin >8 <7 4 -- 6

8.6 %

6.4%

A 1C

(%)

Degree of Glucose Control Action Suggested Goal Non-diabetic Level

* Glycosylated Hemoglobin provides an index of the average blood glucose over the past 2-4 months. * Measurement of GHb, is effective in monitoring long-term glucose control in people with diabetes mellitus. ADA states that the goal of treatment should be to maintain HbA1C less than 7% by NGSP certified methods *ADA recommends that GHb should be routinely monitored at least twice a year in patients meeting treatment goals (and who have stable glycemic control). In certain clinical situations, such as when patients are not meeting treatment goals on when therapy has changed, monitoring every 3 months is recommended.

* Patients with high HbA1c values are at a high risk of developing long term complications such as retinopathy, nephropathy, neuropathy and cardiovascular complications

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

Blood Sugar Fasting

95

mg/dl

70 - 110

(Method: - GOD-POD) (Normal 100mg/dl, Impaired Fasting glucose 100-125 mg/dl, Diabetes mellitus 126mg/dl

Blood Sugar Post Prandial

313.4

mg/dl

Method-GOD-POD (Normal<140mg/dl,Impaired glucose tolerance140-199 mg/dl,Diabetes mellitus>200 mg/dl) According to Amercian diabetes association, 2004

Blood Urea Nitrogen


Method Urease GLDH Kinetic

7.2 0.69 8.7 3.25

mg/dl mg/dl mg/dl mg/dl 0.70 - 1.30 8.4- 10.4

Serum Creatinine
Method- Modified Jaffe"s, no deproteinization

Serum Calcium
(Method: arsenazo III)

Phosphorus
(Method: phosphomolybdate UV

Serum Uric Acid


(Method : Uricase-POD)

7.92

mg/dl

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

Serum Calcium Ionized :

1.1

mmol/l

(Method: ISE above test carried out by Eschweiler combiline electrolyte analyzer )

Checked by..

(Dr. Anju Shukla, MD) Associate Consultant

D-Dimer (Quantitative)

5.02

<0.5g fibrinogen equivalent unit/ml (g FEU/ml)

D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

FDP (D-Dimer) (Quantitative)

1.14<0.5g fibrinogen <0.5g equivalent fibrinogen unit/ml equivalent unit/ml (g FEU/ml)

D-Dimer measure cross linked FDP,is a very sensitive marker for the activation of coagulation.Apart from DVT,PE,and DIC,D-Dimer may reflect other causes associated with fibrin formation such as trauma, pregnancy complication, malignant disease or vascular abnormalities.Elevated D-Dimer levels therefore have to be interpreted in the context of possible underlying diseases and clinical symptoms.

Note : Above test carried out by Cobas Integra 400 plus Automated Biochemistry analyzer.

70 - 110

6 to 20

0.70 - 1.30

8.4- 10.4

2.5 - 4.5
2.5 6.8

ochemistry analyzer.

1.12 1.32

Anju Shukla, MD) ssociate Consultant

115 210 55 135

0.91 2.63

Anju Shukla, MD) ssociate Consultant

he past 2-4 months.

ople with diabetes mellitus. by NGSP certified methods

n patients meeting treatment when patients are not meeting

lications such as retinopathy,

Anju Shukla, MD) ssociate Consultant

70 - 110

70 - 140

6 to 20
0.70 - 1.30 8.4- 10.4

2.5 - 4.5

2.5 6.8

ochemistry analyzer.

1.12 1.32

Anju Shukla, MD) ssociate Consultant

nogen equivalent unit/ml (g FEU/ml)

nogen equivalent unit/ml (g FEU/ml)

You might also like